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INTRODUCTION 
AND STUDy OBjECTIvES
Nattharee Chanchareonsook
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Introduction
Hard and soft tissue reconstruction in the oral and maxillofacial region due 
to trauma, tumor surgery or congenital deformities remains a challenge for 
reconstructive surgeons. The current preferred treatment includes the use of 
vascularized bone grafts, such as pedicled grafts or microvascular free grafts. This 
even extends to the use of computer-assisted modeling to preoperatively design the 
tumor resection and contour the microvascular free flap reconstruction by using a 
customized template. However, the current techniques have inherent disadvantages 
of donor site morbidity, risk of infection or non-acceptance of the flap as well as a 
prolonged healing and waiting time before dental rehabilitation can begin.1 
This thesis aims to investigate novel methods of oral and maxillofacial bone 
reconstruction that may potentially avoid the need to harvest bone from a 
donor site.
Endoprosthesis
The use of an endoprosthesis for mandibular reconstruction in animal models has 
been recently described in the literature.2-6  This device is based on the same principle 
as the modular endoprosthesis in orthopedic surgery for the reconstruction of long 
bones. 
In orthopedics, the metallic modular endoprostheses for skeletal reconstruction 
in limb-sparing surgery was first introduced in the mid 1980s. The term “modular” 
means that the device is prefabricated of different components with various sizes, 
which can be easily assembled together during surgery. This provides an element of 
expandability and flexibility and permits a significant reduction in manufacturing 
costs. Bickels et al., reported in a long term follow-up study that a femoral 
endoprosthetic reconstruction is a safe and reliable technique of functional limb 
sparing.7 The implant survival rate of custom proximal femoral endoprosthetic 
replacement has been reported to be as high as 77% at 10 years and 57% at 20 
years without revision.8 
An orthopaedic endoprosthesis can be installed into the remaining healthy bone 
stump(s) using two different fixation approaches: (1) cemented and (2) cementless. 
The degree of stress shielding in the bone around a cementless endoprosthesis stem 
depends on mechanical factors, such as stem stiffness (which may relate to factors 
such as shape and elastic modulus), pre-operative bone stiffness, interface bonding 
characteristics, and loading force at the reconstruction site.9  On the other hand, the 
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strength of the stem-cement bond in the case of a cemented stem is relatively low. 
Once the stem-cement interface becomes debonded, the stresses in the cement can 
increase dramatically, enhancing the probability of cement-bone interface loosening 
and, eventually, gross loosening. In addition, the metal may rub against the cement 
mantle, producing metal and cement particles and increasing the probability of 
failure due to particulate reactions.
The modular endoprosthesis for mandibular reconstruction was first introduced 
in oral and maxillofacial surgery in 2008.3 The device is composed of a body part 
and two stem components, which are assembled together and the stem parts are 
inserted in the cancellous bone of the remaining bone stump(s). The body of 
the endoprosthesis functions as replacement for the missing part of mandibular 
bone.  Till now, only a cementation technique has been tested for the fixation of 
the device in the mandibular stumps. The device stems are fixed with polymethyl 
methacrylate (PMMA) cement into the remaining mandibular bone stumps. 
After its introduction, several pre-clinical studies have been done, which focused 
on the PMMA cement fixation10, 11 as well as on biomechanical aspects of the 
endoprosthesis.12-14 
No previous studies have been performed to evaluate the feasibility of using 
a cementless endoprosthesis for mandibular reconstruction. Considering the 
available knowledge and continuous advancements on the osseointegration of 
dental implants, it can be hypothesized that a cementless approach can be used 
for the installation of a mandibular endoprosthesis. For example, dental implants 
are provided with surface coatings as well as surface roughness in order to increase 
the bone-implant surface contact. Currently, the mandibular endoprosthesis is in 
the early stage of development. We are exploring the different possibilities and 
modifications from the previous knowledge gained from both in vivo and in vitro 
studies. Many aspects of this novel device still need to be evaluated, including 
the design, biomechanics and  clinical performance, so that we may have a better 
understanding, Eventually, we aim to bring its success rate to a level that will allow 
for clinical use.
Regenerative Medicine
During the last decade, the reconstruction of bone defects has been brought to a 
next level with the introduction of “regenerative medicine”. The term “regenerative 
medicine” was first introduced in 1992, by Dr. Leland Kaiser in a paper on future 
technologies that will impact hospitals.15 In 2006, the US National Institutes of 
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Health defined regenerative medicine as ‘the process of creating living, functional 
tissues to repair or replace tissue or organ function which has been lost due to age, 
disease, damage, or congenital defects’. Regenerative medicine intends to support 
and enhance the physiological mechanisms of tissue repair and regeneration by 
stimulating the body’s own repair mechanisms to heal previously irreparable tissues 
or organs and promises to extend healthy life spans and improves the quality of 
life by supporting and activating the body’s natural healing.16 This emerging 
multidisciplinary field, involving biology, medicine, and engineering, is likely 
to revolutionize the ways to improve the health and quality of life for millions 
of people worldwide by restoring, maintaining, or enhancing tissue and organ 
function. Regenerative medicine has recently influenced basic and translational 
research and is now applied in clinical studies at the translational research stage 
and makes its way into surgical practice. This holds the promise for custom-tailored 
constructs with the potential to regenerate tissue in the host without significant 
donor site morbidity and size limitation.17, 18 The ideal reconstructive goals are 
to return a complete original form and function of the lost tissue. Regenerative 
medicine is using the principles of “tissue engineering”.19, 20 
The paradigm of tissue engineering consists of (1) a scaffold, which includes 
the use of novel biomaterials that are designed to direct the organization, growth, 
and differentiation of cells in the process of forming functional tissue by providing 
both physical and chemical cues, (2) biomolecules, which includes the application 
of angiogenic factors, growth factors, differentiation factors and bone morphogenic 
proteins  biomolecules, and (3) stem cells, which includes the use of enabling 
methodologies for the proliferation and differentiation of cells, acquiring the 
appropriate source of cells such as autologous cells, allogeneic cells, xenogeneic 
cells, stem cells, genetically engineered cells, and immunological  manipulation. 
Current investigations evaluating scaffold materials used for bone reconstruction 
deal with the biomaterials characteristics and their essential properties to favor 
bone healing. Those properties are based on biocompatibility, osteconductivity, 
osteoinductivity, biodegradability, scaffold architecture, surface properties, porosity 
and permeability and load-bearing or mechanical properties. The ideal scaffold 
has sufficient strength to protect cells and sufficient porosity to allow nutrient and 
differentiation factors to diffuse through the scaffold.21, 22 However, due to the 
overall lack of osteoinductive properties in bone scaffolds, biological factors are 
included to improve the ability to induce bone formation. The scaffold acts as a 
carrier for biofactors or stem cells for bone defect restoration. 
The discovery of bone morphogenetic proteins (BMPs) as osteoinductive agents 
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and the subsequent development of commercially available recombinant forms of 
BMPs has offered the potential to replace traditional grafting techniques with de 
novo bone formation.23 The particular bone morphogenetic proteins (BMP-2 and 
BMP-7) are often used and have shown promising results for bone regeneration. 
The quality of the induced and regenerated bone depends on many factors including 
dosages, ability of the carriers (scaffold) in maintaining and releasing BMP to the 
surrounding tissue bed. 
Further, a combination of bone scaffolds with osteogenic cells has been suggested 
as a promising strategy to overcome the lack of osteoinductivity.24 Bone marrow 
mesenchymal stem cells (MSCs) seem to have a promising potential in bone 
regeneration. Stem cell and stem cell based therapies are related to the ability of the 
indefinite self-replication of stem cells throughout the life of the organism. Under 
the right conditions, right signals, stem cells can differentiate into many different 
cell types including bone cells that regenerate a bone defect. 
In bone marrow, a population of progenitor cells is present, which are called 
mesenchymal stem cells. Purification and culture-expansion of these cells has been 
shown to result in functional bone regeneration in experimental animals when 
delivered to the defect site.25 
Regenerative Medicine for 
Mandibular Bone Reconstruction
Regenerative medicine holds also promise for the reconstruction of mandibular 
bone and can perhaps overcome some of the current surgical limitations. However, 
the use of a regenerative medicine approach for this application is still in its infancy 
and only a limited number of studies are available focusing on the use of regenerative 
medicine for mandibular segmental reconstruction. 
This thesis includes an extensive review on tissue engineering approaches 
for mandibular bone continuity defect reconstruction in Chapter 2. Research 
is ongoing to improve the material properties of bone scaffolds by enhancing 
its osteoconductivity, mechanical characteristics and effectiveness as a carrier of 
biomolecules and stem cells. Various approaches have been explored for mandibular 
regeneration using a combination of scaffolds with osteogenic cells/tissues and/or 
bioactive substances. Although tissue engineering approaches to mandibular bone 
reconstruction demonstrate some clinical potential as an alternative to autogenous 
bone grafting, problems related to the complex functional biomechanical forces 
in the mandible and vascularization of the tissue-engineered construct still remain 
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significant challenges.
Combining the concepts of the modular endoprosthesis and tissue engineering, 
this thesis also investigates the feasibility of using a modular endoprosthesis made 
of a bioresorbable scaffold material in combination with growth factors or bone 
marrow cells for the reconstruction of segmental mandibular defects.
 
Objectives of This Thesis
The objective of this thesis is to evaluate methods of reconstruction of oral and 
maxillofacial defects that avoid the harvesting of bone from a donor site, namely: 
1) metallic modular endoprosthesis (cementless or non-cemented) for mandibular 
reconstruction and 2) tissue engineering for alveolar bone reconstruction during 
immediate dental implant placement (small defect size) and segmental mandibular 
reconstruction (large defect size).
The thesis therefore seeks to address the following questions: 
1. What knowledge is currently available in preclinical in vivo as well as clinical 
literature regarding research methodologies and effectiveness of bone tissue 
engineering for mandibular continuity defects?
2. Does the use of poly(ε-caprolactone) (PCL) implants with or without carbonate-
substituted hydroxyapatite (CHA) coating result in a better soft tissue response 
compared to the commonly used titanium alloy (Ti-6Al-4V)-machined 
surface?
3.  What is the feasibility of using a cementless approach for the installation of a 
modular mandibular endoprosthesis? 
4. Does the use of a mandibular endoprosthetic body component made of poly 
(ε-caprolactone) in combination with rhBMP-2 or autologous bone marrow 
result in regeneration of the segmental mandibular defect?
5. Can a 3D polycaprolactone-tricalciumphosphate (PCL-TCP) scaffold be used 
for the regeneration of alveolar ridge defects in combination with immediate 
dental implant installation?
7Chapter 1
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Introduction
Mandibular continuity defects result from a variety of causes including maxillofacial 
trauma, osteomyelitis, osteonecrosis and resection of benign or malignant 
tumors.1, 2 Unrepaired defects are associated with defacement, reduced masticatory 
capability and loss of speech, which severely affects the patient’s quality of life. 
Ideally, mandibular continuity defect reconstruction should not only restore the 
anatomical height and contour of the missing part, but should in addition allow 
reestablishment of oral function.1 Until now, autogenous bone transplantation - 
especially free vascularized tissue transfer - is considered as “gold standard of care” 
for mandibular reconstruction in patients undergoing major ablative surgery.2-4 In 
principle, autogenous bone grafts provide all critical factors for bone regeneration, 
such as a scaffold for osteo-conduction, growth factors for osteo-induction and cells 
for osteogenesis.5 However, the major problem of this approach is the requirement 
of autogenous donor tissue which results for example in donor site morbidity.6 
Moreover, despite the availability of various reconstructive methods by means of 
autogenous tissue, perfect mandibular reconstruction including restoration of 
continuity, sensation, dentition, soft tissue, function, as well as aesthetics is still 
not achievable.1, 2 As a consequence, mandibular bone reconstruction remains still 
a challenge.2
However, development of reliable tissue engineering techniques might offer a 
next step in the evolution of mandibular reconstruction.2, 7 By definition, tissue 
engineering was defined as an interdisciplinary field that applies the principles of 
engineering and the life sciences toward the development of biological substitutes 
that restore, maintain, or improve tissue function.8 Bone tissue engineering is a 
relatively new method that uses scaffolds, bioactive substances and/or cells/tissues 
with osteogenic potential.1 Ideally, the scaffolds should be (1) three-dimensional 
and highly porous with an interconnected pore network for cell growth and 
flow transport of nutrients and metabolic waste as well as (2) biocompatible and 
bioresorbable with a controllable degradation and resorption rate to match cell 
or tissue growth. Furthermore these scaffolds should possess (3) suitable surface 
chemistry for cell attachment, proliferation, and differentiation, and (4) mechanical 
properties to match those of the tissues at the site of implantation.9 At present, a 
multitude of scaffolds made of various material10-19 in combination with bioactive 
substances or osteogenic bone marrow stromal cells (BMSCs)10, 20-26 to initiate or 
enhance bone formation15-17, 19, 27-33 are under study. 
In 2006, Ikada defined a concept on methodology in tissue engineering as (1) 
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placing the construct scaffold in a bioreactor to reconstruct an engineered tissue 
in vitro called in vitro (or ex vivo) tissue engineering and (2) implantation of the 
construct scaffold in the body until a new tissue is regenerated in vivo called in 
vivo (or in situ) tissue engineering.34 However, the construct lacks completely 
a pre-existing vasculature. Cell survival and tissue formation will depend upon 
local vasculature and the speed at which a fully functional vascular supply will 
be developed.35 This makes that the reconstruction of large-volume defects, such 
as mandibular continuity defects, remains challenging. Therefore, vascularisation 
concepts gain on interest and the combination of tissue engineering approaches 
with flap prefabrication techniques. This may eventually allow application of bone-
tissue substitutes grown in vivo with the advantage of minimal donor site morbidity 
as compared to conventional vascularized bone grafts.12 This review included the 
concepts of tissue engineering using axial vascularisation in engineered bone 
tissues.
Nonetheless, to the best of the authors’ knowledge, animal experiments as well 
as clinical case reports or studies on the subject of bone tissue engineering for 
mandibular continuity defects are currently neither systematically reviewed nor 
synopsized.
Therefore, the purpose of the present report was (1) to review systematically 
preclinical in vivo and clinical literature regarding bone tissue engineering for 
mandibular continuity defects, and (2) to analyze their effectiveness.
Materials and Methods
Study Design
The scientific, pre-clinical in vivo and clinical literature regarding tissue engineered 
approaches for mandibular bone regeneration in continuity defects (i.e. segmental 
mandibular defects or total mandibular condyle replacements) was systematically 
reviewed. 
Outcome Variables
In principle, for animal experiments as well as human reports, macroscopical or 
histological or histomorphometric data on amount of total bone defect bridging 
were chosen as primary outcome variable. However, for human reports, clinical 
and/or radiographic evidence of restoration of mandibular continuity were 
accepted as surrogate outcome variable for the presently defined primary outcome 
variable. Concomitantly, histological or histomorphometric data of bone ingrowth, 
12
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results of biomechanical testing, histological or histomorphometric records of 
scaffold degradation as well as clinical wound healing were selected as co-outcome 
variables.
Inclusion/Exclusion Criteria
In general, only animal in vivo experiments and human reports presenting 
macroscopical or histological or histomorphometric data on amount of total 
bone defect bridging, histological or histomorphometric data of bone ingrowth, 
results of biomechanical testing, histological or histomorphometric data of 
scaffold degradation or information related to clinical wound healing as well as 
human reports presenting clinical and/or radiographic evidence of restoration of 
mandibular continuity were included.
The following detailed inclusion criteria were used: 
1. Research paper presenting in vivo animal data;  
2. Research paper presenting human data; 
3. Defect characteristics should be clearly stated; 
4. Implantation site should be clearly mentioned;
5. Reconstructive technique (i.e.: tissue engineering) should be clearly stated; 
6. Healing period should be clearly stated;
7. The animal model used should be described conspicuously (species, age)
8. Amount of total bone defect bridging, and/or percentage of bone ingrowths, 
and/or results of biomechanical testing, and/or percentage scaffold degradation 
and/or information related to clinical wound healing had to be presented
9. For human reports clinical and/or radiographic evidence of restoration of 
mandibular continuity had to be presented
Studies that did not meet all above mentioned inclusion criteria, e.g. ex-vivo 
studies or studies not addressing tissue engineered approaches for mandibular bone 
regeneration in continuity defects were excluded.
Search Strategy 
An electronic search in the database of the National Library of Medicine (http://www.
ncbi.nlm.nih.gov) up to September 30, 2012, was carried out. Only publications 
in English were considered and the search was broadened to animals and humans. 
The following search strategy was applied: ((“tissue engineering”[MeSH Terms] OR 
(“tissue”[All Fields] AND “engineering”[All Fields]) OR “tissue engineering”[All 
Fields]) OR (“tissue scaffolds”[MeSH Terms] OR (“tissue”[All Fields] AND 
13
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“scaffolds”[All Fields]) OR “tissue scaffolds”[All Fields] OR (“tissue”[All Fields] 
AND “scaffold”[All Fields]) OR “tissue scaffold”[All Fields]) OR (“reconstructive 
surgical procedures”[MeSH Terms] OR (“reconstructive”[All Fields] AND 
“surgical”[All Fields] AND “procedures”[All Fields]) OR “reconstructive surgical 
procedures”[All Fields] OR “reconstruction”[All Fields]) OR (“bone morphogenetic 
proteins”[MeSH Terms] OR (“bone”[All Fields] AND “morphogenetic”[All Fields] 
AND “proteins”[All Fields]) OR “bone morphogenetic proteins”[All Fields] OR 
(“bone”[All Fields] AND “morphogenetic”[All Fields] AND “protein”[All Fields]) 
OR “bone morphogenetic protein”[All Fields]) OR (“bone marrow cells”[MeSH 
Terms] OR (“bone”[All Fields] AND “marrow”[All Fields] AND “cells”[All Fields]) 
OR “bone marrow cells”[All Fields]) OR (“intercellular signaling peptides and 
proteins”[MeSH Terms] OR (“intercellular”[All Fields] AND “signaling”[All Fields] 
AND “peptides”[All Fields] AND “proteins”[All Fields]) OR “intercellular signaling 
peptides and proteins”[All Fields] OR (“growth”[All Fields] AND “factors”[All 
Fields]) OR “growth factors”[All Fields])) AND ((“mandible”[MeSH Terms] OR 
“mandible”[All Fields]) OR ((“mandible”[MeSH Terms] OR “mandible”[All Fields] 
OR “mandibular”[All Fields]) AND (“Continuity”[Journal] OR “continuity”[All 
Fields]) AND defect[All Fields])) 
Additionally, the ISI Web of Knowledge database was searched operating 
the same MeSH terms. Again, only publications in English reporting on animal 
experiments and human studies were considered.
Furthermore, the reference lists of related review articles and publications 
selected for inclusion in this review were systematically screened.
Study Selection
Two independent reviewers (Nattharee Chanchareonsook [NC] and Leenaporn 
Jongpaiboonkit [LJ]) initially screened the publication titles and abstracts as 
identified by the electronic as well as manual search for possible inclusion. Full 
texts of all papers that were considered eligible for inclusion by one or both of the 
reviewers were obtained for further assessment against the stated inclusion criteria 
(Figure 1). Both reviewers used an identical data extraction form to acquire the data 
independently. Any disagreement between the reviewers regarding inclusion of a 
certain publication or data extraction was resolved by discussion. 
14
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Results
Study Selection
The electronic search in the databases of the National Library of Medicine and 
ISI Web of Knowledge resulted in the identification of 6727 and 5017 titles, 
respectively. 
As already mentioned, these titles were initially screened by two independent 
reviewers (NC and LJ) for possible inclusion. In order not to exclude scientific 
reports unintended, title screening as well as abstract assessment was accomplished 
to identify articles reporting in general on mandibular defect reconstruction (i.e. 
non-continuity as well as continuity defects). Title assessment and hand search 
resulted in final selection of 128 abstracts, 101 full-text articles and 40 scientific 
papers reporting on tissue engineered reconstruction of mandibular continuity 
defects that could be included in the present review (Figure 1, Tables 1, 2, 3 and 
4). Regarding data extraction and interpretation, any disagreement between the 
reviewers was resolved by discussion. 
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Figure 1. Selection process 
National Library of 
Medicine: 6727
IsI Web of 
knowledge: 5017
abstracts: 128
Discarded abstracts: 30 Manual search: 3
abstracts reporting on 
mandibular continuity 
and non-continuity 
defects: 101
Full text articles: 48
Final number of 
included articles: 
reporting on 
mandibular 
continuity defect 
(table 3 and 4): 40
Discarded articles 
(table 2): 8
Discarded abstracts 
reporting on 
mandibular non-
continuity defects 
(table 1): 53
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General Characteristics of the Included Studies 
In total, twenty-nine papers reported on animal experiments. Twenty-seven of these 
articles presented data on segmental mandibular body reconstruction4, 10, 11, 15-19, 25, 
26, 29-33, 97-103, 105-107, 109, 110, one article reported on mandibular angle reconstruction104, 
and another one presented data on mandibular condyle reconstruction108. Research 
was done in rabbits30, 108, sheep11, 16, 17, 19, 100, 107, goats104, 105, as well as in  minipigs33, 
dogs4, 10, 25, 26, 31, 32, 97, 98, 106, 110 and monkeys15, 18, 29, 99, 101-103, 109. In several studies, 
teeth were extracted in advance and oral mucosa was allowed to heal completely 
before resective surgery and reconstructive therapy4, 26, 105, 106. Beside the diversity in 
animal models, study design as well as healing periods after reconstructive surgery 
(range: 4 - 48 weeks) were not uniform. The follow up periods were related to 
difference animal species; e.g. dog (12-48 weeks), monkey (16-30 weeks), sheep 
(12-20 weeks), rabbit (12-16 weeks), goat (6-16 weeks) and minipigs (16 weeks). 
Furthermore, eleven out of the 40 articles presented human data on mandibular 
reconstruction.111-121 
The general characteristics of the included animal and clinical studies are 
summarized in Table 3 and 4.
Animal Studies
Autogenous Bone Precursor Cells or Autogenous Osteogenic Tissues
As described, bone tissue engineering is an approach that combines scaffolds with 
osteogenic cells/tissues and/or bioactive substances. In preclinical animal models, in 
principle two different strategies for bone reconstruction in continuity defects have 
been intensively investigated, i.e. the implantation of autogenous bone precursor 
cells or autogenous osteogenic tissues - which contain osteoprogenitor cells and/
or mesenchymal stem cells - and the application of bone morphogenetic proteins. 
Both combined with a range of different carrier biomaterials. 
In total, 12 scientific papers4, 10, 11, 18, 25, 26, 100, 104-108 reporting on autogenous 
bone precursor cells or autogenous osteogenic tissues were finally appropriate for 
inclusion in the current systematic review. Due to their experimental diversity these 
studies are briefly summarized. (Details can be found in journal online: Addendum 
No. 1)
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In summary, autogenous bone precursor cells or autogenous osteogenic tissues 
were primarily combined with calcium phosphate ceramic scaffolds, such as 
β-TCP4, 11, 25, 26, 106 and biphasic calcium phosphate ceramic26, or pyrolized bovine 
bone100 or calcium carbonate, such as natural corals10,105. Considering the primary 
outcome variable bone bridging4, 11, 18, 26, 104-107, 117 as well as the co-outcome variables 
bone ingrowth100 and biomechanical testing4,10,25, autogenous bone precursor cells 
or autogenous tissues seeded onto calcium phosphate ceramic scaffolds showed 
in preclinical animal studies the potential of an alternative to autograft bone for 
mandibular bone reconstruction in continuity defects. Moreover, autogenous bone 
precursor cells or autogenous osteogenic tissues seeded onto or mixed with collagen 
sponges18,108 demonstrated in preclinical animal studies promising results in 
terms of the primary outcome variable bone bridging18 or the co-outcome variable 
bone ingrowths108. In contrast, autogenous bone precursor cells containing tissues 
filled in preshaped poly – D, L –lactide trays did not show such a potential as an 
alternative to autograft bone for mandibular bone reconstruction104.
Bone Morphogenetic Proteins
Furthermore, in total 15 scientific papers15, 18, 29, 31, 32, 97-99, 101-103, 105, 106, 109, 110 reporting 
on recombinant human morphogenetic protein-2 (rhBMP-2) as well as 5 
publications16, 17, 19, 30, 33 presenting data on recombinant human morphogenetic 
protein-7 (rhBMP-7) were eventually included in the current systematic approach. 
Thereby, the in brief summarized studies of Kontaxis et al.16, Abu-Serriah et al.19, 
Boyne29, 101, Busuttil Naudi et al.30, and Toriumi et al.97 may give a good general 
impression of the effectiveness of rhBMPs regarding quantity as well as quality of 
induced bone for the reconstruction of continuity mandibular defects. (Details can 
be found in journal online: Addendum No. 2)
In summary, rhBMP-2 and rhBMP-7 were studied in combination with collagen/
collagen composite scaffolds15-19, 29, 32, 33, 99, 101, 108, 110, poly-D,L-lactide coglycolic 
acid based  carriers31, 98, 102, 103, β-TCP30 as well as coralline hydroxyapatite109 and 
allogenic bone matrix97. Regarding the primary outcome variable bone bridging15-
19, 29-33, 97-99, 101-103, 109, 110 as well as the co-outcome variables bone ingrowths17-19, 29, 
30, 32, 33, 97-99, 109 and biomechanical testing16, 19, 30, 33, 97, rhBMP-2 and rhBMP-7 
demonstrated in preclinical animal studies their potential as an alternative to 
autograft bone for mandibular bone reconstruction in continuity defects. However, 
the published results were not uniform. It should be mentioned that in different 
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reports rhBMP-2 or rhBMP-7 combined with demineralized freeze-dried bone 
allograft109, polyglycolic co-lactic acid102 as well as a bovine collagen type I carrier 
wrapped into a sterno-occipitalis muscle flap17 were not associated with predictable 
defect bridging.  
In line with these results are the reported effects of rhBMP-215,31,32,98,99,103,110 and 
rhBMP-733 for mandibular bone regeneration in continuity defects. On the other 
hand, it should be mentioned that rhBMP-2, in the reports of Zhou et al.109 and 
Seto et al.102, as well as rhBMP-7, in the paper of Ayoub et al.17, have not always 
been associated with bony union. Likewise, in the paper of Ayoub et al.17, rhBMP-7 
was not in all animals associated with complete bone regeneration.
Human Case Report 
In addition to animal experiments, bone tissue engineering for reconstruction 
of mandibular continuity defects has been investigated in humans. Similarly to 
preclinical models, considerable interest for therapeutic use has been focused on 
the application of autogenous osteogenic tissues or bone morphogenetic proteins, 
both combined with a range of different carrier biomaterials. In total, 11 scientific 
papers111-121 reporting on 10 different investigation entities were finally included in 
the current systematic review. 
Autogenous osteogenic tissues and Bone morphogenetic proteins (Details can 
be found in journal online:  Addendum No.3)
In summary, transplantation of tissue engineered autogenous osteogenic tissues 
without additional application of osteoinductive BMPs119 or in combination with 
rhBMP-2115,117,120 as well as rhBMP-7110,111 was associated with restored mandibular 
continuity in five cases, but in one case117 no bony union was observed. Furthermore, 
in 16 patients in some reports115,118,121, osteoinductive rhBMP-2 loaded onto 
different biomaterials without concomitant transplantation of autogenous 
osteogenic tissue was followed by restored mandibular continuity. Again, in one 
subject this did not occur117. Moreover, in 10 patients rhBMP-7116, in one patient 
native human BMPs111 and in two patients xenogeneic BMPs112 without concurrent 
transplantation of autogenous osteogenic tissue were associated with reconstructed 
mandibular continuity. However, this was not observed in four subjects treated 
with xenogeneic BMPs112. 
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Discussion
Currently bone tissue engineering can be considered as a highly promising approach 
and as an alternative bone source. Well-performed in vitro and in vivo experiments 
are essential to determine the suitability of the chosen concept and to understand 
the risks before proceeding into the clinical trial.122, 123 In vitro studies require a 
desired monitored environment that mimics the dynamics of the in vivo condition 
by a controlled homogeneity of nutrients media (also in terms of pH/osmolarity), 
additional osteogenic stimuli(s) and providing a physical stimulation as relevant 
key components for bone construction.124 However, the in vitro condition is unable 
to provide physiological function and never being exact the same condition as in 
vivo.124 The results from in vitro studies do not give direct information or can be 
difficult to infer to the in vivo situation125, but are rather considered as baseline 
properties126. For this reason, the use of animal models is often an essential step in 
the testing of tissue engineering prior to clinical use.
The aims of the present report were to review systematically preclinical in vivo 
as well as clinical literature regarding bone tissue engineering for mandibular 
continuity defects and to analyze the effectiveness of this approach for the treatment 
of mandibular continuity defects.
In total, 29 publications reporting on animal experiments and 11 papers 
presenting human cases could be included in the present systematic review. The 
evaluated articles of the first part of the current review report on tissue engineered 
reconstructions of segmental mandibular body, angle or condyle defects in different 
animal species. Thereby, autogenous bone precursor cells or autogenous osteogenic 
tissues were primarily combined with calcium phosphate ceramic scaffolds. 
Regarding bone bridging, bone ingrowth as well as biomechanical testing, these 
tissue engineered approaches demonstrated a certain potential as an alternative 
to autograft bone for mandibular bone reconstruction in continuity defects. In 
principle, these results were not unexpected and were in line with the literature for 
bone tissue engineering in general. It is well known that BMSCs are capable of self-
renewal and differentiation into various osteogenic lineage cells127. Furthermore, 
their osteogenic potential has been demonstrated both in vitro and in vivo. 
Consequently, BMSCs became a major seed cell source for bone tissue engineering. 
Moreover, many previous studies have succeeded in repairing bone defects by using 
BMSCs in animal models as well as in humans.24, 127-129 
Besides, due to their compositional similarities to bone mineral, their excellent 
biocompatibility, osteoconductivity as well as drug delivery potential, calcium 
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phosphates, especially tricalcium phosphate and hydroxyapatite, are the most widely 
used bone substitutes in bone tissue engineering127. Moreover, BMSCs seeded onto 
calcium phosphate scaffolds induced ectopic bone formation in a mice model.129
However, the currently presented favorable data for bone tissue engineered 
constructs as compared to scaffolds alone have to be interpreted with caution. 
In principle, sample-size and thereby statistical power of the reviewed pre-clinical 
in vivo experiments tended to be low. For example, the compared twelve weeks 
bone bridging and bone ingrowths106 originate from only two animals/segmental 
defects without statistical analysis. Another example is the three months data25. 
Their statistically significant better biomechanical results (p<0.05) for bone tissue 
engineered bone as compared to the scaffold alone originate from not more than 
three animals/segmental defects. Thus, with an assumed α-error of 0.05, post hoc 
analysis for e.g. compression strength reveals a statistical power as low as 0.385. 
Furthermore, next to autogenous bone precursor cells or autogenous osteogenic 
tissues, bone morphogenetic proteins (i.e.: rhBMP-2 and rhBMP-7) were studied. 
Predominantly, rhBMP-2 and rhBMP-7 were combined with collagen/collagen 
composite scaffolds. However, a few papers examined combinations with poly-D,L-
lactide coglycolic acid as well as calcium phosphate carriers. Regarding bone bridging, 
bone ingrowth as well as biomechanical testing, these tissue engineered approaches 
displayed some potential as an alternative to autograft bone for mandibular bone 
reconstruction in continuity defects. However, the published results were not 
uniform. For example, rhBMP-2 or rhBMP-7 combined with a bovine collagen 
type I carrier17, polyglycolic co-lactic acid102 as well as demineralized freeze-dried 
bone allograft109 were not associated with predictable defect bridging. Overall, the 
published outcomes for bone morphogenetic proteins were not surprising and were 
in line with the reports for bone tissue engineering in general. The osteoinductive 
potential of BMP-2 and BMP-7130 as well as the general importance of carrier 
selection in conjunction with growth factor application15, 115, 131-133 are well known. 
Also for these reviewed pre-clinical in vivo experiments, sample-size and thereby 
transferability tended to be low. For instance, the three months bone bridging data 
and the found wide range of mechanical properties of Abu-Serriah et al.19 were 
obtained from not more six animals/segmental defects. Another good example is 
the publication of Boyne29. Their five months bone bridging and bone histology 
data originate from only three animals/segmental defects. Unfortunately, a meta-
analytical approach to increase the power of statistical analysis by pooling the results 
of all retrieved available trials was not feasible. Research of results that are combined 
in a meta-analysis should preferably be done in a similar manner. As shown in Table 
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3, this is clearly not the case for the presently included papers. The publications, 
which were eligible for inclusion in the present study, display experimental 
variability for the utilized animal model, the anatomical site of reconstruction, the 
used bone tissue engineering approach, the number of enrolled animals/defects as 
well as the healing time after reconstruction. 
Apart from BMPs, alternative growth factors may serve as potential therapeutic 
agents to enhance bone and cartilage formation e.g. recombinant human platelet-
derived growth factor (rhPDGF), transforming growth factor-beta (TGF-β), 
fibroblast growth factor, recombinant human growth/differentiation factor-5 
(rhGDF-5) and insulin-like growth factor.134 PDGF is known to simulate 
angiogenesis through activation of the macrophages134, which secrete factors cells 
to form new capillary sprouts. Transforming growth factor-β1) has been proven to 
promote cartilage regeneration.79 RhGDF-5 has the potential to grow the same type 
of tissues as where it is naturally present. Its possible using in a tissue engineering 
approach has been reported for the regeneration of dento-alveolar tissues.135, 136 
However, a single dose of an exogenous protein will not induce adequately 
a biologic response in compromised tissue conditions. Gene therapy is another 
concept in which genetic information is transferred into target cells. Subsequently, 
the cells synthesize the endogenous protein encoded by the gene.137 The process 
that involves the transfer of functional genetic information into the target cell 
is known as transduction. This is accomplished when the recombinant vector 
(virus) that contains the therapeutic DNA binds to the cell, usually via a receptor-
mediated process, and then enters that cell. The DNA passes into the nucleus of 
the cell, where it may become integrated into the host genome or may remain 
extrachromosomal. The transduced cells can then produce and secrete the growth 
factor encoded by the DNA98-100.56, 70 In this review, the use of gene therapy was 
found being applied in the reconstruction of mandibular continuity defects in 
animals and humans. On the other hand, gene therapy has been reported for the 
repair of the mandibular condyle and temporomandibular joints and was found to 
support mineralized tissue formation.138-140 
In the second part of the review eleven papers, presenting human cases 
regarding tissue engineered reconstruction of mandibular continuity defects, 
were eventually included. The review included the reports on microvascular tissue 
transfer of prefabricated bones in the study. Although, these techniques belong to 
tissue regeneration, they are important for the reconstructive surgeon. Thereby, 
transplantation of tissue engineered autogenous osteogenic tissues without additional 
application of osteoinductive BMPs or in combination with rhBMP-2/rhBMP-7 
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produced restored mandibular continuity in five out of six cases. Furthermore, in 
29 out of 34 patients, the application of native human BMPs, xenogeneic BMPs, 
rhBMP-2 or rhBMP-7 without concomitant transplantation of autogenous 
osteogenic tissue was associated with complete bony defect bridging. Unfortunately, 
no direct comparison of the results with autogenous bone transplantation can be 
done due to lack of direct control. However Herford and Cicciù120 stated that 
bone growth cytokines can be considered as a predictable alternative to traditional 
grafting techniques. In general, these results were not astonishing and in line with 
the literature15, 115, 141-144. Thus, it might be assumed that these tissue engineered 
approaches may have, in certain selected patients, some potential as an alternative 
to autograft bone for mandibular bone reconstruction in continuity defects. 
However, it should be underlined that until now only a few successfully treated 
cases have been published. Furthermore, to date the clinical predictability has to be 
questioned. An additional issue is the limited license of the use of rhBMP-2 in oral 
and maxillofacial surgery. According to the Center for Devices and Radiological 
Health (CDRH) of the U.S. Food and Drug Administration (FDA), rhBMP-2 is 
not licensed for use in surgery of mandibular continuity defects and may only be 
applied for sinus augmentation and localized alveolar ridge augmentation. 
Conclusions
The reviews showed a various study methodology, review period and different control 
groups. Not all studies compared the finding with a reconstruction with autologous 
bone substitute. None of the human study was performed as a randomized control 
trial study. Within the limits of this systematic approach to the literature regarding 
tissue engineered bone reconstruction in continuity defects of the mandible, we 
conclude that: (1) published preclinical in vivo as well as clinical data are limited, 
and (2) tissue engineered approaches demonstrate some clinical potential as an 
alternative to autograft bone. The future research in this area needs to include 
process evaluation research in order to define the characteristics contributing to the 
success and failure of any intervention.
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Addendum 
  
Addendum No .1
In a rabbit unilateral, segmental defect model of the temporomandibular joint 
condyle, El-Bialy et al.108 evaluated tissue-engineered mandibular condyles 
(TEMCs). TEMCs consisted of osteogenic and chrondrogenic differentiated 
autogenous bone marrow stem cells (BMSCs) seeded into distinct sections 
of collagen sponges, which were inserted into biodegradable urinary bladder 
extracellular matrix (UBM ECM) scaffolds. They compared TEMCs combined 
with low-intensity pulsed ultrasound (LIPUS) (TEMC + LIPUS) versus TEMCs 
without LIPUS (TEMC) versus empty scaffolds with LIPUS (Scaffold + LIPUS) 
versus empty scaffolds without LIPUS (Scaffold).  After a healing period of 4 weeks, 
histomorphometric bone trabeculae /osteogenic tissue measurements revealed for 
TEMC + LIPUS 1.2 µm2 (SD: 0.5 µm2), for TEMC 1.1 µm2 (SD: 0.1 µm2), for 
Scaffold + LIPUS 0.5 µm2 (SD: 0.5 µm2), for Scaffold 0.3 µm2 (SD: 0.1 µm2) 
and for the normal condyles 1.2 µm2 (SD: 1.4 µm2). The differences between the 
normal condyles, TEMC + LIPUS and TEMC were not statistically significant. 
However, there was statistically significant less bone trabeculae/osteogenic tissue 
formation in the UBM ECM scaffolds with or without LIPUS as compared to 
normal condyles or TEMC + LIPUS (p<0.05). Data regarding proportion of total 
bony defect bridging, biomechanical testing, percentage scaffold degradation or 
clinical wound healing were not presented. Finally, it was concluded that the use 
of UBM ECM along with chrondrogenic and osteogenic differentiated BMSCs 
showed promise for joint tissue engineering of mandibular articular condyles and 
that UBM ECM without cells is not a practical option for mandibular condyle 
tissue engineering.    
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Fennis et al.104 assessed in a goat unilateral, segmental defect model of the 
mandibular angle preshaped poly – D,L –lactide (PDLLA) trays filled with an 
autogenous particulate bone graft taken from the anterior iliac crest mixed with 
platelet-rich-plasma (PRP). It was hypothesized that these grafts would heal, 
providing bone continuity with the grafted bone. After six weeks of healing, in all 
cases macroscopically the defects were bridged by newly formed bone on the buccal 
and lingual aspect of the mandible. However, evaluation of cross-sections showed 
that the PDLLA scaffolds had shrunk, thus narrowing the space containing the 
grafted bone.  Furthermore, light microscopic evaluation showed that extensive 
resorption of the particulate bone grafts had taken place. The remaining particulate 
bone chips within the confines of the PDLLA tray showed signs of remodeling, 
predominantly osteoclastic activity as well as some deposition of osteoid tissue. 
Moreover, the PDLLA scaffolds itself showed no signs of degradation and in all 
specimens the PDLLA scaffolds were encapsulated by fibrous tissue. However, 
on the external surface of the PDLLA scaffold, callus formation provided bone 
continuity between the mandibular stumps. In one animal, with loose screws of 
the osteosynthesis plates, a necrotic grafted area without any signs of remodeling 
directly adjacent to the PDLLA scaffold was seen. Nonetheless, also in this specimen 
abundant callus formation had appeared, providing bony continuity of both 
mandibular stumps. It should be mentioned that this experiment was uncontrolled 
and data regarding biomechanical testing were not presented. Finally, it was 
concluded that the study did not completely confirm the formulated hypothesis 
of healing by bone continuity with the grafted bone. However, because bony 
continuity between the mandibular stumps was provided by newly formed bone 
on the outside of the scaffold, maintaining the original shape of the reconstructed 
area, it was supposed that PDLLA scaffolds might be a promising alternative in 
mandibular reconstruction.
Moreover, Xi et al.105 studied in a goat unilateral, segmental defect model of 
the mandibular body recombinant human morphogenetic protein-2 (rhBMP-2) 
induced autogenous marrow mesenchymal stem cells (MSCs) seeded into 
natural coral granules (test) against unloaded natural coral granules (control), 
both implanted into a titanium reticulum stent. After 16 weeks of healing, 
macroscopically the graft surfaces of the test group were covered with smooth and 
glistering red bone tissue. Furthermore, the shape of the newly formed bone grafts 
was coincident with that of the original host bone. In contrast, in the control group, 
coral scaffolds were absorbed and had rough and white surfaces. Histologically, new 
bone formation was demonstrated in all specimens of the test group, whereas no 
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evidence for osteogenesis in the center of the titanium reticulum was found in the 
control group. In spite of this, also in the control group bone healing was observed 
outside the titanium reticulum and explained by periosteal osteogenesis. In addition, 
this explains the clinical finding that survived animals in the experimental as well as 
in the control group recovered mandibular continuity. However, quantitative data 
on proportion of total bony defect bridging, bone ingrowths, scaffold degradation 
or results of biomechanical testing were not presented. Finally, the potential 
of rhBMP-2 induced MSCs seeded into natural coral granules for mandibular 
continuity defect reconstruction was assumed.
Furthermore, in a sheep unilateral, segmental defect model of the mandibular 
body, Schliephake et al.100 evaluated autogenous osteoprogenitor cells cultivated 
from bone biopsies from the iliac crest and seeded into scaffolds of pyrolized bovine 
bone (test) against the empty scaffold (control). After five months of healing, in 
the test group on average 34.4% of the evaluated surface units exhibited bone 
formation. However, the distribution of newly formed bone across the defect 
was variable. The marginal sections of the defect exhibited bone tissue on average 
in 43.5% and 46.5% of the evaluated surface units. These values decreased in 
the intermediate and central parts to 19.7%, 23.8% and 20.3%, respectively. 
Furthermore, bone quantity of the five sections was statistically significant different 
(p<0.05). In contrast, in the control group exhibited on average 10.4% of surface 
units bone formation. Once more, the distribution of newly formed bone across 
the defect was variable. The marginal sections had the highest percentage of bone 
fill with 19.5% and 22.4% of the evaluated units. The intermediate and central 
parts showed very low values with the presence of bone tissue in only 0.2%, 3.0% 
and 3.7% of the evaluated units. Also the distribution of the newly formed bone in 
the five sections of the control group was statistically significant different (p<0.05). 
Furthermore, the difference in extend of bone formation between test and control 
group was statistically significant different (p<0.05). Data regarding proportion of 
total bony defect bridging, biomechanical testing, percentage scaffold degradation 
or clinical wound healing were not presented. Finally, it was concluded that 
extend of bone regeneration in calcium phosphate scaffolds in segmental defects 
of the sheep mandible can be enhanced by the presence of cultivated autogenous 
osteoprogenitor cells.
Also Nolff et al.107 used a sheep unilateral, segmental defect model of the 
mandibular body to compare blood soaked, beta-tri calcium phosphate (β-TCP) 
cylinders loaded with autogenous bone marrow and cancellous bone (test) with 
blood soaked, β-TCP cylinders (control). After 12 weeks of healing, in the test 
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group complete bony union was achieved. Moreover, the main parts of the ceramic 
scaffolds were degraded and the residual material was integrated within the newly 
formed bone. On the contrary, in the control group bone ingrowths into the 
defect was rare and none of the specimens achieved defect union. Furthermore, 
incomplete osseointegration of the ceramic material that mainly occurred in close 
proximity to the cut ends of the mandible was observed. Moreover, direct bone-to-
scaffold contact was rare due to an intervening layer of fibrous tissue. In addition, 
the core of the ceramic graft was intact and the void pore spaces were completely 
filled by highly cellular vascularized fibrous tissue. Accordingly, within the central 
parts of the scaffolds in the test group statistically significant more bone formation 
and statistically significant less residual graft material was found (p<0.05). 
Unfortunately, percentages of total bone area as well as ceramic area were not 
presented as overall means. Furthermore, two sheep (one of each group) presented 
total graft failures with inflammation of the graft side associated with sequestration 
at the time of sacrifice. Moreover, biomechanical testing was not done. Finally, it 
was proposed that blood soaked, β-TCP cylinders loaded with autogenous bone 
marrow and cancellous bone may qualify as a promising alternative to autograft 
bone for mandibular reconstruction.
Furthermore, Nolff et al.11 investigated in a sheep unilateral, segmental defect 
model of the mandibular body blood soaked, beta-tri calcium phosphate (β-TCP) 
cylinders loaded with autogenous bone marrow aspirate and morselized cancellous 
bone received during segment mandibulectomy (test) versus blood soaked, β-TCP 
cylinders (control). After twelve weeks of healing, in the test group complete 
bony union was achieved. Moreover, the main parts of the ceramic scaffolds were 
degraded and the residual material was integrated within the newly formed bone. 
Three-dimensional reconstruction of the residual cylinders showed extensive mean 
scaffold degradation of 94.2% (SD: 3.3%) as well as fragmentation of the ceramic 
material. On the contrary, in the control group incomplete osseointegration of the 
ceramic material that mainly occurred in close proximity to the cut ends of the 
mandible was observed. Moreover, the remaining graft surface was enveloped by 
woven bone with an intervening layer of radiolucent soft tissue while the center 
of the defect was occupied by moderately degraded ceramic material. In addition, 
three-dimensional reconstruction of the residual cylinders showed a mean scaffold 
degradation of 53.6% (SD: 9.7%). Furthermore, two sheep (one of each group) 
presented total graft failures with inflammation of the graft side associated with 
graft displacement and sequestration as well as necrosis of the mandibular bone at 
the time of sacrifice. Data regarding percentage of bone ingrowths or biomechanical 
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testing were not presented. Finally, it was concluded that ceramic bone –graft 
substitutes such as β-TCP represent a promising solution for reconstruction of 
large bone defects.
Likewise, Wu et al.106 assessed in a dog unilateral, segmental defect model of the 
mandibular body recombinant human bone morphogenetic protein-2 (rhBMP-2) 
osteogenically induced autogenous bone marrow stromal cells (BMSCs) seeded 
on porous β-tricalcium phosphate (β-TCP) versus β-TCP without BMSCs or 
transplanted autologous iliums. After twelve weeks of healing, the gross resected 
specimens showed that the mandibles with BMSCs/β-TCP constructs or autologous 
bone had repaired defects and restored mandibular continuity. Moreover, in the 
BMSCs/β-TCP group, tissue engineered bone was observed to completely bridge 
the defect and was indistinguishable at the margins from native bone. In contrast, 
only partial repair was seen in the β-TCP without BMSCs group. In this group, 
only a thin bone bridge was observed on the top of the defect and no bony tissue 
was observed in other sections of the defect site. Histological, in the BMSCs/β-TCP 
group abundant mature bone and in the autogenous bone group substantial bone 
formation was found. In contrast, in the β-TCP without BMSCs group large parts 
of the scaffold degraded with only scattered bone tissue enclosed. Furthermore, in 
this group the osteoid synthesis was poor compared with the corresponding cell-
scaffold transplant. Clinically, no signs of inflammation or adverse tissue reactions 
around the implants were observed. Data regarding percentage of bone ingrowths, 
biomechanical testing or percentage scaffold degradation were not presented. 
Finally, it was concluded that BMSCs/β-TCP is a vulnerable alternative to autograft 
in the treatment of traumatic bone defects and atrophic non-unions, by which the 
disadvantages of the harvest of autologous bone can be prevented.      
Also Yuan et al.4 compared in a dog unilateral, segmental defect model of the 
mandibular body, osteogenically induced autogenous bone marrow stromal cells 
(BMSCs) seeded on porous β-tricalcium phosphate (β-TCP) (test) versus resected 
autologous mandibular segments or β-TCP without BMSCs. After thirty-two weeks 
of healing, macroscopically the mandibles repaired with BMSCs/β-TCP constructs 
or autologous mandibular segments achieved bony-union. Moreover, the shapes 
of repaired mandibles were very close to that of normal edentulous mandibles. 
On the contrary, β-TCP without BMSCs was not associated with bony-union. 
Furthermore, in the test group bony-union was microscopically observed without 
clear boundary between newly formed bone and native bone. Also in the autograft 
group a bony-union, with intrinsic dead bone and newly form bone coexisting in 
the repaired area, was observed. In contrast, in the β-TCP without BMSCs group, 
51
Chapter 2
only fibrous tissues in the defect area with minimal new bone formation at the 
cutting ends were observed. In addition, to evaluate the biomechanical properties 
of the repaired mandibles after thirty-two weeks of healing a three-point bending 
test was performed. In the BMSCs/β-TCP group, bending strength load was 1.8 
kN (SD: 0.4 kN), bending displacement was 1.9 mm (SD: 0.8 mm), bending 
stress was 44.7 MPa (SD: 10.1 MPa) and Young´s modulus was 437.2 MPa (SD: 
199.5 MPa). For the contralateral normal edentulous mandible bending strength 
load was 3.0 kN (SD: 1.1 kN), bending displacement was 3.7 mm (SD: 1.9 mm), 
bending stress was 54.4 MPa (SD: 4.3 MPa) and Young’s modulus was 275.8 MPa 
(SD: 107.3 MPa). Furthermore, for the autograft group bending strength load was 
2.7 kN (SD: 0.3 kN), bending displacement was 2.6 mm (SD: 0.4 mm), bending 
stress was 43.1 MPa (SD: 12.0 MPa) and Young´s modulus was 250.0 MPa (SD: 
77.3 MPa). No statistically significant differences, neither between the BMSCs/β-
TCP group and the normal edentulous mandible nor between the BMSCs/β-TCP 
group and the autograft group were found. Because there was no bony-union in 
the β-TCP without BMSCs group, three point bending test could not be applied 
in this group. Quantitative data on bone ingrowths or scaffold degradation were 
not presented. The authors concluded that engineered bone from osteogenically 
induced BMSCs seeded onto biodegradable β-TCP can well repair critical sized 
segmental mandibular defects in canines. 
Furthermore, He et al.25 investigated in a dog unilateral, segmental defect 
model of the mandibular body, osteogenically induced autogenous bone marrow 
stromal cells (BMSCs) seeded on biodegradable and porous β-tricalcium phosphate 
(β-TCP) (test) versus β-TCP without BMSCs (control). After three months of 
healing, histologic micrographs demonstrated new bone formation together with 
osteoblast seems, osteoclastic resorption and cartilage formation in central sections 
of the scaffolds in the test group. However, control group data were not presented. 
Additionally, to appraise biomechanical properties of the test and control treatment, 
compression strength, stress and strain were assessed. On average, in the test group 
compression strength was found to be 102.8 N, stress 3.5 N/mm2 and strain 17 %, 
whereas in the control group compression strength was found to be 42.9 N, stress 
1.9 N/mm2 and strain 54.5 %. All differences were statistically significant (p<0.05) 
and might be in part explained by a significant difference of the mean height of 
the reconstructed mandible (test: 18.5 mm, control: 9.2 mm, p<0.05). Moreover, 
gross macroscopical inspection as well as 3D computed tomographic imaging of 
the test mandibles showed no obvious absorption, whereas apparent absorption 
was found in the control group. However, qualitative or quantitative data on bone 
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bridging, quantitative data on bone ingrowths or histomorphometric data on 
scaffold degradation were not provided. The authors presume the clinical potential 
of osteogenically induced autogenous bone marrow stromal cells (BMSCs) seeded 
onto biodegradable and porous β-tricalcium phosphate (β-TCP) in segmental 
mandibular defect reconstruction.
Moreover, Jégoux et al.26 examined in a dog unilateral, segmental defect model 
of the mandibular body, delayed autologous bone marrow grafts injected into 
macropores biphasic calcium phosphate ceramic (MBCP) wrapped in a cross-linked 
porcine collagen membrane (test) versus delayed autologous bone marrow grafts 
injected into empty not reconstructed defects (control). Twenty-four weeks after 
mandibular segmental resection along with reconstruction and sixteen weeks after 
autologous bone marrow graft injection, complete defect bridging was seen in all 
test sites, whereas nonunion was observed in all control defects. However, these data 
were retrieved by three-dimensional reconstruction from x-ray microtomographs 
and not by histology. Moreover, new bone formation both surrounding the MBCP 
granules and within the macropores of the granules was verified histological. 
Nonetheless, it should be mentioned that spontaneous mucosal fistulas in regard 
to the bone defect occurred at the seventh postoperative day in all animals (test 
and control). For that reason, every animal underwent a further surgical procedure 
that finally leads to adequate mucosal healing. However, quantitative data of bone 
ingrowths, results of biomechanical testing or data regarding scaffold degradation 
were not given. Finally, the authors concluded that the composite of calcium 
phosphate ceramics plus collagen membrane combined with delayed autologous 
bone marrow grafts was successful in regenerating large mandibular segmental 
defects.
In addition, Yuan et al.10 investigated in a dog unilateral, segmental defect 
model of the mandibular body osteogenically induced autologous bone marrow 
stromal cells (BMSCs) seeded onto natural corals (test) against natural corals 
without BMSCs (control). Healing was allowed for 12 or 32 weeks. For both 
healing periods, bony-union was achieved with BMSCs/coral constructs. Moreover, 
the shapes of repaired mandibles were very close to that of normal edentulous 
mandibles. On the contrary, natural coral without BMSCs was not associated 
with bony-union. Furthermore, in the test group bony-union was microscopically 
observed without clear boundary between newly formed bone and native bone. In 
addition, to evaluate the biomechanical properties of the repaired mandibles a three-
point bending test was performed. After 12 weeks of healing, bending strength 
load in the BMSCs/coral group was 1.7 kN (SD: 0.4 kN), bending displacement 
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was 1.8 mm (SD: 0.4 mm), bending stress was 33.4 MPa (SD: 9.5 MPa) and 
Young´s modulus was 507.6 MPa (SD: 194.9 MPa). For the contralateral normal 
edentulous mandible bending strength load was 2.4 kN (SD: 0.6 kN), bending 
displacement was 2.6 mm (SD: 0.5 mm), bending stress was 42.3 MPa (SD: 5.6 
MPa) and Young´s modulus was 239.6 MPa (SD: 71.8 MPa). Moreover, after 
32 weeks of healing, bending strength load for the BMSCs/coral group was 1.5 
kN (SD: 0.4 kN), bending displacement was 1.9 mm (SD: 0.8 mm), bending 
stress was 54.4 MPa (SD: 9.9 MPa) and Young´s modulus was 433.0 MPa (SD: 
159.5 MPa). Whereas for the contralateral normal edentulous mandible bending 
strength load was 1.8 kN (SD: 0.8 kN), bending displacement was 2.6 mm (SD: 
0.6 mm), bending stress was 61.2 MPa (SD: 13.0 MPa) and Young´s modulus 
was 292.9 MPa (SD: 113.6 MPa). Neither at 12 nor at 32 weeks bending strength 
load, bending displacement or bending stress were statistically significant different 
between tissue-engineered and normal mandibular bone. Since there was no bony-
union in the control (coral without BMSCs) group, three-point bending test could 
not be applied in this group. Quantitative data on bone ingrowths or scaffold 
degradation were not presented. The authors concluded that engineered bone from 
osteogenically induced BMSCs seeded onto biodegradable coral scaffolds can repair 
critical sized segmental mandibular defects in canines. 
Moreover, Seto et al.18 investigated in a monkey unilateral, segmental defect 
model of the mandibular body, culture expanded autogenous bone marrow 
stromal cells (BMSCs) mixed with rhBMP-2 impregnated collagen sponges (test). 
After 24 weeks of healing, the combination graft of culture expanded BMSCs with 
rhBMP-2 soaked collagen sponges regenerated the mandibular bone completely. 
Additionally, histological evaluation revealed for rhBMP-2/BMSCs bone formation 
that reached the height of the host bone. Furthermore, the newly formed bone 
was remodeled and patterned lamellar bone, but it showed an irregular trabecular 
outline, its surface was rough and the regenerated bone seemed to be still immature. 
However, quantitative data on scaffold degradation or results of biomechanical 
testing were not presented. Finally, the authors suggested that culture expanded 
autogenous BMSCs mixed with rhBMP-2 impregnated collagen sponges is a 
promising new technique for bone regeneration in large bone defects.
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Addendum No. 2
Busuttil Naudi et al.30 investigated in a rabbit unilateral, segmental defect model of 
the mandibular body histological as well as biomechanical properties of rh-BMP-7 
loaded onto β-TCP scaffolds (test) versus β-TCP scaffolds alone (control). In the 
test group, after three months of healing, next to complete bridging with woven as 
well as lamellar bone, union between the regenerated bone and the proximal bony 
segments was found. However, pattern of bone formation varied. In some cases a 
well-formed cortex was identified, whilst in others the new bone formation was 
primarily cancellous. In addition, in the test group the mean percentage regenerated 
bone volume was found to be 29% (SD: 6%), while the mean percentage for the 
control group was found to be 6% (SD: 3%). Moreover, in the mid surgical field, 
the bone volume of the test group was 23% (SD: 5%), whereas it was only 3% 
(SD: 2%) in the control group. Furthermore, it was reported that β-TCP resorbed 
more completely in the cases treated with rhBMP-7/β-TCP. However, quantitative 
data on scaffold degradation were not presented. Biomechanical testing revealed 
for rh-BMP-7/β-TCP failure moments of 0.06 to 2 Nm that were consistently 
greater than those treated with β-TCP alone (0 to 0.05 Nm). In addition, in 
some cases the mechanical properties of the regenerated bone were comparable 
to those of untreated bone. Finally, it was concluded that rh-BMP-7 loaded onto 
β-TCP scaffolds appeared to be an effective method for bone regeneration in the 
mandibular, critical size defect rabbit model.
Furthermore, in a sheep unilateral, segmental defect model of the mandibular 
body, Abu-Serriah et al.19 studied rh-BMP-7 conjoined with a bovine type-I collagen 
carrier. After 12 weeks of healing histological examination showed complete defect 
reconstruction. In principle, woven as well as lamellar bone that was entirely fused 
with the adjacent native bone was found. However, none of the newly formed bone 
showed restitution of the buccal and lingual cortices. Moreover, the newly formed 
bone was more porous and the Haversian systems were oriented at right angles 
to the direction of those of the native bone. Furthermore, histomorphometric 
measurements showed that the newly formed bone contained statistically 
significantly more marrow spaces (mean: 28.8%, SD: 11.5%) as compared to the 
native bone (mean: 3.5%, SD: 2.6%). Although all animals achieved bony union, 
a wide range of biomechanical properties was found. The rhBMP-7 induced bone 
reached a mean and median of 36% (range: 9 - 63%) of the strength of the bone 
of the non-operated, intact hemi-mandibles (NOS). The mean value of absorbed 
energy and stiffness of the rhBMP-7 induced bone were 61% and 24% of the NOS, 
respectively. These differences were statistically significant (p<0.05). However, 
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while half of the samples of the rhBMP-7 induced bone had “weak” mechanical 
properties (9 – 25% strength of NOS) and a lower stiffness (6-18% of NOS); the 
other half showed relatively higher strength (47-63% of NOS) and was stiffer (35-
47% of NOS). Unlike NOS, rhBMP-7 induced bone showed cracks that initiated 
at the superior border of the mandible and failed under tensile stresses. In addition, 
histomorphometric assessment revealed approximately 20% more porosity in less 
rigid as compared to rigid rhBMP-7 induced bone. Once again, quantitative data 
regarding scaffold degradation were not presented. Conclusively, the potential of 
rhBMP-7 as regards craniofacial bone reconstruction was supposed. 
Similarly, Kontaxis et al.16 investigated rhBMP-7 loaded onto a bovine collagen 
type-1 carrier (test) in a sheep unilateral, segmental defect model of the mandibular 
body. Three months after surgery, complete bone regeneration occurred in all six 
test hemi-mandibles. However, quality as well as mechanical properties of the new 
bone were highly variable. In three out of six samples the newly formed bone 
contained fibrous tissue and was weaker and less stiff as compared to intact, non-
operated hemi-mandibles (strength: 10-20%, stiffness: 6-15% of intact, non-
operated hemi-mandibles). However, the other half of the test hemi-mandibles had 
“better-quality” bone and was significantly stiffer and stronger (strength: 45-63%, 
stiffness: 35-46% of intact, non-operated hemi-mandibles). These differences were 
statistically significant. 
Moreover, in a dog unilateral, segmental defect model of the mandibular body, 
Toriumi et al.97 studied inactive dog bone matrix carrier with rhBMP-2 (test) versus 
inactive dog bone matrix without rh-BMP-2 (control 1) or empty defects (control 
2). Healing was allowed for 3 and 6 months. For both healing periods, inactive 
dog bone matrix carrier combined with rhBMP-2 was associated with bony-union. 
Furthermore, after 3 months of healing histomorphometric analysis revealed that 
50% of the defect tissue was mineralized and that degradation resulted in only 
occasionally found islands of residual carrier material. Moreover, after 6 months of 
healing histomorphometric analysis revealed that 68% of the tissue occupying the 
defects was mineralized with only minimal evidence of residual carrier material. 
Additionally, the newly formed bone appeared normal, making it difficult to identify 
the point of transition from the inactive dog bone matrix carrier combined with 
rhBMP-2 to normal bone. On the other hand, inactive dog bone matrix without 
rh-BMP-2 was never associated with bony-union. After 3 as well as 6 months of 
healing, in principle fibrous scar tissue bridged the defect. In addition, in contrast to 
inactive dog bone matrix carrier combined with rh-BMP 2, relative large amounts 
of residual, nonviable bone matrix was found. Similarly, histological examination of 
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control group 2 (empty defects) revealed fibrous scar tissue with no bone formation 
at 3 as well as 6 months. Furthermore, biomechanical testing after 3 and 6 months 
revealed bending mean maximum moments in the test group of 7.4 Nm and 22.6 
Nm, respectively. These values represented 9% and 27% of the mean maximum 
moment values of the contralateral (non-operated) hemi-mandibles for the 3 and 
6 months specimens. In contrast, due to absence of bone, the mean maximum 
moments in the control 1 group (inactive dog bone matrix carrier without rh-
BMP 2) were 0.0 Nm at both time points. Furthermore, biomechanical testing for 
control group 2 (empty defects) was not performed. Concisely, inactive dog bone 
matrix carrier with rhBMP-2 was associated with functionally stable mandibular 
reconstruction in the currently used dog model. 
Furthermore, in a pilot study in an adult male non-human primate (Macaca 
fascicularis monkey) bilateral, segmental defect model of the mandibular 
body, Boyne29 investigated rhBMP-2 loaded onto bovine tendon derived type I 
collagen carrier. After five months of healing bone bridging was found. Moreover, 
histological analysis revealed osseous repair with a trabecular outline, cortical bone 
structures as well as pattern of remodeling that may indicate bone stability and thus 
permanency of the regenerated area. However, beside these more qualitative data and 
presumptions, quantitative information of bone ingrowths, results of biomechanical 
testing or data regarding scaffold degradation were not given. Nonetheless, it was 
concluded that rhBMP-2 - without the use of bone grafts - might be a powerful 
inductor of osseous regeneration in large discontinuity mandibular defects in non-
human primates. 
Likewise, Boyne101 studied in a middle-aged as well as in an aged, adult male 
non-human primate (Macaca fascicularis monkey) unilateral, segmental defect 
model of the mandibular body, rhBMP-2 loaded onto a collagen carrier. After 
four and six months of healing histologic examination revealed, bone bridging, 
excellent bone regeneration as well as good bone remodeling and thick outer cortex 
formation in the middle-aged group. Moreover, six months after implantation 
of rhBMP-2, there was no gross or microscopically discernible difference in the 
amount or quality of bone formation in the younger or older animals. In fact, in 
numerous cases, more bone had formed in the older animals. Obviously, aging 
appeared to have no effect on the osteoinductive effect of rhBMP-2. Again, beside 
these more qualitative data, quantitative information of bone ingrowths, results 
of biomechanical testing or data regarding scaffold degradation were not given. 
Finally, it was suggested that the use of rhBMP-2 - without bone grafting materials 
- will offer a new method of osseous reconstruction in clinical facial bone defects.
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For instance, Zhou et al.109 compared in a non-human primate (Rhesus 
monkey) bilateral, segmental defect model of the mandibular body, mandibular 
reconstruction with prefabricated, vascularized tissue-engineered bone flaps with 
rhBMP-2 (i.e.: demineralized freeze-dried bone allograft carrier loaded with 
rhBMP-2 (P-DFDBA-BMP) or coralline hydroxyapatite loaded with rhBMP-2 
(P-CHA-BMP) implanted in the latissimus dorsi muscle for prefabrication) and 
rhBMP-2 in situ (i.e.: DFDBA loaded with rhBMP-2 (S-DFDBA-BMP)  or CHA 
loaded with  rhBMP-2 (S-CHA-BMP)  directly applied to the segmental defect). At 
26 weeks after implantation the mandibular defects were reconstructed successfully 
with P-DFDBA-BMP, P-CHA-BMP as well as S-CHA-BMP. However, this was 
not the case for S-DFDBA-BMP. With S-DFDBA-BMP implants, half of the area 
of the defect was occupied by bone regenerated from the two ends to the center, but 
the center of the defect was occupied by soft tissues and thus the discontinuity of 
the mandible remained. However, mechanical testing of the restored jaw segments 
was not done. Moreover, for the P-CHA-BMP and S-CHA-BMP groups the CHA 
blocks were partly absorbed, whereas for P-DFDBA-BMP as well as S-DFDBA-
BMP the blocks of DFDBA had disappeared completely. Apparently, in the current 
primate model DFDBA, which is mainly composed of insoluble, highly cross-
linked type I collagen, might not be a favorable carrier for the in-situ application 
of rhBMP-2.
Furthermore, Seto et al.102 evaluated in a non-human primate (Japanese 
monkey) unilateral, segmental defect model of the mandibular body, reconstruction 
with an rhBMP-2/polyglycolic co-lactic acid (PGLA) complex and autogenous 
bone marrow in different ratios. Therefore, rhBMP-2 was suspended in a solution 
of PGLA and lyophilized to make an rhBMP-2/PGLA complex. Thereafter, the 
rhBMP-2/PGLA complex combined with autogenous bone marrow in ratios of 
3:0, 2.5:0.5, 2:1 or 0:3 (i.e.: vol:vol) were implanted into mandibular continuity 
defects. Sixteen weeks after surgery, the implantation of rhBMP-2/PGLA alone 
resulted in the formation of only small amounts of bone in 2 out of 3 monkeys and 
was associated with the infiltration of fibrous tissue into the bone defects. Similarly, 
the 2.5:0.5 combination of rhBMP-2/PGLA and bone morrow, although it was 
associated with larger amounts of new bone, did not generate complete bony union 
in 2 of 3 monkeys. Conversely, in all monkeys implanted with the 2:1 or the 0:3 
mixtures of rhBMP-2/PGLA and bone marrow complete bone formation in the 
site of the mandibular continuity defects as well as complete bone bridging was 
established. However, results of biomechanical testing or data regarding scaffold 
degradation were not given. Moreover, the biologic activity of rhBMP-2 within the 
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rhBMP-2/PGLA polymer was not tested. Thus, the substantiation for judgment of 
the authors that it is not clear whether BMPs will definitely induce bone formation 
in humans is somewhat speculative.
In a sheep unilateral, segmental defect model of the mandibular body, Ayoub 
et al.17 applied rhBMP-7 in a bovine collagen type I carrier wrapped into a sterno-
occipitalis muscle flap. Three months after surgery, bridging of the surgical defect 
was found in only 3 out of 5 animals.
Addendum No. 3
Kokemueller et al.119 restored an unilateral, segmental defect of the mandibular body 
in a patient with prefabricated, vascularized bioartifical bone grafts. The patient was 
a 57-year old man, who had suffered from chronic osteomyelitis for many years 
and finally underwent continuity resection with loss of his left hemimandible. For 
prefabrication of vascularized bioartifical bone grafts, three bone biopsies from the 
iliac crest were harvested, morselized and mixed with amorphous bone marrow 
aspirate from the depth of the biopsy areas. After dissection of the latissimus dorsi 
muscle on the patient’s left side and preparation of perforating vessels from the 
thoraco-dorsal trunk, four blood soaked β-TCP cylinders were supplied with a 
central vascular bundle and loaded with the harvested osteogenic material. Six 
months thereafter, the prefabricated, vascularized bioartifical bone grafts were 
transplanted into the mandibular continuity defect area and kept in place by a 
titanium mesh. There were no complications regarding postoperative recovery. 
Twelve months after surgery, there were no signs of infection or rejection at the site 
of transplantation. However, bone histology or data regarding scaffold degradation 
were not presented. Finally the authors assumed that prefabricated, vascularized 
bioartifical bone grafts have the potential to change the current principles of bone 
transplantation and that they may serve as a new therapeutic option in the future.
Comparable results were reported by Warnke et al.113, 114 after mandibular 
reconstruction of one patient with a prefabricated, vascularized bioartifical bone 
graft. For prefabrication, xenogeneic bone mineral blocks as osteoconductive 
carrier, autologous bone marrow from the iliac crest and rhBMP-7 loaded onto 
bovine collagen type I were combined.
Furthermore, Herford and Cicciù120 reconstructed, after en bloc resection of a 
giant cell tumor, a segmental defect of the mandibular body in a 25-year-old patient 
by using autogenous hip bone transplants screwed onto a titanium reconstruction 
plate covered by a rhBMP-2 containing collagen sponge. After three months of 
healing, clinical palpation of the mucosa overlying the resected area displayed the 
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hard indurated calcifying surface of the regenerated bone. Moreover, six months 
postoperatively radiographic evidence of mandibular continuity was found. 
However, bone histology was not presented. Somehow speculative, as Herford and 
Cicciù120 combined rhBMP-2 with autogenous hip bone, bone growth cytokines 
were considered as predictable alternative to traditional grafting techniques.
Likewise, Herford et al.115 reported in an 18-year-old patient comparable effects 
for the combined therapeutic use of autogenous iliac crest bone and rhBMP-2. 
Additionally, Carter et al.117 published for autogenous bone marrow combined with 
allogenic bone as osteoconductive scaffolds and rhBMP-2 impregnated collagen 
sponges similar results in two patients. However the published outcomes were not 
uniform. It should be highlighted that in one case of Carter et al.117 autogenous 
bone marrow combined with allogenic bone and rhBMP-2 impregnated collagen 
sponges was not associated with bony union. 
After en bloc resection of a dentinogenic ghost cell tumor, Cicciù et al.121 
restored an unilateral, segmental defect of the mandibular body in an 18-year-old 
patient by rhBMP-2 loaded onto collagen mixed with mineralized or demineralized 
allograft bone as osteoconductive scaffold. After three months of healing, clinical 
palpation of the mucosa overlying the resected area displayed the hard indurated 
calcifying surface of the regenerated bone. Moreover, radiographic evidence of 
mandibular continuity was presented after nine months of healing. Accordingly, 
nine months postoperatively the titanium mesh was removed and dental implants 
were placed. However, bone histology or data regarding scaffold degradation were 
not presented. Finally the authors speculated that for osseous defect regeneration, 
the use of exogenous cytokines, particularly those in the BMPs series, will become 
common. 
Comparable outcomes for rhBMP-2 loaded onto collagen sponges without the 
additional application of osteoconductive bone allografts were reported by Herford 
et al.115 as well as Herford and Boyne118. However, the outcomes were not consistent. 
It should be underlined that in one case of Carter et al.117 rhBMP-2 loaded onto 
absorbable collagen sponges did not induce bone formation. 
Moreover, Clokie and Sandor116 reconstructed segmental defects of the anterior 
mandible (one case), the mandibular body (five cases), the ramus of the mandible 
(one case) as well as the combination of ramus and body of the mandible (three cases) 
in a total of ten patients with rhBMP-7 mixed with osteoconductive demineralized 
bone matrix in a reverse-phase medium (BMP bioimplant). However, the paper 
of Clokie and Sandor116  is somehow inconsistent. For example, they report that 
all patients were followed for a minimum of nine months and that all patients 
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demonstrated clinical as well as radiographic evidence of restored mandibular 
continuity, but they also state that radiographic evidence of bone formation was 
not fully evident until one year after reconstruction. Additionally, according to the 
authors, both functional and esthetic results were comparable if not superior to 
those achieved with autogenous bone grafting, but bone histology or data regarding 
scaffold degradation were not presented. 
Similar effects for native human BMPs delivered in an allogenic demineralized 
bone matrix gel (Moghadam et al.111) as well as xenogeneic BMPs combined with 
an allogenic bone matrix as delivery system (Ferretti C and Ripamonti U112) have 
been published. However, it should be mentioned that only two out of six patients 
of Ferretti C and Ripamonti U112 treated with xenogeneic BMPs combined with an 
allogenic bone matrix as carrier demonstrated histological evidence of osteogenic 
activity or radiographic signs of ossification. 
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Introduction
In previous studies, a titanium modular mandibular endoprosthesis has been 
developed to repair segmental defects of the mandible, which demonstrated 
stability and good fixation to bone in animal studies.1, 2 However, in some instances, 
dehiscence has proven to be a problem especially when the soft tissue does not 
adhere to the body of device, with subsequent exposure of the prosthesis.3   
It is known that implant surface chemistry, shape, and mechanical properties 
are all factors that affect the implant-soft tissue adhesion.3 For example, implant 
surface topography has a major effect on implant tissue response.4 Smooth surfaced 
implants result in a foreign body reaction, which is characterized by fibrous tissue 
encapsulation of the implant and the presence of inflammatory cells at the implant-
soft tissue interface. On the other hand, implant surface roughness can have a 
favorable effect on the soft tissue response. It has been suggested that implants with 
a surface roughness value of 3.3 microns or larger tend to become infiltrated with 
inflammatory tissue, while implants with a surface roughness value 1 to 2 microns 
porosity appear to allow direct fibroblast attachment to the surface, which is 
supposed to be independent of the physico-chemical nature of the implant surface.4 
Although the relationship between material surface topography and cellular behavior 
is complex and still not fully understood, Unadkat et al., hypothesized that changes 
in the surface topography can affect cellular responses to a material by mimicking 
the influence and action of growth factors.5  Substrate surface features have been 
shown to induce significant modulation of focal adhesion formation, cytoskeletal 
development, and cellular spreading, changes that are subsequently transduced to 
signaling pathways, affecting functional differentiation through integrin-specific 
signaling pathways.6 Surface roughness and total surface area of an implant can 
be favorable for increased cell adhesion and migration as well as the production of 
extra cellular matrix (ECM). In view of this, implant surfaces with a texture such 
as nodes, pores, grooves or random patterns are often associated with a marked 
change of cell morphology, cell activity and cellular production of autocrine as well 
as paracrine regulatory factors compared to smooth surface.7 
Implant surface roughness can be created by adding or subtracting material from 
the implant surface. Addition of material can be done by a coating procedure8, 9 i.e. 
titanium plasma spraying and subtraction can be done by grit-blasting10-12 or etching 
procedures13, 14. Most of the studies to date have investigated the effect of increased 
surface roughness of the implant on bone regeneration. However, there were less 
studies investigating the effect on soft tissue attachment. Lee et al., 2010, designed 
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an experiment to study the effect of titanium surface modification on soft tissue 
attachment.3 Both machine surfaced and etched titanium bullets were implanted 
for 6 months in the muscle of Macaca fascicularis monkeys. The histological results 
showed a lack of direct contact between muscle tissue and machined titanium 
implant surface. Also, surface etching did not result in a significant improvement 
to the soft tissue attachment compared to the machined titanium surface.3 
Although titanium is preferred for bone reconstruction due to its mechanical 
strength and ability to withstand long-term loading, tissue adaptation to titanium 
surface is still limited.  The soft tissue response to an implant material is also 
dependent on the mechanical properties of the biomaterial.15 In general, less stiff 
biomaterials improve the soft tissue response. The mechanical properties of polymers 
are easier to fine-tune in order to get a better soft tissue response than metals, like 
titanium. A candidate material, as can be used for the fabricating of a modular 
endoprothesis with an improved soft tissue adaptation, is poly(ε-caprolactone) 
(PCL). This material has several advantages over other polymers. It is more stable 
in ambient conditions, significantly less expensive and is readily available in large 
quantities.16, 17 In addition, PCL can be easily combined with other materials in order 
to further formulate the tissue response. Active screen plasma surface modification 
has been shown to improve osteoblast cell adhesion and spreading on PCL surface18, 
while chemical hydrolysis to introduce carboxylate groups onto the surface of the 
PCL was found to improve surface wettability and roughness of the PCL, which 
was correlated with increased cell attachment.19 Several techniques are available to 
manufacture an implant from PCL. One of the approaches is laser sintering, where 
small PCL particles are selectively fused layer-by-layer by a high power laser to build 
a three-dimensional (3D) device. This method allows adaptation of the mechanical 
properties of the final implant.20 Selective laser-sintered (SLS) and solid free-form 
fabrication (SFF) manufactured PCL scaffolds with a porosity between 37-55% 
were reported to have mechanical properties comparable with human trabecular 
bone. The compressive modulus of such scaffolds was found to be within the 52–68 
MPa range, and the ultimate compressive strength was within the 2.0–3.2 MPa 
range, which makes this material an attractive substitute for human bone and its 
application in for bone reconstruction in load bearing areas.20 
For the current study, we hypothesized that implants made of PCL would 
lead to better soft tissue adaptability and adhesion than commercially pure 
titanium implants. In addition, we supposed that surface roughening, created by 
the deposition of a CHA coating on PCL, would further improve the soft tissue 
response. Therefore, implants were incubated in modified Simulated Body Fluid 
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(mSBF), which resulted in the nucleation and growth of a CHA coating on the 
implant surface.
A subcutaneous rabbit model was used to study the soft tissue response. Analysis 
after 5 weeks of implantation was based on a tissue peel test to determine the force 
required to separate the soft tissue from the various implant surfaces and on light 
microscopy examination. 
Materials and Methods
Implant Materials
Non-coated PCL, CHA coated PCL, and commercially titanium (Ti) implants 
were manufactured. The implants were rectangular-shaped, measured 10 x 5 x 3 
mm, and were provided with rounded off corners and edges. The PCL implants 
were fabricated via laser sintering as previously reported.20 The PCL implants were 
used as-received or were coated with CHA by incubation at 37°C in mSBF for 8 
days under continuous rotation. Prior to mSBF incubation, the PCL plates were 
hydrolyzed in a 1 M NaOH for 60 min. After hydrolysis, plates were rinsed and 
incubated in the mSBF. The mSBF solution has a similar composition to that of 
human plasma and also to that of the SBF solution reported by Kokubo et al., 
but with double the concentration of calcium and phosphate to enhance mineral 
growth, and was prepared as previously reported.21, 22 Briefly, 141mM NaCl, 
4.0mM KCl, 0.5mM MgSO4, 1.0mM MgCl2, 4.2mM NaHCO3, 5.0mM CaCl2, 
and 2.0mM KH2PO4 in deionized ultra-filtered water, pH was adjusted to 6.8 with 
2N HCl or 2N NaOH.  
Prior to their use in the in vivo study, PCL and CHA coated PCL implants were 
sterilized by ethylene oxide and Ti plates were sterilized by autoclave.
Animal Model and Implantation Procedure
The animal experimental protocol was approved by the Institutional Animal Care 
and Use Committee (IACUC) of Singhealth, Singapore. The animal laboratory 
was certified by the International Association for Assessment of Laboratory Animal 
Care (IAALAC).
Nine female New Zealand white rabbits, 3–4 months old, were used in this study. 
The surgery was performed under general anesthesia by intramuscular injection 
of 1.5 mg Ketamine (Parnell Laboratories, Alexandria, Australia). Anesthesia was 
maintained by 1-1.5% isoflurane gas through a mask with constant volume ventilator. 
Heart rate and oxygen saturation were monitored during the procedure. 
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Prior to surgery the skin was shaved, washed and disinfected with povidone 
iodine 1% solution, Hexodane 0.5% (Chlorhexidine 0.05% W/V in Methylated 
Spirit 70%) and centrimide 1% solution. Each animal was given a unique code. 
Six longitudinal incisions of about 1.5 cm were made at the left and right side 
of the vertebral column at 3 cm apart of each other. Six subcutaneous pockets 
were prepared by blunt dissection with scissors. Each of the pockets in each 
animal received one of the 3 types of implants. A randomization schedule was 
made for implant allocation, which listed the animal’s code and the corresponding 
subcutaneous pocket number (1–6) in each animal.
Six implants (2 PCL, 2 CHA coated PCL and 2 Ti) were inserted into each 
rabbit. With 9 rabbits used, a total of fifty four implants were inserted (18 PCL, 18 
CHA coated PCL and 18 Ti). After implant installation, the wounds were closed 
using 3-0 Vicryl® intracutaneous sutures (Ethicon Inc., Somerville, NJ, USA). After 
5 weeks, all animals were euthanized and the implants with surrounding tissues (a 
rectangular patch of the skin encompassing each plate) were harvested.
After harvesting, the retrieved specimens were divided into two equally-sized 
groups, i.e., one group was used for testing of the soft tissue adhesion strength and 
the other was used for histological analysis.
Peel-Test Procedure
Immediately after harvesting of the plates, 27 samples (9 of each plate type) were 
subjected to a soft tissue peel-test using an Instron® 8800 microforce tester (Instron 
Corporation, Satec™, Norwood, MA, USA) equipped with a static load cell with 
a capacity of 10 N. 
All specimens were prepared before installation into the Instron® machine (Fig. 
1), i.e., one-third of the plate surface was exposed to allow its grip by the lower 
grip of the machine, while the remaining two-third of the attached tissue was kept 
intact to the plate for peel test. One end of the soft tissue was attached vertically 
to the upper grip of the testing machine and the plate surface was kept parallel 
(180 degree) to the tension force. A tension force was applied with the top upper 
arm of the machine, which was moving upwards at a speed of 5 mm/min. The 
test was carried out until tissue was completely peeled off from the plate surface. 
Mechanical data were recorded and the corresponding force-displacement curves 
were generated. The values of maximum force attained were then averaged and 
the standard deviations were calculated. After performance of the peel test, the 
specimens were fixed in 10% formaldehyde for further evaluation with scanning 
electron microscopy (SEM). 
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(a)                                                                                 (b)
Figure 1. Specimens were installed in Instron® 8800 machine for tissue peel test; 
(a) before and  (b) during peel test for PCL plate
   
Scanning Electron Microscopy (SEM)
The morphology of the plates before and after implantation was investigated by 
SEM. PCL and CHA coated PCL plates were mounted on aluminum stubs and 
sputter coated with a thin layer of gold. Samples were imaged under high vacuum 
using a Philips XL30 FEG scanning electron microscope (Hillsboro, Oregon, USA) 
operating at 10 kV. Ti plates were mounted on stub and examined at 20 kV without 
gold sputter coated. 
Histological Analysis
Before histological preparation, the specimens with their surrounding tissues were 
immersed for 1 week in buffered 10% formalin solution for fixation (ICM Pharma 
Pte Ltd, Singapore), then dehydrated in a graded series of alcohol and embedded in 
methylmetacrylate (MMA). After polymerization, the tissue blocks were mounted 
in a modified inner circular saw microtome (Leica® RM 2165, Wetzlar Germany). 
At least, three histological sections were made from each specimen. Sections had 
a thickness of 10-15 µm and were stained with methylene blue/basic fuchsin and 
examined using a light microscope (Olympus® U-D03, Tokyo, Japan)
All sections were observed and independently scored by two blinded observers 
(N Chanchareonsook and Lee S) using an established soft tissue histology grading 
scale23, as shown in Table I. When the two observers disagreed on a score, the 
section was discussed until a consensus was reached. The thickness of capsule around 
implants was measured in micrometers (µm) using ‘CellA’ digital imaging software 
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program (Olympus®, Germany). Subsequently, the means of capsule thickness of 
each implant type were calculated.
Table I. Soft Tissue Histologic Grading Scale 
(adapted and modified by Jansen et al., 1994)
Evaluation Response Score
Capsule 
qualitatively
Capsule is fibrous, mature, not dense, resembling 
connective or fat tissue in the non-injured regions
4
Capsule tissue is fibrous but immature, showing 
fibroblasts and little collagen
3
Capsule tissue granulous and dense, containing both 
fibroblasts and many inflammatory cells
2
Capsule consists of masses of inflammatory cells with 
little or no signs of connective tissue organization
1
Cannot be evaluated because of infection or other 
factors not necessarily related to the material
0
Interface 
qualitatively
Fibroblasts contact the implant surface without the 
presence of macrophages or leucocytes
4
scattered foci of macrophages and leucocytes are 
present
3
one layer of macrophages and leucocytes are present 2
Multiple layers of macrophages and leucocytes are 
present
1
Cannot be evaluated because of infection or other 
factors not necessarily related to the material
0
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Statistical Analysis
Data from the peel-test and histological measurements were statistically analyzed 
using SAS 9.2 statistical software (SAS Institute Inc, Cary, North Carolina). 
Measurements were evaluated by Analysis of Variance (ANOVA) with pair-wise 
comparison post test to identify the groups that differed from each other. This was 
done with no correction for the Type I error rate across the pair-wise tests. A P-value 
< 0.05 was considered significant.
Results
Clinical Examination
At 5 weeks after surgery, all rabbits tolerated the implant installation very well. 
Tissue necrosis was observed in only one animal in the area where Ketamine was 
injected. This site was close to a CHA coated PCL plate. Therefore, this specimen was 
subsequently excluded from further analysis to avoid an effect on the experimental 
results. In all other animals, the surgical sites presented good healing without any 
wound dehiscence. All plates were palpable through the skin. It appeared that some 
of the plates had migrated from the insertion site. The Ti-plates had migrated over 
a distance of 0-4 cm, while CHA coated and non-coated PCL plates had migrated 
by 0-1 cm.
Peel-Testing
Two of the 27 samples were excluded from the peel-test study. One CHA coated 
PCL was excluded due to necrosis of skin from the effect of Ketamine injection 
and one Ti plate sample was excluded due to formation of hematoma on the plate 
surface during tissue manipulation at tissue harvesting. 
The average energy used for the peel test for Ti, PCL and CHA coated PCL was 
0.728x10-3, 0.543x10-3 and 0.274x10-3 J respectively. The average peel force for Ti, 
PCL and CHA coated PCL was 0.17, 0.104 and 0.098 N respectively. (Fig. 2)
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FIGURE 2. Peel test analysis of machined surface Ti implant, non-coated PCL 
implant and PCL surface coated with carbonate-substituted hydroxyapatite (CHA). 
 
3.3 Surface morphology 
It is shown from SEM images that the non-coated PCL implants have rougher 
surface appearance than those of the Ti implants. The CHA coating, as deposited on 
the PCL implants, had a microscale plate-like morphology and increased the surface 
roughness of the PCL implants compared with the non-coated ones. After 5 weeks 
of implantation, the surfaces of the Implants after the peel test were not altered 
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Figure 2. Peel test analysis of machined surface Ti implant, non-coated PCL implant 
and PCL surface coated with carbonate-substituted hydroxyapatite (CHA).
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Surface Morphology
It is shown from SEM images that the non-coated PCL implants have rougher 
surface appearance than those of the Ti implants. The CHA coating, as deposited 
on the PCL implants, had a microscale plate-like morphology and increased the 
surface roughness of the PCL implants compared with the non-coated ones. After 
5 weeks of implantation, the surfaces of the Implants after the peel test were not 
altered considerably compared to images before implantation (Fig.3). There were 
no remaining tissue and cells visible on all plate types after the peel test.
Non-coated PCL
(a) Before                                                                  (b) After
Coated PCL 
(c) Before                                                                  (d) After
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Ti
(e) Before                                                                  (f) After
Figure 3. Scanning electron microscopy (SEM) images of Ti-plates, coated and non 
coated PCL plates before and after 5 weeks of subcutaneous tissue implantation 
in the rabbit model: a) non-coated PCL before surgery, b) non-coated PCL after 
implantation and peel test, c) coated PCL before surgery, d) coated PCL after 
implantation and peel test, e) machined-surface titanium plate before surgery and 
f) machined-surface titanium plate after implantation and peel test. The images 
demonstrated the rough surface of each implant type, i.e. the excellent pattern of 
microscale plate-like morphology of coated PCL as well as the machined surface 
appearance of the Ti-plates. The implant surfaces in all type did not show any 
remnant of connective tissue as left on the surface.
Histological Analysis
Evaluation of the histological sections revealed a fairly uniform tissue response for 
the 3 types of implant. In all sections, normal skin and underlying tissues, including 
fat tissue, could be observed. The surface of both CHA coated and non-coated PCL 
plates appeared to be rougher compared with those of the Ti implants. The CHA 
layer on the coated PCL implants could easily be identified and was visible a thin 
red layer on the outer surface of these implants. 
All implants were found to be surrounded by a fibrous tissue capsule. This 
capsule was about 7 to 8 cell layers in thickness for PCL and CHA PCL coated 
implants and 14 to 17 cell layers for Ti- implants. The capsule had an aligned 
morphology with collagen bundles running parallel to the implant surface. 
Occasionally inflammatory cells were seen in the interface between capsule and 
implant surface. The presence of inflammatory cells was more evident for the PCL 
implants compared with the titanium implants (Fig.4). 
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Figure 4. Histological images of non-coated PCL plates, coated PCL plates and 
Ti-plates after 5 weeks of subcutaneous tissue implantation in the rabbit model Ti: 
Titanium implant; FC: Fibrous capsule; PCL: Polycaprolactone implant; C : carbonate-
substituted hydroxyapatite (CHA) Coating; IC: Inflammatory cells (Methylene blue 
and basic fuchsin) a) to c) magnification of x4, d) to f) magnification of x10 and g) to 
i) magnification of x40.
Histomorphometry
The average capsule thickness around the PCL implant was 34.3 ± 15.5 µm, around 
CHA coated PCL 50.8 ± 16.4 µm and around the Ti-plate was 62.2 ± 15.7 µm. 
Statistical testing revealed that the capsule around the non-coated PCL plate was 
significantly thinner compared with the CHA coated PCL and Ti plates (Table II). 
Also, the capsule around the CHA coated PCL plates was found to be significantly 
thinner compared to that on the Ti plates (Table II). 
(a) Ti-plate (x4)  (b) Non coated PCL-plate (x4)  (c) CHA Coated PCL-plate (x4)
 (d) Ti-plate (x10)  (e) Non coated PCL-plate (x10)  (f) CHA Coated PCL-plate (x10)
(g) Ti-plate (x40)  (h) Non coated PCL-plate (x40)  (i) CHA Coated PCL-plate (x40)
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Table II. The average capsule thickness and Pair-wise comparisons between implant 
type. The result showed significant different with respect to capsule thickness.
Type of 
plates
Mean of 
capsule 
thickness (µm) 
(± SD.)
Pair-wise Comparisons between Means
Non-coated 
PCL
ChA Coated 
PCL
Ti
Non coated 
pCL
34.3(±15.5) - 0.0003** <.0001**
Cha Coated 
pCL-plate
50.8(±16.4) 0.0003** - 0.0101**
ti 62.2(±15.7) <.0001** 0.0101** -
**Statistically significant difference (p≤0.05)
The soft tissue grading scores for capsule quality and interfacial tissue response 
are depicted in Figure 5. The mean soft tissue grading score for capsule quality 
of PCL, CHA coated PCL and Ti implants are 1.6 ± 0.6, 2.5 ± 0.5 and 2.8 ± 0.4 
respectively. The mean soft tissue grading score for interface quality of PCL, CHA 
coated PCL and Ti implants are 1.0 ± 0.0, 1.4 ± 0.8 and 3 ± 0.7 (Fig. 5).
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(b)
Figure 5. Grading scale scores of capsule quality and interface quality for PCL, CHA-
coated PCL and Ti implants. The comparison of percent score distribution of capsule 
quantity, capsule quality and interface quality between implant types were analyzed 
by pair-wise comparison. The Significant differences for capsule quality were found 
between non-coated PCL vs PCL coated with CHA (p < .001), non-coated PCL vs 
Ti (p < .001) and PCL coated with CHA vs Ti, (p = .042).  Significant differences for 
capsule interface quality were found between non-coated PCL vs PCL coated with 
CHA (p = .010), non-coated PCL vs Ti (p < .001) and PCL coated with CHA vs Ti (p 
< .001).
Statistical analysis by Fisher’s exact test on global null hypothesis testing showed 
homogeneity of data distribution for all three implant groups. The comparison of 
percent score distribution of capsule quality and interface quality between implant 
types was analyzed by Pair-wise comparisons. The results show that all three groups 
differed significantly relative to capsule quality and capsule interface quality.
Discussion
Soft tissue adherence between host tissues and an implant is important to minimize 
implant-soft tissue dehiscence, to improve the long-term performance of a device 
in vivo and to reduce the occurrence of infection. Metallic and polymeric implants 
are known to become surrounded by a fibrous tissue capsule after their installation 
in soft body tissue.3, 24, 25 Physical properties such as implant shape, mechanical 
properties of the implant material, and degree of surface roughness as well as 
chemical properties determine the final soft tissue response.3  
In this study, rectangular plates composed of different materials, i.e., 
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commercially pure titanium (Ti), non-coated PCL and CHA coated PCL were 
inserted subcutaneously into the back of rabbits for 5 weeks. It was hypothesized 
that: (1) the PCL implant would show an improved soft tissue response compared 
to the Ti implant, and (2) the CHA coating, as provided to the PCL plates, would 
further favor the soft tissue reaction. However, histological analysis after retrieval 
of the implants did not confirm the hypothesis. Overall, the soft tissue response to 
all implants was very similar and no direct attachment of connective tissue to the 
various surfaces was observed. 
Clinical observation of the implants after 5 weeks of installation in the rabbits 
showed that the machined surfaces Ti plates had migrated over a distance of 0-4 
cm. This was more than the coated and non-coated PCL plates, which were found 
to have migrated 0 to 1 cm. Such migrational behavior is commonly found when 
implants are inserted in soft tissue without any additional fixation to the soft tissue 
layer and is related to the soft tissue adhesion of each particular implant surface. The 
degree of migration indicates a lack of soft tissue adhesion of the implant surface. 
The current findings corroborate with an earlier study dealing with the migration of 
microchips in Beagle dogs.26 In this study, microchips made of 3 different materials, 
i.e., bioglass, acid-etched bioglass and bioglass provided with a polypropylene cap 
were installed in the soft tissue around head and shoulder of the Beagle dogs for 
16 weeks. Different degrees of microchip migration were observed, which was 
depending on the location and the used material. The microchips in the shoulder, 
which had more muscle activity, showed a migration up to the maximum of 11 cm. 
In contrast, the microchips in the head area moved only to a maximum distance of 
2 cm from their insertion point. Further, the microchips made of etched bioglass 
or provided with a polypropylene cap were found to migrate significantly less than 
microchips made of just bioglass.26  
To define the level of soft tissue attachment with the implant surface, we made 
use of a tissue peel test. Bobyn JD et al.27, found that the increased strength of tissue 
attachment is correlated with implantation time. Similarly, in an earlier pilot study, 
we demonstrated that specimens at 2 weeks of plate implantation (result not shown) 
demonstrated a poor soft tissue attachment irrespective of the implant surface finish. 
Therefore in the current study, the implantation time was increased to 5 weeks to 
allow for the maturation of the tissue attachment. Subsequently, the peel test data 
demonstrated that there was no significant difference in peel test readings between 
the different implant surfaces and therefore no relevant mechanical effect of implant 
surface preparation on soft-tissue bonding was observed. However, we found that 
during the peel test, tissue adhesion between implant and fresh subcutaneous rabbit 
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specimen was fragile and the peel test required highly delicate tissue manipulation 
especially when the samples were small in size.  As a consequence, the protocol for 
the tissue peel test still has room for improvement in future studies. Furthermore, 
the pores and channels in the PCL structure allowed a better maintenance of 
moisture than the titanium implant. This can inadvertently affect the peel test 
result, as faster desiccation of the soft tissue on the titanium implant during testing 
may lead to increased adhesion. In future experiments, environmental control 
of moisture and temperature should be regulated to ensure that the soft tissue 
specimens remain in their optimal condition. 
No previous studies are available, in which a peel test was done for PCL. Overall, 
our peel force results were found to be lower compared with previous studies.27, 
28, 29 Hacking et al.28, studied fibrous tissue ingrowth and attachment to porous 
tantalum after insertion in the dorsal subcutaneous tissue in dogs. A peel test was 
done using a servo-hydraulic tensile test machine at a rate of 5 mm/min. Peel force 
at 4, 8, and 16 weeks was reported at 61, 71, and 89 g/mm respectively.28 Zhao D et 
al.29, studied titanium fiber mesh with 84.7% porosity and compared this material 
with conical implants coated with various compositions of bioactive glass. Ti mesh 
was inserted into the dorsal subcutaneous soft tissue and muscles in the back of rats 
for 8 weeks. Titanium fiber mesh implants showed a relatively high pull-out force 
in subcutaneous tissue (12.33 ± 5.29 N, mean ± SD) and in muscle tissue (2.46 
+ 1.33 N).29 Bobyn JD et al.27, installed porous metal plates in the subcutaneous 
tissue of mongrel dogs. The largest metal pore size with the approximate range of 
50-200 microns produced a mean peel strength of attachment of 27.5 g/mm after 
16 weeks of implantation period. All these high values can be explained by the 
nature of the implant material used. A highly porous material will allow a better 
penetration of the soft tissues compared with the current materials.
The histological analysis showed a lack of direct contact between the soft tissue 
and implant surface. The observed formation of a fibrous capsule around the 
machined surface titanium implant with the presence of none or very minimal 
inflammatory cells, is similar to a previous study.3 Titanium is an ‘inert’ material 
and causes a minimal immune response and foreign body reaction in soft tissue.30 
This is the reason that many commercially available implantable devices (like 
pacemaker) are made of medical grade titanium (alloy).
In the present study, coated and non-coated PCL plate was found to be superior 
compared to the Ti implant in terms of fibrous capsule thickness. However, the 
fibrous capsule was found to be less mature and contained more macrophages and 
inflammatory cells at the tissue–implant interface than the Ti implants. The surface 
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modification with a CHA coating on PCL plate increased the surface roughness as 
shown in the SEM images (Fig. 3). PCL implant with CHA surface coating showed 
a significant improvement in capsule quality and tissue–implant interface quality, 
as observed by the reduction of inflammatory cells. This effect can be due to the 
increased surface roughness as created by the CHA coating. On the other hand, 
coating of PCL with CHA can also change the mechanical properties of PCL, i.e 
the material becomes less flexible, which can also affect the soft tissue response. 
PCL matrices are known to degrade at low rates by hydrolysis of the ester bonds 
and break down to their constituent monomer-hydroxycaproic acid, which then 
undergoes phagocytosis. PCL is characterized by a very low hydrolysis rate, which 
can vary from months to years.31 Therefore, the degradation process of PCL during 
the 5 weeks implantation period in this study was supposed to have no effect on the 
study result. For PCL coated with CHA, the CHA was still found to be intact at 
the end of 5 weeks and was clearly visible in the histological sections. Nevertheless, 
future research has to elucidate the effect of CHA on the biodegradation rate and 
bone regeneration properties of PCL.
Conclusions
The data of the current study indicate that none of the materials as well as surface 
modifications resulted in a superior soft tissue response. The peel test showed that 
adhesion of the soft tissues did not occur. Although, both types of PCL implants 
showed less migrational behavior compared with the Ti implants, soft tissue 
adhesion was not observed for any of the investigated implants, as demonstrated 
by the peel test data. Fibrous capsule formation around the non-coated and CHA 
coated PCL implants was less than around the Ti implants. On the other hand, an 
increased amount of interfacial inflammatory cells was present for all PCL implants 
compared with the Ti implants. 
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Introduction
In orthopaedics, the use of a metallic endoprosthesis for skeletal reconstruction 
after segmental bone resection has been reported for several decades.1, 2 A modular 
concept was introduced in the late 1980s, which helps to eliminate the need for 
device customization.3 The prefabricated components of the various modular 
sizes allow to be assembled together during surgery.4 Both cemented and non-
cemented methods have been used to fixate the device into the remaining bone. 
The cementless approach requires the use of materials that support the achievement 
of a good secondary fixation into the bone in order to avoid later loosening. 
Controversial failure and success data have been reported with the use of cementless 
orthopaedic devices.5 Abraham et al. found that the complication rate in the short-
term outcomes of cementless modular endoprostheses to reconstruct the proximal 
femur, distal femur, and proximal tibia were relatively low to previously reported 
results of cemented implants.6 
In oral and maxillofacial reconstruction, a titanium-6 aluminum-4 vanadium 
(Ti6Al4V) modular endoprosthesis was introduced for mandibular segmental 
reconstruction by Lee et al.7 The devices were fixed in the mandible of Macaca 
fascicularis using polymethyl methacrylate (PMMA) cement into the remaining 
bone stumps for 6 months. The study showed an abundance of bone formation 
around the body of the modular endoprosthesis. Problems encountered, however, 
included loosening of the module connections and infection. In addition, the soft 
tissue healing was not ideal resulting in dehiscence and hardware exposure in some 
cases, while uneventful healing was experienced with a developed ramus/condyle 
replacement in a later study.8-10 
Based on the results of these previous studies, our research group modified 
the design of the endoprosthesis to better withstand the stresses from mastication 
forces. Therefore, the inter-modular connection of the device was re-designed using 
mechanical testing and finite element analysis to prevent component loosening.11, 12 
The biomechanical stability was found to be firm under simulated functional forces 
without having excessive stresses beyond the material strength of bone or titanium 
alloy.10 
Further, the surface of the modular stems was modified to allow fixation into the 
mandibular bone without using bone cement, i.e. a cementless endoprosthesis. The 
bioactive surface coating with hydroxyapatite (HA) [Ca10(PO4)6(OH)2]  and bioglass 
(BG) [SiO2-Na2O-CaO-P2O5] are selected for titanium surface modification to 
improve soft and hard tissue healing. HA and related calcium phosphates (CaP) 
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are present in large amounts in bone.13 HA-based materials are basically not 
biodegradable, but are found to possess excellent bone biocompatibility14-16 and 
are widely used in clinical practice in both the orthopaedics and dental field. HA 
coatings on dental implants have been shown to accelerate bone apposition, thereby 
shortening the waiting period for implant restoration.17 The additionally provided 
surface roughness increases the interface strength even further.18 As a consequence, 
higher survival rates have been reported than for just commercial pure-titanium 
and titanium-alloy implants.19 
Bioglass (BG) is an inorganic component with high bioactivity index and 
has the ability to bond to both soft as well as hard tissues.20 BG has been shown 
to increase the expression of vascular endothelial growth factor (VEGF) in vitro 
and to enhance vascularisation in vivo, suggesting that BG might stimulate neo-
vascularisation.21, 22 
The current study was designed to evaluate the effectiveness of bioactive-coated 
cementless modular mandibular endoprosthesis for mandibular reconstruction 
in Macaca fascicularis. The device was coated with HA/BG at the modular body 
surface, while the stems were coated with HA. We hypothesize that the bioactive-
coated cementless mandibular endoprosthesis will have: (1) sufficient load-bearing 
capability for masticatory function, (2) good bone and soft tissue healing at the 
reconstruction site and (3) no loosening of the device components during 6 months 
of study period. 
Materials and Methods
Animals
Nine, adult male, M. fascicularis monkeys, with an age of 4-6 years and weight of 
6-7 kg were used in this study. All monkeys were pathogen free, presented with 
full adult dentition and were in healthy condition. The experimental protocol was 
approved by the Institutional Animal Care and Use Committee of SingHealth in 
Singapore. The animal laboratory has been certified by the International Association 
for the Assessment of Laboratory Animal Care (IACUC), Singapore.
Ti6Al4V Modular Endoprosthesis
 
Design and Characterization 
The bioactive-coated cementless Ti6Al4V modular endoprosthesis is composed of 
two modular components, i.e.; (1) anterior module and (2) posterior module. The 
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connected device was 15 mm long, which was appropriate to replace and maintain 
the defect dimension. The device height was kept at 12 mm or 70% height of 
original mandible, while the width was 6 mm at occlusal and 4 mm at lower border, 
similar to the original size of mandible.  The two modules were joined together with 
a dovetail connection and secured with a vertical screw. The anterior and posterior 
stems consisted of tapered screws of 12 mm length. The stems were non-self cutting 
and therefore drilling of the cancellous bone of the mandibular stumps was required 
before their insertion (Fig. 1).
 
Figure 1. The bioactive-coated cementless Ti6Al4V mandibular endoprosthesis 
device. Body of the module was coated with Hydroxyapatite (HA) and Bioglass (BG). 
Both stem of the module were coated with Hydroxyapatite (HA).
Device surface coating with Hydroxyapatite (HA) & Hydroxyapatite/Bioglass (HA/BG)
The Ti6Al4V mandibular endoprosthesis was Al2O3 grit-blasted (60 mesh). 
Hydroxyapatite granules (HA, particle size 0.5-1.0 mm, CAMCERAM®, CAM 
Implants B.V, Leiden, Netherlands) and melt-derived bioglass crushed particles 
(Bioglass S53P4, particle size 30-315 µm, BonAlive®, Vivoxid Ltd, Turku, Finland) 
were used for coating deposition on the implant surfaces.
Hydroxyapatite (HA) and Hydroxyapatite/Bioglass (HA/BG) coatings were 
made by using a commercially available RF magnetron sputter deposition system 
(Edwards ESM100, Sussex, UK). The target materials for the coating deposition 
were the hydroxyapatite granules and bioglass particles. The endoprostheses were 
mounted on a rotating water cooled substrate holder. The distance with the targets 
was 80mm. During deposition, the argon pressure was kept at 5x10-3 mbar. The 
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following coatings were created:
1) Endoprosthesis body modules coated with  a mixture HA/BG; at a discharge 
power of respectively 100W and 100W, with a deposition time of 20 hours, 
resulting in a coating with a thickness of 2 µm.
2) Endoprosthesis stems coated with HA; at a discharge power of 400W for both 
targets, with a deposition time of 5 hours, resulting in a coating with a thickness 
of 2 µm.
After deposition, the coated specimens were subjected to an additional heat-
treatment for 2 h at 650°C. The composition of the coatings was confirmed by 
X-ray diffraction and Fourier Transform Infared analysis. The devices were sterilized 
by autoclave before placement in the experimental animals.
Surgical Procedure
The animals were made to fast overnight. They received 0.05 mg/kg of 
subcutaneously atropine and 10 mg/kg of Ketamine preoperatively.  Induction and 
maintenance of anesthesia were performed by a veterinarian using 2% isoflurane. 
Endotracheal intubation was done using oral endotracheal tubes of gauge 3.5 mm 
that was secured around the upper premolar tooth with ligature wire. Antibiotics 
(Ampicillin/Cloxacillin (Betamox®, Norbrook Pharmaceuticals Worldwide, Newry, 
Northern Ireland) 6-8 mg/kg subcutaneous) were given on induction and analgesics 
was given at the end of the surgery.   
The operation site was disinfected with 1% cetrimide followed by 2% 
chlorhexidine and povidone iodine and draped for surgery. Using an intra-oral 
approach, two vertical incisions were made; between the second bicuspid and the 
first molar as well as behind the second molar. A horizontal incision 2-3 mm below 
the attached gingiva was made connecting the two vertical incisions. The periosteum 
was reflected to expose the lower border of the mandible. A tapered fissure bur was 
employed to perform the resection which included a 1.5 cm mandibular segment, 
containing the first and second permanent molars and the attached gingiva. 
Bleeding from inferior mandibular canal was easily staunched.  The anterior and 
posterior bone stumps were prepared with a 0.8 mm fissure bur to 10 mm depth 
of the cancellous bone. The device stems were inserted with manual rotation until 
they fitted tightly and the edge of the module body was flushed with bone margin 
of the mandibular stump. The size of modular stems was selected to match the size 
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of mandibular bone stumps in each mandible. The modules were then connected 
and secured with the vertical screw at the superior aspect of the device (Fig. 2).
(2A)                                                                            (2B)
Figure 2. Mandibular segmental reconstruction using a bioactive-coated cementless 
Ti6Al4V modular endoprosthesis was inserted in segmental defect of Macaca 
fascicularis Monkey. Anterior and posterior modules were inserted tight fit to 
mandibular stumps (2A). The modules parts were connected and found immediate 
stability with well maintained the dimension of mandible (2B).
After insertion of the endoprostheses, the occlusion was evaluated. As intermaxillary 
fixation is not possible in this animal study, one titanium mini-plate (Medicon® 
miniplate, Germany) was fixed to the mandibular stumps using four 5mm screws. 
The buccinator and mylohyoid muscles were dissected, mobilized and approximated 
over the device using 4-0 Vicryl® sutures. This was followed by closure of the mucosa 
also using 4-0 Vicryl® sutures, therefore achieving a 2-layer closure. 
Immediately after the surgery, a lateral mandibular radiograph was taken using 
a Siemens POLIMOBIL plus® machine (Siemens Medical Solutions, Erlangen, 
Germany) set at 40 kV for 2 ms at a distance of 70 cm.  Thereafter, the animals 
were maintained in individual cages without restrain. Soft diet was provided until 
sacrifice. Ampicillin/Cloxacillin (Betamox®, Norbrook Pharmaceuticals Worldwide, 
Newry, Northern Ireland) 6-8mg/kg IM was given for 7 days post-surgically and 
repeated for 7 days, if there were signs of infection. Ketorolac trometamol (Toradol®, 
Hoffmann-La Roche Inc, Basel, Switzerland) 15-30mg/kg IM was given for 2-3 
days post-surgically. During the experimental period, the animals were monitored 
regularly and lateral mandibular radiographs were repeated using the same protocol, 
at 1 month, 3 months and 6 months. 
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Specimen Retrieval 
All animals were euthanized at 6 months postoperatively and weighed before 
euthanasia. The reconstruction site was examined for signs of infection, dehiscence, 
stability and occlusion. Mandible specimens were harvested from condyle to condyle 
with the device in situ. Soft tissue was removed except around the reconstructed 
site.
In four animals, the mandibles were harvested fresh as they were used for 
mechanical testing. In these animals, 3 ml of pentobarbitone sodium (Valabarb, 
Jurox, Rutherford, NSW, Australia) was injected into the cardiac chamber to 
euthanize the animals. The retrieved specimens were kept at frozen condition at 
-20ºC until ready for analysis. 
For the remaining five monkeys, harvesting was done after perfusion fixation. 
In these five animals, a 16-gauge intravenous catheter was inserted into the left 
ventricle and used to rinse the circulation with 300-500 ml of Hartman’s solution 
followed by 750 ml of a mixture of 2.5% paraformaldehyde and 2% glutaraldehyde. 
The specimens were kept immersed in 10% glutaraldehyde.
Analysis 
Micro-CT Evaluation
The specimens containing the endoprosthesis were scanned using a GE eXplore 
Locus SP MicroCT scanner (GE Healthcare, Thermo Scientific, Waltham, MA, 
USA), with a focal spot of 8 µm and pixel size of 18 µm and scanning configuration 
isotropic voxels of 8 µm x 8 µm x 8 µm focal spot size and isotropic resolutions at 
8 µm (Fig. 3).
 
(3A)                                                                            (3B)
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Figure 3. Micro CT scan image; A) lateral view, B) occlusal view and cross sectional 
views, C) anterior stem, D) mid body and E) posterior stem.[B; Buccal and Li; 
Lingual] 
The mini-plates and screws were removed before the scanning process to avoid 
scattering. The scan area was extended to the maximum diameter of scan view and 
covered beyond the region of interest (ROI) at the reconstruction site, including 
the entire anterior and posterior stems. The digitized signals were then transferred 
to a computer for reconstruction of the micro-CT slices. Standardized calibration 
was used compared to bone, air and water. All images were calibrated in Hounsfield 
units (HU) for quantitative analysis. New bone was analyzed using MicroView® 2.2 
software (GE Healthcare, Waukesha, WI, USA). 
Micro-CT slices were reconstructed perpendicular to the long axis of the 
mandibular reconstruction. The percent bone volume (BV %) around the stems of 
the device was analyzed modified from the method described in a previous study.3 
Briefly, three circular regions of interest (ROI) with standardized diameter of 0.52 
mm were selected for each specimen. These were located directly next to stem 
surface in the buccal, lingual and inferior aspects. The selection of an ROI superior 
to the stem was not done as a tooth was frequently present in that area. In the case 
where a screw hole or tooth structure was seen to be within the ROI, the ROI was 
manually moved to the immediate adjacent area. Percent bone volume (BV %) was 
calculated using MicroViewTM 2.2 GE Healthcare computer software (Fig. 4).
 
(3C)                                                 (3D)                                                (3E)
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Figure 4. The area of interest of bone growth around the Ti device’s stem. A 
standardized diameter of 0.52 mm in 3 areas was selected for each specimen. There 
was located directly nest to the stem surface at buccal, lingual and inferior region. 
Percent bone volume (BV %) in ROI was identified and analyzed using Microview 
computer software.
Mechanical Testing 
The four specimens for mechanical testing were processed at the Biomedical 
Engineering Laboratory, College of Engineering, The University of Michigan, Ann 
Arbor, MI, USA. Three-point bending test was done to determine their stiffness 
using an MTS Alliance RT/30 Elite™ Controller testing machine (TestResources 
Inc, Minnesota, USA). 
The specimens were thawed from -20°C to room temperature for 2 hours before 
mechanical testing. All specimens were maintained in a moist condition until the 
test was completed. Before mechanical testing, the mini plates and screws as well as 
most of the soft tissue around the mandible were removed. Due to the instability 
of the bone segments of the samples, a thin layer of muscle tissue enveloping the 
mandibles was preserved to help maintain the integrity of the reconstruction site. 
Bilateral mandibular coronoid processes and canine cusps were trimmed to prevent 
interference with the fixation jig during mechanical testing. Subsequently, each 
specimen was placed on the biomechanical 3-point bending testing fixtures in a 
reverse position with both condyles and mid-anterior lingual bone surface placed 
on the custom-made jig. A force with constant displacement rate of 25 mm/min 
was applied on the lower border of the mandibular until 111.20 N was reached. 
The load-displacement data were recorded at a frequency of 15 Hz to determine 
the elastic stiffness (N/mm) of the reconstructed mandibles without breaking 
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the specimens. After mechanical testing, all specimens were immersed in 10% 
formaldehyde for histological analysis.
Histological Analysis
The specimens were reduced in size, dehydrated in a graded series of ethanol, 
embedded in methyl methacrylate resin and polymerized. The tissue blocks were 
mounted in a modified inner circular saw microtome (Leica® RM 2165, Wetzlar 
Germany) and 10 µm thick sections were prepared. Serial bucco-lingual cross 
sections were stained with methylene blue and basic fuchsin for histological and 
histomorphological analysis. At least, seven bucco-lingual histological cross sections 
were made from the reconstructed mandible from each specimen i.e. one at the 
midline of the device’s body, three at the junction between device body and the 
stem and three at mid of the scaffold’s stem.
Histological sections were recorded using a light microscope equipped with 
a camera (Carl Zeiss, Oberkachen, Germany) and then evaluated with a digital 
image analysis system (Leica QWin Pro, Wetzlar, Germany). Histological and 
histomorphometrical analysis was done in three regions; (1) mid scaffold, (2) 
junctions between device body-stem and (3) mid posterior stem. Bone quality and 
quantity analysis was performed using a bone score scale for ‘bone presentation’ and 
‘bone-device contact’ at each region (Table 1). The percentage bone–stem contact 
and the BV% were analyzed for the area around the posterior stem.
Table 1. Parameters and scoring for histology evaluation by light microscopy 
Parameter Score
Bone Formation around device•	  
(Body of device, Body-stem 
Junction, stem)
2 : Completely surrounded with bone
1 : partially surrounded with bone
0 : No bone (fibrous formation)
Bone contact at device surface•	  
(Body of device, Body-stem 
Junction, stem)
2 : Completely device surface contact 
      with bone
1 : partially surface contact with bone
0 : No bone contact (fibrous formation)
Percent bone-device surface •	
contact (%) (stem)
0-100%
Bone volume and Percent Bone •	
Volume (%) (stem)
Bone volume (mm3) and percent Bone 
volume  (0-100%) at the area of  bone 
at 2 mm from stem  surface
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Statistical Analysis
Descriptive statistic analysis was applied for mechanical test result using stiffness 
values due to limited in sample size.
Micro CT and histological measurements were statistically analyzed using SAS 
9.2 statistical software (SAS Institute Inc, Cary, North Carolina). Measurements 
were evaluated by non-parametric Mann-Whitney U Test to identify the existence of 
differences between the anterior and posterior stem. The results were also compared 
with those of a previous study on PMMA cemented endoprosthesis.23 A P-value < 
0.05 was considered statistically significant.
Results
Clinical Observation
The operation was completed in an average time of 1.5 hour for each animal. 
The marrow cavity preparation was performed without difficulty and the modular 
stems were able to fit tightly into the native marrow bone quite easily by manual 
manipulation. All animals recovered well after operation. 
At one month post surgery, five monkeys presented with good wound healing, 
while three monkeys showed a small fistula and one animal had wound dehiscence 
related to loosening of the mini-plate and screws. This loosened mini-plate and 
screws were removed and wound was debrided and re-sutured. None of the monkey 
showed signs of severe infection or sepsis. The occlusion and bone segments 
appeared stable. The lateral mandibular radiograph showed that the devices were 
in good position. 
At three months, wound dehiscence was noted at the superior aspect of the 
endoprosthesis body in five animals, including the one that had dehiscence at 1 
month. Oral fistulas were found in another two animals, while healing proceeded 
well in the remaining two animals. The occlusion and bone segments in all animals 
remained stable and none showed any signs of severe infection or sepsis. Lateral 
radiographs indicated that enhanced bone formation had occurred at the lower 
border of the defect in eight animals. 
At 6 months, all monkeys were still healthy and there was no obvious weight 
loss. Two of nine reconstruction sites remained stable with good wound healing 
(Fig. 5A). One animal, which previously presented with a small wound dehiscence, 
was found to have healed well. The remaining six monkeys presented with 
exposure of the superior surface of the device modules (Fig. 5B). In two of these, 
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the fixation screws were loose and consequently, the mini-plates were displaced. 
The reconstruction site and occlusion remained stable in all animals. Radiographs 
showed increased amount of bone formation at the reconstruction sites especially 
at the lower border and lingual site (Fig. 5C and D).  
Figure 5. The clinical and radiographic pictures at 6 months post operation. The 
reconstruction sites remained stable and intact in 3 animals (A), however the 
remaining 6 animal presented with exposure at occlusal surface of the device (B). 
Radiographs showed bone formation at the lower border and lingual side of the 
reconstruction site (arrows). Mandibles specimens were maintained in shape and 
contour (C) and (D).
(5A)                                                                            (5B)
(5C)                                                                            (5D)
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Micro-CT Result
The micro CT scans generally showed that the endoprosthesis had maintained 
the contour and dimension of the reconstructed side of the mandible, which was 
grossly similar to the contra lateral non-operated side. All specimens showed a 
variable amount of bone formed at the lower border and lingual aspect of the defect 
but none had complete bone bridging between segments.  
Micro CT analysis indicated a mean BV% of 55.62±32.84% at the buccal, 
56.19±27.60% at the lingual and 59.98±39.42% at the inferior regions of the 
anterior stem compared to 77.18±30.73% at the buccal, 75.27±35.00% at the 
lingual and 63.33±21.72% at the inferior regions of the posterior stem. There 
was no significant difference in percentage bone volume between the anterior and 
posterior stem in all regions (Buccal; p=0.31, Lingual; p=0.31 and Inferior; p= 0.86 
(Fig. 6). 
 
Figure 6. Bone volume (BV %) around the stem of the device, three circular regions 
of interest (ROI) with standardized diameter of 0.52 mm measured directly next to 
stem surface
Mechanical Testing 
The four mechanically tested specimens showed a mean stiffness of 110.43±59.53 
N/mm when loading force was applied to the reconstruction side and 
164.95±172.44 N/mm  when loading force was applied to the contralateral side 
of mandible (Fig. 7).
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Figure 7. Stiffness values from 3 point bending
Histological and Histomorphological Analysis 
Light microscopical analysis 
The histological sections through the midline of the prosthesis module showed a 
thick fibrous capsule and minimal inflammatory cells surrounding the metallic 
device. Newly deposited mature bone was found in most of the specimens (8 of 
9) at the inferior border without direct bone contact to the body of the modular 
surface. Discontinuity of the covering soft tissue seen on occlusal and buccal surfaces 
correlated with the clinical finding of wound dehiscence (Fig. 8A).
At the junction between body-stem of the device, bone had formed, which 
showed direct bone contact in 4 of 9 specimens (Fig. 8B). The sections through 
the posterior stems showed that the stems were surrounded by native mandibular 
bone in 7 of 9 specimens (Fig. 8C), while the remaining two specimens presented 
a buccal fenestration.  Four of the specimens showed excellent bone-stem contact, 
while in the remaining five specimens the stem surface was surrounded by a thick 
fibrous capsule showing varying degrees of inflammatory reaction (Fig. 9).
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Figure 8. The 2D-image taken from Micro CT scan shows region where histological 
sections were made. Histology sections (magnification 1X) were made at the mid 
prosthesis device’s body (A), junction of device body-posterior stem (B) and section 
of posterior stem (C).
 
Histology section regions
(8A)                              (8B)                           (8C)
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Figure 9. The histology section show excellent ‘device-bone interface’ at 
the posterior stem area which coated with HA; (A) Magnification10X and (B) 
Magnification 40X. Fibrous capsule with inflammatory cells was found at the stem 
section in some specimens; (C) Magnification10X and (D) Magnification 40X.
Histomorphological analysis
The mean bone score scale for bone presentation around the devices (range from 
0 - 2)’ was 0.22 (buccal) and 0.89 (lingual) at the mid section of the device body 
and 0.81 (buccal) and 1.56 (lingual side) at the junction of the device body and 
the stem, while the mean bone score around the stem was 1.78. 
The mean grading scores for bone-device contact (range from 0 - 2) was 0 or no 
bone contact at the mid section of the device body in all samples, 0.56 (buccal) 
and 0.63 (lingual) at the junction of the device body and the stem and 0.52 
around the posterior stem of the device. The percent bone-stem contact around the 
posterior stem was analyzed for 4 of 9 specimens, which had score scale of at least 
1, and was found to be 64.17% (44.30% - 80.17%). 
The mean BV (%) was calculated from the area of 2 mm around the surface of 
stem device (n=9) and was found to be 45.56% (range from 21.10%-66.50%). 
(9A)                                                                            (9B)
(9C)                                                                            (9D)
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Discussion
A modular endoprosthesis has been used with great success in orthopaedic surgery.24 
The major anatomic joints with their adjacent segmental bone can be reconstructed 
safely and reliably with a modular endoprosthetic replacement.25 The cementless 
endoprosthesis was designed to prevent aseptic loosening of the endoprosthesis. 
In theory, a better stability can be achieved by having direct bone contact with the 
device at the interface in a cementless endoprosthesis, while this is nearly always 
absent when bone cement is used.26 The cemented modular endoprosthesis for 
mandibular reconstruction, as used in an earlier monkey study, was found to 
result in good function and stability of the reconstruction sites up to 6 months. 
Nevertheless, fistulas were noted at the reconstruction site that seemed to be related 
to loose intermodular connection screws23. In the effort to overcome this problem, 
we developed the bioactive-coated cementless modular endoprosthesis as used in 
the current study.
The modular parts of the endoprosthesis were designed connection as a dove-
tailed interlock. Our observations revealed that this design prevented loosening of 
the intermodular connection components throughout the 6 months study period 
in all animals. This clinical observation corroborated with the results of the in vitro 
biomechanical study reported earlier by Wong et al.11 Radiographs and micro CT 
scans in this current result confirmed that the dovetail locking mechanism and 
vertical pin remained in a stable position throughout the experimental period. 
Therefore, it can be deduced that this new dove-tail interlock design is able to solve 
the problem of inter-modular fixation screw loosening.
The stems of the current endoprosthesis were designed as tapering screws that 
were manually inserted into the marrow space of the mandibular bone without 
using bone cement. The surgical technique was simple and shortened the operation 
time. The tapered stem design allows matching of the stem part with the size of the 
individual mandibular bone stump. As a consequence, the reconstructed mandible 
provided an immediate accurate three-dimensional replacement of the lost part of 
the mandible with initial stability. 
Although titanium is commonly used as a favourable bone implant material, 
a number of studies have modified their titanium implant surface to improve 
the bioactive properties. For decades, studies of hydroxyapatite coating on the 
titanium implant surface reported a significant improvement of direct bone-
implant contact.27-30 Therefore, HA coating deposition on the stem device surfaces 
was selected in this study. The result showed positive effect of HA coating with 
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good bone contact at stem–bone interface from the micro-CT and histological 
analysis.
Besides bone-device contact, good soft tissue healing is essential to the success 
of the endoprosthesis reconstruction. To enhance the soft tissue-titanium implant 
interface in medical and dental uses, changing the implant surface topography 
increases the survival rate of devices by improving soft tissue stability to help seal 
against bacterial leakage.31 Lee et al. reported that HA/BG coated submucosal plates 
showed favourable oral mucosa adaptation at 1 month after implantation.32 They 
found a thinner capsule quantity and an increased capsule quality and interface 
quality score for HA/BG coated implant compared to acid etched Osseotite® surface 
plates.32 However, HA/BG coating showed no beneficial effect on soft tissue healing 
in the current study. The height of the device, a limited blood supply and a lack 
of a thick muscle protection layer and the lack of stability of the reconstructed site 
during the healing period all contributed to an unfavourable soft tissue response, 
which apparently cannot be overcome by a HA/BG coating. 
The results showed that only three of the nine animals had a complete soft 
tissue healing with a stable reconstruction system. In contrast, the remaining six 
animals suffered from complications of intraoral wound breakdown, similar to 
those mandibular reconstruction using an over contour conventional titanium 
plates with or in patients with radiated tissue. Local infection was found to be 
related to loosening of the mini-plate and screws, subsequent loss of rigid fixation 
of the device stem(s). The monkeys were not able to be placed into intermaxillary 
fixation due to the requirement for feeding, which placed additional strain on 
the device stems during masticatory function, which could easily be avoided in 
humans. It was also observed that the monkeys frequently inserted their fingers 
into their oral cavities. This was probably due to a feeling of discomfort, and likely 
disturbed normal wound healing as well.
The cementless, stem retained endoprosthesis requires sufficient stability 
in bone at the initial stages of healing, to provide an optimal environment for 
osseointegration. The current method of fixation with a semi-rigid plate does not 
provide for sufficient stability, resulting in non-union of the device stems to the 
surrounding bone. Further mechanical testing of the stability requirements of 
the endoprostheses will provide more data with which to design a proper fixation 
system to improve the stability of the device during the early phases of stem 
osseointegration.
In addition, an extraoral approach instead of an intraoral approach for the 
endoprothesis installation possibly prevents early exposure of the device to the 
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non-sterile oral cavity and can reduce wound breakdown and infection.
On basis of these findings, we have to reject the hypothesis that: (1) the current 
designed cementless mandibular endoprosthesis has sufficient load-bearing 
capability and (2) a HA/BG titanium surface is able to achieve soft tissue attachment 
and healing.
Henderson et al. described that the causes of failure in the orthopaedic 
endoprosthesis that could relate to 5 reasons; soft-tissue failures (Type 1), aseptic 
loosening (Type 2), structural failures (Type 3), infection (Type 4), and tumour 
progression (Type 5).33 In the in vitro study reported by Wong et al., on the 
mechanical testing and finite element model of the modular endoprosthesis, the 
weak point of the device was found to be at the superior surface of the stems, 
especially at the junction between the stem and the body of the device.11 The 
irreversible deformation described as bending or crack lines, was found to be 
located at the junction of the body and the device’s stem, related to high shear 
stress. However, this weak point was not found to be present in our design, as 
described in the current animal study. Our postulation of the laboratory difference 
in the mechanical finding reported by Wong et al., in this current in vivo study 
could be due to a few reasons; (1) the design of the taper stem used in this study was 
stronger than the cylinder screw used in the laboratory, (2) the porosity structure 
and the biologic factors of the mandible used in the animal model differ from those 
tested in the artificial mandibles. For example, in the in vivo study there was the 
presence of a natural bone structure with cells and blood supply, which contributed 
to a healing process and the presence of masticatory function and loading in the 
animals, and (3) an additional mini-plate with screws was inserted in the animal 
study, but not in the in vitro study. This was included to increase the stability of the 
reconstruction site as intermaxillary fixation (IMF) was not possible in the animal 
model. The mini-plate fixation was believed to act as a cross-brace to minimize 
movement of the bone segments and the device during masticatory function so 
as to allow a period of healing to achieve bone contact with the stem surface. The 
mini-plate used could also contribute to the sharing of the loading force, yet this 
additional fixation had not been tested and analyzed in the laboratory.
 Mechanical analysis of the reconstructed specimens has often been used to 
assess the performance of the prosthesis and the bone-device interface.34 The test 
methodologies that mimic a simulating bite force for mandibular reconstruction 
have been reported in the literatures.35-37 The current mechanical test setting was 
modified from a previous study by Schupp et al. on  osteosynthesis systems in 
segmental resection of on the synthetic mandibles.31 However, we subjected our 
100
Oral and Maxillo-Facial Bone Reconstruction
specimens to mechanical testing without fracturing them, which allows subsequent 
histological analysis of the specimens. To the best of the authors’ knowledge, the 
stiffness value of a monkey mandibular bone has not been reported in the literature. 
Also, no control data are available either from intact fresh specimen or previous 
PMMA cemented mandibular endoprosthesis study.23 
Prior to mechanical testing, a pilot study was done using a dry intact macaque 
mandible (with the limitation that no fresh specimens were available) to determine 
the maximum load before fracture of the mandible occurred. A force of 889.6 N 
had to be applied to achieve fracturing. Subsequently, the mandibular specimens 
were tested using the same conditions, with the exception that the maximum load 
was reduced to 12.5% of the failure load to avoid fracturing of the specimen. 
Loading force was applied on both the operated and non-operated site, although 
it has to be noted that it is possible that the stiffness value of the non-operated 
side was affected by the reconstructed side, as the specimens were fixated on both 
condyle heads and anterior mandible.  
Further, we observed that the stiffness values of the reconstructed specimens 
showed a wide data distribution.  This can be due to the lack of direct bone contact 
with the anterior stem. It is possible that the anterior part of the endoprosthesis 
received a higher functional loading force due to the long span segment of the 
opposite side of mandible.
BV % determined by micro-CT scan around the stem part of the endoprosthesis 
(Table 2) was found to be significantly higher at the buccal and lingual regions of 
the anterior stem as well as the buccal regions of the posterior stem when compared 
with previously reported data.23 We suppose that this effect is due to the non-
cemented approach used. As a consequence, the transfer of load proceeds directly 
to the surrounding bone without intervening mass. This can result in an increased 
bone deposition, as characterized by an enhanced BV%. There was no significant 
difference in BV% around the anterior stem compared with the posterior stem at 
buccal, lingual and anterior to the stem. A similar observation was made when the 
analysis was done with the ROI positioned 1.5 mm away from the stem surface (data 
not shown). Based on these Micro-CT data, the histological analysis was performed 
only at the posterior stem and not for the anterior stem region. Three of the nine 
specimens showed better soft tissue healing and a stable mandibular reconstruction, 
with a high percentage of bone–device contact. This improved healing can be due 
to the presence of a HA coating on the stem part. Also, the histological sections 
showed that the  regenerated bone was abundantly present between the mandibular 
segments and around the body of the module. This observation was similar to 
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the results with the PMMA cemented mandibular endoprosthesis.23 However, 
light microscopy indicated that the new bone around the body of the device had 
no direct contact with the device surface and an intervening fibrous tissue layer 
was seen. Probably, this is creeping bone formation or a reaction from an intact 
periosteum. This bone formation is expected to be limited in the massive tissue 
resection of a malignant tumour during ablative surgery, with the periosteum 
commonly removed. 
Nevertheless, the sample size of specimens in the current study was limited 
and complicated with local infection and wound dehiscence, and therefore the 
results need to be interpreted with caution. There were also no control devices, i.e. 
endoprosthesis without additional HA coating or comparisons between different 
fixation method at the reconstruction site. Unfortunately, this was not possible due 
to the limitation in available animals.
Table 2. The comparison of bone volume 
(calculated from Micro CT Scan) with previous study 
group
Percent Bone volume Around Stem of Device (Mean ±SD.) 
Calculated from Micro CT Scan 
anterior  stem Posterior stem
Buccal Lingual Inferior Buccal Lingual Inferior
previous study¥
Modular 
endoprosthesis 
with pMMa 
cement 
[Number of 
specimens(n)=4]
10.83
(±6.35)
14.59
(±7.47)
29.42
(±28.13)
38.45
(±29.68)
43.07
(±13.89)
45.89
(±31.79)
Current study
Bioactive-coated 
cementless 
modular 
endoprosthesis : 
non- cemented 
[Number of 
specimens(n)=9]
55.62
(±32.84)
56.19
(±27.60)
59.98
(±39.42)
77.18
(±30.73)
75.27
(±35.00)
63.33
(±21.72)
P-value p=0.02* p=0.05* p=0.20 p=0.05* p=0.20 p=0.50
NOTE: ¥ Data from Lee et al. [Int. J Oral Maxillofac Surg. 2009 Jan; 38(1):40- 7]
 *significant difference at p < 0.05
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Conclusion
 
Based on the current findings, it can be concluded that the cementless modular 
endoprosthesis can potentially be used for the successful reconstruction of the 
mandible. The success of a cementless mandibular endoprosthesis is dependent 
on several factors, i.e. design of the device, device’s material and surface coating, 
surgical technique and primary stability. In future studies, several modifications 
have to be tested to create an optimal device i.e. reduction of the height of the 
device’s body, provision of sufficient stability during the early healing phase, and 
improvement of the soft tissue attachment to the titanium surface. In addition, the 
uses of an extra-oral surgical approach can possibly achieve a better result.
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Introduction
Mandibular bone provides the skeletal base for teeth, which play a critical role in 
mastication, speech, and maintenance of the facial profile.1 Reconstruction of large 
mandibular defects caused by trauma, tumor resection, and congenital defects is a 
significant clinical challenge.2 Various methods of mandibular defect reconstruction 
have been reported in several surgical techniques involving reconstruction plate, 
free bone graft, pedicle bone graft, particulate bone cancellous marrow graft, 
microvascular free flap, transport distraction osteogenesis, modular endoprosthesis, 
and tissue engineering. Each technique has its own benefits and limitations. 
The current ‘gold standard’ treatment is either an autogenous free bone graft or 
a vascularized microvascular free fibular flap.1 However, even this standard has 
limitations in terms of aesthetic and functional outcomes when the bone graft 
does not replicate the original complex mandibular geometry. The procedure is also 
time-consuming, including a hospital stay, and is associated with significant donor-
site morbidity. These problems have led clinicians to explore alternative procedures 
for mandibular reconstruction. 
In 2006, Lee and co-workers3 introduced a modular endoprosthesis for 
mandibular reconstruction. This device was made of titanium alloy, and the 
prosthesis stems were cemented into the remaining bone stumps on either side of 
the mandibular defect. The experimental animal study with this approach showed 
an abundance of bone formation around the body of the modular endoprosthesis 
at 6 months post-surgery; however, the soft-tissue healing was not ideal, resulting 
in dehiscence and, in some cases, hardware exposure. In addition, hardware failure 
(i.e., several screws of the modular endoprosthesis becoming loose) was found.3-5  
A recently introduced alternative direction for mandibular bone reconstruction 
involves tissue-engineering techniques, which offer potential advantages such as 
the absence of donor-site morbidity and an ability to regenerate original bone 
geometry. Based on the results of the earlier study with the titanium modular 
endoprosthesis, we decided to pursue such a tissue-engineering approach and 
designed a biodegradable osteoinductive modular endoprosthetic scaffold for the 
regeneration of a segmental mandibular defect.
Poly(ε-caprolactone) (PCL) was selected for the manufacture of the 
endoprosthesis. PCL is a bioresorbable polymer with potential applications for 
bone and cartilage repair and has several advantages over other polymers. PCL is 
more stable in ambient conditions, is readily available in large quantities, and can 
be easily combined as well as processed with other materials to further formulate 
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the tissue response.6, 7 PCL scaffolds can be fabricated by selective laser sintering 
(SLS), a rapid prototyping/Solid Free-Form Fabrication (SFF) technique to fit 
complex anatomic locations. This technology allows for the design of a scaffold with 
computationally predicted properties and a possible global anatomic architecture 
that matches the original bone defect and supports the in-growth of bone tissue.8, 9 
The selected percentages of scaffold porosity, structure, and mechanical design can 
be controlled. Porosity between 37 and 55% has been reported to possess mechanical 
properties comparable with those of human trabecular bone, and the compressive 
modulus of such a scaffold was found to be within the 52- to 68-MPa range, with 
ultimate compressive strength within the 2.0- to 3.2-MPa range.9 This makes such 
a manufactured material an attractive substitute for human bone and enhances its 
application for bone regeneration. 
Osteoinductive or autoinductive bone formation is a mechanism of cellular 
differentiation towards bone of one tissue due to the physicochemical effect or 
contact with another tissue.10 It generally can only be induced by heterotopic 
implantation of demineralised bone matrix (DBM) or BMPs into a region 
where bone does not naturally grow.11 PCL is not osteoinductive, which limits 
its applications in the regeneration of critical-sized bone defects. To enhance the 
bone-regenerative properties, PCL scaffolds containing growth factors, and in 
conjunction with a carbonate-substituted hydroxyapatite coating, have been shown 
to be promising in creating osteoinductive scaffolds. In 2011, Suárez-González et 
al. reported mineral coatings on polycaprolactone scaffolds serving as templates for 
growth-factor binding and release.12 Mineral coatings were formed by a biomimetic 
approach that consisted of the incubation of scaffolds in modified simulated body 
fluids (mSBF) with a composition similar to that of human plasma, but with 
double the concentrations of calcium and phosphate. Such scaffolds demonstrated 
the ability of attachment and sustained release of growth factors, such as VEGF and 
BMP-2, which were dependent on the solubility of the mineral coating.12, 13 
In addition to growth factors such as rhBMP-214-18 and rhBMP-7,14, 19-21 
bone marrow stromal cells (BMSCs) have been found to be a stimulus for bone 
regeneration, being capable of differentiation into mesenchymal tissues such as 
bone and cartilage.22-26 BMSCs or cultivated osteoprogenitor cells can be seeded 
into a porous scaffold, and, when given the appropriate environmental signals, can 
be directed down the osteogenic lineage and cued to form bone tissue.27 BMSCs 
are readily available and can be isolated from bone marrow or fat tissue. Numerous 
successful animal studies have been reported, where mandibular continuity defects 
were regenerated on a scaffold provided with bone marrow stromal cells.26, 28-30
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In view of the above, the aim of the current study was to regenerate a segmental 
mandibular bone defect by means of a 3-D designed PCL scaffold provided 
with a carbonate-substituted hydroxyapatite (CHA) coating for the delivery of 
osteoinductive factors to the defect site. The study compared the use of empty 
PCL scaffolds (PCL-control), PCL scaffolds seeded with autologous bone marrow 
cells in a bovine collagen type I gel (PCL-CELL), and PCL scaffolds provided 
with additional rhBMP-2 (PCL-BMP). We hypothesized that the osteoinductive 
scaffold loaded with rhBMP-2 or bone marrow cells could achieve bone union and 
overlying soft-tissue healing with sufficient load-bearing capacity within 6 months 
after its installation into the mandibular segmental defect in a non-human primate 
model. 
Materials and Methods
Animals
Twenty-four healthy, adult male Macaca fascicularis monkeys, with an average 
weight of 6-7 kg, were used in this study. The experimental protocol was approved 
by the Institutional Animal Care and Use Committee of SingHealth in Singapore. 
Animal surgery was performed at the SingHealth Experimental Animal Centre 
(SEMC), Singapore. The animal laboratory has been certified by the International 
Association for the Assessment of Laboratory Animal Care (IACUC), Singapore.
PCL Scaffolds and Calcium Phosphate Coating 
Poly-ε-caprolactone (PCL) powder (CAPA 6501, Solvay Caprolactones, 
Warrington, Cheshire, UK) was used to fabricate the PCL scaffolds. This particular 
form of PCL has a melting point of 60°C, a molecular weight of 50,000 kDa, and 
particle size distribution in the 10- to 100-µm range. 
Fabrication of PCL Scaffolds
The PCL scaffolds were fabricated by the Department of Biomedical Engineering, 
University of Michigan, Ann Arbor, USA. For the fabrication process, computed 
tomographic (CT) scans of dry monkey mandibles were made, and scaffolds were 
fabricated via laser sintering as previously reported.9 With the CT images as a guide, 
mandibular scaffolds were created with a controlled architecture. The design was 
then exported to a Sinterstation 2000™ machine (3D Systems, Valencia, CA, USA) 
in STL file format and used to construct scaffolds layer-by-layer, with a powder 
layer, by the selective laser sintering (SLS) processing. The body of the implant was 
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15 mm long and 12 mm high and possessed a 3-D orthogonal periodic porous 
architecture. The body of the implant was also modular, comprised of anterior 
and posterior components, which were fixed together with a special lock-on 
design  Mechanical analysis confirmed that the “dovetail joint” between the two 
components was failing (fracture point) at 30 N. The stems were 12 mm long, 
4 mm high, and 2.5 mm in diameter and were made to fit the marrow space 
of the mandible as closely as possible. In cross-section, the stems showed a star-
shaped appearance, to increase the bone-scaffold contact area. Micro-CT analysis 
reviewed that the PCL scaffolds had a reasonably homogenous structure, with total 
surface area of 2089 mm2, porosity 75%, and pore size of 1200µm. All pores are 
interconnected (Fig. 1).
 
Figure 1. Poly(ε-caprolactone) (PCL) Polymer endoprosthetic mandibular scaffold 
has anterior and posterior parts with a ‘dovetail’ inter-lock  design. A scaffold pin 
is used to stabilize the two parts. Anterior and posterior endoprosthetic stems 
are designed to fit into the prepared cavity in the cancellous bone of native 
mandibular segments. The surface of scaffold is coated with carbonate-substituted 
hydroxyapatite (CHA).
PCL Scaffolds with Carbonate-Substituted Hydroxyapatite (CHA) Coating
The PCL scaffolds were used as-received or provided with a carbonate-substituted 
hydroxyapatite (CHA) coating. The scaffold components were incubated in 
a modified simulated body fluid (mSBF) for 8 days at 37°C under continuous 
rotation. Prior to mSBF incubation, the PCL components were hydrolyzed in 1 M 
NaOH for 60 min. After hydrolysis, plates were rinsed and incubated in the mSBF. 
The mSBF solution had a composition similar to that of human plasma, but with 
double the concentrations of calcium and phosphate to enhance mineral growth, 
and was prepared as previously reported:9, 13 briefly, 141 mM NaCl, 4.0 mM KCl, 
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0.5 mM MgSO4, 1.0 mM MgCl2, 4.2 mM NaHCO3, 5.0 mM CaCl2, and 2.0 
mM KH2PO4 in deionized ultra-filtered water, with pH adjusted to 6.8 with 2 N 
HCl or 2 N NaOH. Before use in the animal study, all scaffolds (non-coated and 
CHA-coated) were sterilized by ethylene oxide gas.
Bone Morphogenic Protein
Recombinant human Bone Morphogenic Protein-2 (rhBMP-2) in white freeze-
dried powder form (GenScript, Piscataway, NJ, USA) was used. RhBMP-2 
solution was prepared according to the manufacturer’s instructions, i.e., 0.75 mL 
of 20 mMol of acetic acid was gently dripped directly onto 1 mg rh-BMP2, and 
0.75 mL of sterile 1xPBS was added. Then, this solution was gently dripped onto 
and absorbed by the PCL scaffolds. Subsequently, scaffolds were incubated in 
a continuously shaking machine at 250 rpm. The scaffolds were turned over at 
7.5 min, and shaking continued for an additional 7.5 min. This preparation was 
performed under sterile conditions in the operating room, while the mandibular 
segmental operation was performed in each individual monkey. 
Preparation of Monkey Autologous Bone Marrow Cells in Collagen Gel
After the monkeys were anesthetized, a 3-mL quantity of bone marrow was aspirated 
from the trochanter bone from each monkey. The aspirate was processed with red 
blood cell lysis and cell counting under sterile conditions.
Ultrapure Bovine Collagen Solution (Sigma-Aldrich®- C4243, St. Louis, MO, 
USA) was used as a carrier for bone marrow cell-seeding. Collagen gel was prepared 
by the pipetting of 0.8 mL of 3 mg/mL Ultrapure Bovine Collagen Solution into 
an Eppendorf tube. Subsequently, 0.1 mL of 10x PBS was added to the solution, 
followed by gentle mixing with 75 µL 0.1 M NaOH.  The pH of the solution was 
kept in the range of pH 7 to 8. Then, a 125-µL quantity of bone marrow cells 
(equivalent to 5x106 cells) was mixed with 475 µL (pH-adjusted for appropriate 
gelling conditions) collagen solution. Bone marrow cells in collagen gel were 
incubated at 37°C, in a humidified atmosphere of 95% O2 and 5% CO2, for 40-
45 min. 
Analysis of preliminary data from a pilot study confirmed that the collagen 
solution evoked no inflammatory or allergic reaction in the monkeys and proved 
that the viability of the marrow cells was maintained in the prepared collagen gel 
(data not shown).
Autologous bone marrow cells in 0.6 mL of collagen gel were transferred into 
the porous PCL scaffold and placed in an incubator. After 15 min, the outer surface 
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of the cell-seeded scaffold was coated with an additional 0.4 mL of collagen gel. 
The construct was re-incubated for another 30 min before placement into the 
mandibular defect site.
Surgical Procedure 
The monkeys were fasted overnight and received 0.05 mg/kg of intravenous atropine 
and 10 mg/kg of Ketamine (Parnell Laboratories, Alexandria, Australia) pre-
operatively. All animals were weighed prior to surgery. Induction and maintenance 
of anesthesia were performed with 2% isoflurane. Endotracheal intubation was 
performed with oral endotracheal tubes (gauge, 3.5 mm). Intravenous analgesic 
2 mg/kg carprofen (Rimadly®) (Pfizer Inc, NY, USA) and antibiotics (ampicillin/
cloxacillin) 6-8 mg/kg were administered. The surgical site was disinfected with 
1% Cetrimide, followed by 0.05% chlorhexidine and povidone iodine, and sterile 
drapes were used. An incision was made intra-orally, beginning with two vertical 
incisions between the second bicuspid and the first molar as well as behind the 
second molar. A horizontal incision 2-3 mm below the attached gingiva was made 
to connect the two vertical incisions. The periosteum was reflected to expose the 
lower border of the mandible at the ostectomy sites. A tapered fissure bur was 
used to perform the resection, and the block was subsequently removed. A 15-
mm section of the segmental defect was taken from the right side of the mandible. 
Bleeding from the inferior alveolar artery and vein was easily controlled with 
diathermy when necessary. 
Three experimental groups were created: (1) PCL scaffold with CHA surface 
coating and soaked with rhBMP-2 (PCL-BMP, n = 8); (2) PCL scaffold with CHA 
surface coating and seeded with bone marrow cells (PCL-CELL, n = 8); and (3) 
PCL scaffold with CHA surface coating, as a control group (PCL-control, n = 8). 
Before installation of the scaffolds, the medullar space of the anterior and posterior 
bone stumps was prepared with a tapered drill (2.3 mm in diameter) to a depth of 
12 mm, to conform to the dimensions of the stems of the PCL scaffolds. The stems 
of the anterior and posterior modules were then inserted into the prepared grooves 
and press-fitted, and the stability was checked. The anterior and posterior modules 
were then connected and stabilized with a vertical pin (Fig. 2).
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Figure 2. Clinical images of segmental mandibular reconstruction with PCL 
Endoprosthesis. The mandibular segment is stabilized by two titanium mini-plates 
and -screws.
After insertion of the endoprosthesis, occlusion was evaluated. Since intermaxillary 
fixation was not possible in this animal model, two Ti mini-plates with 5-mm Ti 
screws were fixed between mandibular stumps to immobilize the reconstruction 
site. The buccinator and mylohyoid muscles were dissected, mobilized, and sutured 
over the device by means of 4/0 Vicryl® (Ethicon Inc., Somerville, NJ, USA), 
followed by closure of the mucosa, thus creating a 2-layer closure. After surgery, 
radiographs were taken with a Siemens Polymobil Plus machine set at 40 kV for 
2 ms at a distance of 70 cm. During imaging, animals were positioned with their 
right mandibles adjacent to the plate. 
The animals were maintained in individual cages.  Soft diet was provided until 
sacrifice. Ampicillin/cloxacillin 6-8 mg/kg IM was administered for 7 days post-
surgery, and Ketorolac trometamol (Toradol) 15-30 mg/kg IM was given for 2-3 
days post-surgery. 
Endoprosthesis Retrieval
All animals were weighed and sacrificed at 6 months post-operatively. Mandibular 
specimens from condyle to condyle, with the device in situ, were harvested. 
Surrounding soft tissue was removed except around the reconstructed site. 
Radiographic examination was performed at the same settings as used for the 
preliminary assessment.
In half of the animals of each group, mandibles were harvested fresh to be used 
for mechanical testing. A 3-mL quantity of pentobarbitone was injected into the 
cardiac chamber to euthanize the animals. All retrieved specimens were kept frozen 
at -20ºC until needed for analysis.
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For the other half of the animals in each group, harvesting was done after 
perfusion fixation. A 16-gauge intravenous catheter was inserted into the left 
ventricle and used for circulation with 300-500 mL of Hartman’s solution, followed 
by 750 mL of a mixture of 2.5% paraformaldehyde and 2% glutaraldehyde. The 
specimens were kept soaked in 10% glutaraldehyde.
Micro-CT Evaluation
The specimens containing the reconstruction device were scanned in a GE eXplore 
Locus SP MicroCT scanner (GE Healthcare, Thermo Scientific, Waltham, MA, 
USA), with a focal spot of 8 µm, pixel size of 18 µm, scanning configuration 
isotropic voxels of 8 x 8  x 8 µm focal spot size, and isotropic resolutions at 8 µm. 
Mini-plates and screws were removed before the scanning process, to avoid 
scattering due to the presence of metal. The area of scan was extended to the 
maximum diameter of the scan view and beyond the region of interest (ROI) and 
the reconstruction site, which included end-points of the anterior and posterior 
scaffold stems. The digitized signals were then transferred to a computer for 
reconstruction of the micro-CT slices. Standardized calibration was used for 
comparison with bone, air, and water. All images were calibrated in Hounsfield 
units (HU) for quantitative analysis. The new bone analysis was analyzed with 
MicroView® 2.2 software (GE Healthcare, Waukesha, WI, USA) and Mimics® 
Software (Mimics 14.01 64-bit, Materialise, Leuven, Belgium).
Micro-CT slices were reconstructed perpendicular to the long axis of the 
mandibular reconstruction. Bone union of the mandibular stem was evaluated. 
Bone volume (%) at the reconstruction site was identified with Microview computer 
software. To investigate new bone formation inside the scaffold, we used the Stereo 
Lithography (STL) digital data of the scaffold to indicate the region of interest 
(ROI) as the boundary of the scaffold body, with Mimics® Software. The created 
ROI was transferred to the individual scan of the specimen in the MicroView® 
program. Bone volume (%), tissue mineral density (TMD) value (mg/cc), and bone 
mineral density (BMD) (mg/cc) were then evaluated (Fig. 3).
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Figure 3. The region of interest (ROI) inside the scaffold was created along the 
boundary of the scaffold body with the Mimics x64 14.0 computer program. The 
quantity of newly regenerated bone inside the body of the scaffold was analyzed 
with MicroViewTM 2.2 GE Healthcare computer software.
Mechanical Testing Examination
The specimens for mechanical testing were processed at the Biomedical Engineering 
Laboratory, College of Engineering, The University of Michigan, Ann Arbor, MI, 
USA. The three-point bending test was used to determine their stiffness in an MTS 
Alliance RT/30 Elite™ Controller testing machine (TestResources Inc., Shakopee, 
MN, USA). Each specimen was placed on the biomechanical 3-point bending test 
fixture, with both condyles and the mid-anterior lingual bone surface placed on a 
custom-made jig (Fig. 4). A force at a constant displacement rate of 25 mm/min 
was applied to the lower border of the mandibular body. The load-displacement 
data were recorded at a frequency of 15 Hz, for determination of the stiffness of the 
reconstructed mandibles without breaking the specimens.
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Figure 4. Each of the mandibles was placed on the 3-point bending jig for 
biomechanical testing with the Alliance RT/30 Elite™ Controller. The jig model was 
designed by the Department of Biomedical Engineering, University of Michigan, 
Ann Arbor, USA. The mechanical testing system was exposed to compression loads 
that simulated masticatory loads on each side of the mandible (reconstructed and 
non-reconstructed sides). Vertical linear displacement was applied by the Alliance 
RT/30 Elite™ Controller machine.
A pilot study was conducted to determine the maximum load that could be applied 
without mandibular fracture. The data were acquired from 2 dry intact macaque 
mandibles. The first dry mandible was placed on the biomechanical 3-point bending 
testing fixture as above. The vertical linear displacement was applied by vertical load 
on one side of the mandibular body. Once the pre-load was reached, data were 
acquired at a rate of 15 Hz, while a load was applied at a displacement rate of 0.25 
mm/min until the failure load resulted in mandibular fracture at a loading force 
of 889.6 N. The second dry mandibular specimen was tested similarly, except that 
the maximum load was reduced to 111.21 N, or 12.5% of the failure load, to avoid 
mandibular fracture. The stiffness of the mandibular specimen was found to be 420 
N/mm and 643.7 N/mm on the contralateral side without fracture.
Before mechanical analysis, the harvested specimens were thawed to room 
temperature from -20°C for 2 hrs. All specimens were maintained in moist 
conditions until the test was completed. Before mechanical testing, mini-plates 
and screws were removed, including most of the soft tissue around the mandible. 
Bilateral mandibular coronoid processes and canine cusps were trimmed to prevent 
interference with the fixation jig during mechanical testing. Into the anterior lingual 
bone of each mandible, a 3-mm hemisphere was drilled by means of a surgical 
round bur to prevent displacement of the specimen during force application. 
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Mechanical testing was done for both sides of the mandible at a displacement rate 
of 0.25 mm/min until 111.201 N was reached. The maximum applied moment 
(MAM) or maximum moment at failure (MMF) point due to the conclusion 
of bending force application was stopped before the breaking failure point of 
each specimen. Force and displacement as well as elastic stiffness (N/mm) were 
recorded. Unstable mandibular specimens were excluded from mechanical testing. 
After mechanical analysis, specimens were immersed in 10% formaldehyde for 
subsequent histological preparation and analysis.
Histological Analysis
All histological processing and specimen analyses were performed at the Department 
of Biomaterials of the Radboud University Nijmegen Medical Centre, The 
Netherlands. 
The specimens were reduced in size, dehydrated in a graded series of ethanol, 
embedded in methyl methacrylate resin, and polymerized. The tissue blocks were 
mounted in a modified inner circular saw microtome (Leica® RM 2165, Wetzlar, 
Germany), and 10-µm-thick sections were prepared. Serial bucco-lingual cross-
sections were stained with methylene blue and basic fuchsin for histology and 
histomorphometric analysis. At least 7 bucco-lingual histological cross-sections 
were prepared from the reconstructed mandible from each specimen, i.e., 1 at the 
midline of the device’s body, 3 at the junction between the device body and the 
stem, and 3 at the midpoint of the scaffold’s stem (Fig. 5). 
Light microscopy (Leica®, Rijswijk, The Netherlands) was used for histological 
evaluation, which included a general description of the tissue surrounding the 
implant’s body, the junction of the body and the scaffold’s stem, and the stem 
areas.
Histomorphometric analysis was performed by one observer (CN). A modified 
hard-tissue histologic grading scale31 (Table I) was used to quantify the histological 
findings. The score of each sample was calculated. Total bone contact (TBC) (%) 
and bone volume (BV) (%) were measured for at least 3 sections of the stem, 
junction, and mid-scaffold. 
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Table I. Hard-tissue Histologic Grading Scale 
(adapted and modified from Jansen et al., 1994)
Parameter Score
Bone Formation
2 : Completely surrounded with bone
1 : partially surrounded with bone
0 : No bone (fibrous formation)
Bone-Device  
Interface
2 : Completely interfaced with bone
1 : partially interfaced with bone
0 : No bone (fibrous formation)
Scaffold Degradation
3 : Completely disappeared – almost complete degradation 
or complete fragmentation
2 : Marked degradation – marked cracks in implant and/or 
some fragments toward edges and outer surface
1 : Limited degradation – some minor dissolution on edges, 
minor cracks in implant, and/or small fragments present
0 : No degradation – Completely intact polymer
Figure 5. Histology slide sections (magnification 1x) from 3 areas of the scaffold: 
(1) the stem of the scaffold, (2) the junction between the stem and the body of the 
scaffold, (3) and a mid-scaffold section. The sections showed better bone formation 
inside the scaffold structure of the PCL-BMP group, while mostly fibrous tissue was 
found in the PCL-CELL and PCL-control groups. The stem of the scaffold in the PCL-
BMP group was surrounded with bone, while fibrous connective tissue was again 
found in the other two groups.
PCL-BMP
(1)         (2)         (3)
PCL-CELL
(1)         (2)         (3)
PCL(control)
(1)         (2)         (3)
Histology Section Areas
(1) Section at the stem of the scaffold
(2) Junction between the stem 
and the body of the scaffold
(3) Mid-scaffold section
(1)   (2)          (3)
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Total bone contact (TBC) (%) at the stem was quantified by microscopy at 5x and 
10x magnification (Zeiss® computer program). TBC (%) was calculated with the 
Image-Pro® 5.0 system (Media Cybernetics, Silver Spring, MD, USA). TBC (%) 
was calculated according to the formula:
TBC (%) = Total length of bone interface   x 100
       Total length of stem surface
The mean bone volumes (%) were calculated 2 mm from the stem surface (Fig. 6). 
Bone volumes were calculated with the QWin computer program (Q-win;Leica®, 
Wetzlar, Germany) using the average value of 3 parallel slices and according to the 
formula:
Bone Volume (%) = Total Bone Volume (- area of tooth or plate/screw)  x 100
                         Calculated area 2 mm from the stem surface
(a)                                                                      (b)
(c)                                                                      (d)
Figure 6. The Qwin computer program was used to calculate the percent bone 
volume from the area 2 mm around the stem implant surface. The images show the 
method for identification of the region of interest (ROI). The computer program 
identified: (a) the stem area. (b) the bone around the stem, and (c) removal of other 
defects, i.e., screw or root tip. The selected area (ROI) around the scaffold’s stem is 
used to calculate the percent bone volume, as shown in (d). 
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Statistical Analysis
Data from the mechanical tests were described by stiffness values. 
Data on bone regeneration from the micro-CT study and data on histological 
measurements were statistically analyzed with SAS 9.2 statistical software (SAS 
Institute Inc., Cary, NC, USA). Measurements were evaluated by Analysis of 
Variance (ANOVA) with a pair-wise comparison post-test to identify the groups 
that differed from each other. This was done without correction for Type I error rate 
across the pair-wise tests. A P-value < 0.10 was considered statistically significant.
Results
Gross View and Clinical Findings
Although all 24 animals survived the experimental period and maintained their 
body weight well, at retrieval only 14 specimens were found to be useful for further 
assessment (PCL (control)  (n = 3), PCL-BMP (n = 6) and PCL-CELL (n = 5)). 
The rest of the animals had to be excluded due to loosen plates and screw, clinical 
mobility and wound infection at the reconstruction sites (Fig. 7). 
Figure 7. Images of reconstructed mandibular specimens at 6 months. Several of the 
specimens successfully maintained their shape, mandibular contour, and an intact 
oral mucosa (white arrow) (a), while others presented with wound dehiscence. The 
scaffold and miniplates are exposed through intraoral wounds (black arrow) (b).                  
(a)                                                                     (b)
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Serial radiographic examinations and gross examination showed incomplete union 
between bone segments in all groups at 6 months after surgery. Radiographic bone 
formation was found to be higher in the PCL-BMP than in the PCL-CELL and 
PCL (control) groups, and regenerated bone was also found outside the scaffold, 
especially in the area adjacent to the lingual periosteum. The fixation plates and 
screws appeared to be loose in some specimens (Fig. 8). 
Figure 8. Radiographic images of the reconstructed monkey mandibles: (a) PCL- 
BMP, (b) PCL-CELL, and (c) PCL-control. The mandibles maintained both shape and 
dimension. The new bone regeneration was found to be nearly complete in the 
PCL-BMP group. Incomplete bone union was observed in the other two groups. 
Loosening of plates and screws was found in several specimens. 
Micro-CT Analysis
Micro-CT revealed that bone regeneration in the various PCL scaffold groups never 
resulted in complete repair of the continuity defects at 6 months. Deformation of 
the scaffold, i.e., bending or fracture between the stem and the body of the scaffold, 
was found in two specimens (PCL-control and PCL-CELL). The lingual side of the 
mandibular defect showed homogeneous bone regeneration.
Calculated Mean Bone Volume (mm3) at the reconstruction side (area between 
mandibular segments) was found, for PCL-control, PCL-CELL, and PCL-BMP, 
to be 210.07 ± 112.37, 566.66 ± 371.30, and 481.98 ± 281.60 mm3, respectively. 
However, bone formation presented mainly at the lingual side of the defect, and 
some regenerated bone was separated from the scaffold. Further evaluation of new 
bone formation inside the scaffold structures revealed a high level of bone formation 
in the PCL-BMP group compared with the other groups (Fig. 10). Mean Bone 
(a) PCL-BMP (b) PCL-CELL (c) PCL(control)
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Volume inside the scaffold for PCL-control, PCL-CELL, and PCL-BMP was 27.98 
± 34.64, 9.21 ± 7.42, and 153.45 ± 171.42 mm3, respectively.
The mean Tissue Mineral Content (TMC) for PCL-control, PCL-CELL, and 
PCL-BMP was 14.15 ± 17.34, 4.87 ± 4.08, and 82.96 ± 91.33 mg, respectively, 
and the mean Tissue Mineral Density (TMD) for PCL-control, PCL-CELL, and 
PCL-BMP was 521.48 ± 25.59, 491.62 ± 60.73, and 547.23 ± 40.13 mg HA/
cc, respectively. Nevertheless, statistical analysis demonstrated that the observed 
differences in bone volume (outside and inside), TMC, and TMD between and 
among the various groups were not significant (p > 0.10) (Figs. 9, 10).
 
Figure 9. Micro-CT scan analysis results. a) Bone volume at the reconstruction 
site of each specimen. b) Bone volume formation inside the PCL scaffold in each 
specimen.
(a)
(b)
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Figure 10. Micro-CT scan analysis. a) Mean bone volume at the reconstruction site 
of each specimen. b) Mean bone volume inside the PCL scaffold. There was no 
significant difference in mean bone volume at the reconstruction site and inside the 
scaffold among the 3 groups (P > 0.010).
Mechanical Testing
Successful mechanical testing could be undertaken only on 4 specimens, i.e., PCL-
BMP (n = 2) and PCL-CELL (n = 2), while the other 4 specimens presented 
with poor stability at the reconstruction site, which did not allow for mechanical 
assessment. The stiffness values on the experimental side of the mandible were 7.1 
and 24.4 N/mm in the PCL-CELL group and 193 and 61.9 N/mm in the PCL-
BMP group. The mean stiffness values on the contralateral side of the mandible 
were 129.4 and 198.2 N/mm in the PCL-CELL group and 820.9 N/mm in the 
PCL-BMP group. The peak load, reported as 40.41 N, was found in one of the 
two samples from the PCL-CELL group and also in one sample of the PCL-BMP 
group, which was found to be at 72.09 N (Fig. 11). 
(a)
(b)
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Figure 11. Stiffness values of 3-point bending in monkey mandibles. Stiffness 
value in the PCL-CELL is 7.1 and 24.4 N/mm while loading force was applied to the 
experimental side and 129.4 and 198.2 N/mm with force applied to the contralateral 
side. Stiffness value in PCL-BMP is 193 and 61.9 N/mm while loading force was applied 
to the experimental side and 820.9 N/mm with force applied at the contralateral side. 
Mechanical testing could not be performed on any of the PCL-control specimens, 
due to weakness at the reconstruction site.
Analysis by Light Microscopy
Successful histological analysis was performed on 14 specimens, i.e., PCL-BMP (n 
= 6), PCL-CELL (n = 5), and PCL-control (n = 3), while the rest of the specimens 
were excluded due to infection. The histological sections showed more enhanced 
bone regeneration in the PCL-BMP than in the PCL-CELL and PCL-control 
groups (Fig. 12). The PCL scaffolds showed minimal signs of degradation in 
all groups.  In detail, the PCL-BMP group showed normal-appearing mature 
trabecular bone both outside and inside of the scaffold’s porosity in 2 of the 6 
specimens. The majority of the cells detected were osteocytes and osteoblasts. The 
porosity of the PCL-CELL and the control groups was mainly filled with soft 
tissue, with an abundant presence of fibroblasts and inflammatory cells. Islands of 
bone were found related to the periosteum, especially at the lingual side, outside 
the scaffold. At the junction of the body and scaffold stem, bone formation starting 
from the mandibular stump and progressing into the scaffold porosity and bone 
was found to be present at the lower border and lingual side of the mandible in 3 of 
the 6 specimens from the PCL-BMP group, 2 of 5 specimens from the PCL-CELL 
group, and 1 of 3 specimens from the PCL-control group. Again, the amount of 
bone formation in this region appeared to be higher for the PCL-BMP group. 
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Around the stems of the scaffolds, a thick connective tissue layer was present 
between the stem surface and native bone in most specimens. However, direct bone 
contact at the interface was found in 3 specimens of the PCL-BMP group and in 
1 of the PCL-control groups. 
 
Figure 12. Histology slide sections of scaffold porosity at the mid-scaffold region: 
PCL-BMP (a) to (c), PCL-CELL (d) to (f), and PCL-control (g) to (i). Bone formation was 
found in PCL-BMP scaffold pores, while connective tissue was observed in the other 
two groups. Good bone-scaffold contact with areas of scaffold degradation was 
seen along the edge in the PCL-BMP group. CN = connective tissue, *inflammatory 
cells, and arrows = bone-scaffold contact areas.
(a) PCL-BMP (x4) (b) PCL-BMP (x10) (c) PCL-BMP (x40)
(d) PCL-CELL (x4) (e) PCL-CELL (x10) (f) PCL-CELL (x40)
(g) PCL(control) (x4) (h) PCL(control) (x10) (i) PCL(control) (x40)
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Histomorphologic Analysis
Bone formation around the device and bone-device interface was analyzed in 3 areas 
(mid-scaffold, junction between the scaffold body and stem, and mid-posterior 
stem), and the grading scale used is depicted in Figs. 13 and 14. 
The mean total bone presentation grading score for the ‘area around the devices’ 
was 0.69 ± 0.01 for the PCL-control group, 0.63 ± 0.01 for the PCL-CELL group, 
and 1.21 ± 0.29 for the PCL-BMP group. The difference in total bone presentation 
score between the PCL-BMP and PCL-control groups, and also between the PCL-
BMP and PCL-CELL groups, was found to be statistically significant (p < 0.10). 
There was no statistically significant difference between the PCL-control and PCL-
CELL groups. 
The mean total grading scores for the ‘bone-device interface’ were 0.19 ± 0.29 
for the PCL-control group, 0.12 ± 0.15 for the PCL-CELL group, and 0.55 ± 0.46 
for the PCL-BMP group. Statistical testing revealed no significant differences in 
the mean total grading scores between and among groups. 
The percentages of bone-device interface calculated around the stem of the 
implant to the native bone were 2.26% ± 5.30 for the PCL-control group and 
2.96% ± 5.01 for the PCL-BMP group, and there was no bone-device interface 
(0%) in the PCL-CELL group. There were no statistically significant differences 
between the PCL-control and PCL-BMP groups. 
(a)
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Figure 13. Bone present around the scaffolds: a) mid-body, b) junction, and c) 
scaffold stem. The score scale: 0, no bone (fibrous formation); 1, partially surrounded 
with bone; and 2, completely surrounded with bone.
 
(b)
(c)
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Figure 14. Scoring of bone-scaffold interface at 3 areas: a) mid-body, b) junction, 
and c) scaffold stem. 0, No bone (fibrous formation); 1, partial interface with bone; 
and 2, complete interface with bone. Percentage of bone interface around the stem 
of the scaffold and scoring of scaffold degradation are shown in (d). Score scale for 
scaffold degradation is described as: 0, no degradation; 1, limited degradation; 2, 
severe degradation; and 3, bone has completely disappeared.
The mean scores for scaffold degradation were 0 for the PCL-control group, 0 for 
the PCL-CELL group, and 0.78 ± 0.43 for PCL-BMP groups (Fig. 14d).
The results of the bone contact and bone volume percentages, as determined 
with image analysis software, are depicted in Fig. 15. The differences in mean 
percent bone volume (%), calculated in the area of 2 mm around the stem implant 
surface, were 27.67% ± 0.19 for the PCL-control group, 32.65% ± 15.58 for the 
PCL-CELL group, and 56.33% ± 6.98 for the PCL-BMP groups. 
(a) (b)
(c) (d)
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Figure 15. Percentage bone volume (%) calculated from the ROI (area 2 mm around 
the scaffold stems). 
The mean percent bone volume between the PCL-BMP and PCL-CELL groups 
and between the PCL-BMP and PCL-control groups was found to be statistically 
significant (p < 0.10) among the groups. There was no statistically significant 
difference between the PCL-control and PCL-CELL groups.
Discussion
This study is the first attempt to reconstruct a mandibular body segmental defect 
using the endoprosthesis-designed PCL scaffold combined with either rhBMP-2 
or autologous bone marrow cells in a non-human primate model. The continuity 
defect of segmental resection in the study was similar to those resulting from ablative 
surgery, e.g., trauma, tumors, or osteomyelitis in the oral and maxillofacial region. 
We proposed to compare the degrees of bone regeneration that occurred from the 
PCL scaffold reconstruction resulting from the addition of either rhBMP-2 or 
autologous bone marrow cells. 
Macaca fascicularis monkeys were selected in this study due to their anatomic 
and biological mandibular similarity to humans.3, 32 The six-month follow-up 
period was considered suitable based on results from previous studies on the similar 
healing of a defect site in the same model evaluating bone bridge formation in a 
mandibular continuity defect by a tissue-engineering technique,16, 33-36 including 
reconstruction with a titanium alloy modular endoprosthesis.5 Although the non-
primate human model is closed to clinical study, the immobilized jaw movement 
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by the inter-maxillary fixation (IMF) cannot be performed, unlike in humans. 
Therefore, the identification of an alternative method for early stabilization of the 
reconstruction site was crucial. Although the addition of internal fixation with 
2 mini-plates and screws was used to maintain the mandibular integrity of bone 
segments in the study, unfortunately, the results demonstrated insufficient load-
bearing capacity in most of the animals, and, subsequently, infection was found in 
many specimens. 
The immediate loading force and the intra-oral surgical approach appeared to 
be related to wound dehiscence and disrupted the achievement of bone union. 
Wound dehiscence was experienced by the animals as an ‘uncomfortable feeling’ 
and resulted in additional disturbance of the wounds by the monkeys with their 
fingers. Wound dehiscence as well as dislodgement of the mini-plates and screws 
led to a limited number of appropriate specimens for further evaluation. Therefore, 
the data should be interpreted with caution.
There was incomplete bone union in all study groups; therefore, we rejected the 
hypothesis that an osteoinductive scaffold loaded with rhBMP-2 or bone marrow 
cells could achieve bone union and overlying soft-tissue healing with sufficient 
load-bearing capacity within 6 months.  However, the findings showed that the 
amount of bone in-growth was higher in the PCL-BMP-2 group compared with 
that in the PCL-CELL and PCL-control groups. The micro-CT imaging in one 
specimen from the PCL-BMP group showed a nearly complete bone union with 
bone in-growth. The mechanical test showed that the mandible reconstructed 
with PCL-BMP had a higher load-bearing capacity compared with that of the 
other groups. Nonetheless, with the limitation that the study was discontinued at 
6 months, it might be possible that bone formation and bone union in the PCL-
BMP group may or may not continue if a follow-up period was set at more than 6 
months. However, based on the current findings, the PLC-BMP-2 reconstruction 
has potential for bone regeneration in mandibular continuity defects. 
Basic bone bioengineering can be accomplished relative to many factors, 
including bone scaffold, growth factors, biologic cells, and surrounding vascular 
blood supply, especially in large reconstruction sites.37, 38 The ideal biomaterial 
properties for bone scaffolds were identified as biocompatibility, a capacity for 
facilitating revascularization, osteoinductive and osteoconductive properties, and a 
structure providing a framework for new bone development while allowing for the 
incorporation of osteogenic factors.38 Furthermore, the material should be easily 
shaped into complex components, as well as being malleable, sterilizable, storable, 
and affordable. The material stiffness should offer an initial primary stability for 
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the reconstruction site with subsequent gradual degradation corresponding with 
newly deposited bone in-growth, to maintain the proper load-bearing capacity. 
The candidate scaffold materials which closely fulfill such requirements are 
bioresorbable aliphatic polyesters, such as polyglycolide, polylactide, PCL, and 
their copolymers. 
PCL is the FDA-approved material used in multiple medical device 
formulations.12 It already has a significant history of regulatory approval, with 
minimal inflammatory and immunological responses,39, 40 and has been used in 
clinical applications highly biocompatible with osteoblasts. The thermoplastic 
quality of PCL allows it to be processed in 3 dimensions with the desired geometry, 
and for controlled porosity with interconnectivity by modern computer-based solid 
free-form fabrication technology. In the current study, the scaffold was designed 
to follow the anatomy of a monkey mandible based on the computed scan (CT) 
data. It was comprised of a body segment with two modular endoprosthesis 
stems inserted into the prepared cancellous cavity of a native mandible. The PCL 
scaffold was intended to maintain the stability of the mandible and to support the 
anatomical regeneration of the bone defect.
Among growth factors for the enhancement of bone regeneration, BMPs have 
been reported to be successful in bone reconstruction. The selected carriers reported 
in the  literature were collagen sponges16, 35, 41, 42, poly-D, L-lactic-co-glycolic acid-
coated gelatin sponges (PGS)43, poly D,L-lactic coglycolic acid (PLGA)-coated 
gelatin sponges (PGS)44, polyglycolic co-lactic acid (PGLA)45, and autologous bone 
graft of freeze-dried bone.46 Among these materials, the collagen type-I sponge was 
found to be the most frequently used in preclinical and clinical studies in segmental 
mandibular reconstruction with promising results. However, the collagen sponge 
lacks sufficient structural integrity to maintain the defect space compared with a 
bone graft and also lacks loading capacity.18 Therefore, there is great interest in the 
search for other bone scaffold carriers better suited to bone defect repair.18 PCL is a 
candidate material. Although it has non-osteoinductive properties, an engineered 
CHA surface coating on PCL has been proven to allow protein molecules such as 
rhBMP-2 to attach and be released in a controlled manner,12, 13 as was used in this 
study.
The porosity of the scaffold functions as a repository for housing bone marrow 
mesenchymal cells to be transported to the reconstruction site. The autologous bone 
marrow cells utilized in this study were aspirated from the autologous trochanter 
bone, since we noted that the monkey’s iliac bone size was small. The autologous 
bone marrow cells were processed and seeded into the scaffolds for reconstruction 
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without the in vitro incubation process, so that the bone reconstruction process 
could be completed within the same operation. This approach was found to 
compromise the function and morphogenic ability of the bone marrow cells 
possibly related to poor cell viability after implantation. The bone regeneration 
results in the PCL-CELL group were complicated by wound infection without 
bone in-growth. The lack of bone formation in the center of the scaffold possibly 
resulted from insufficient blood supply to the inner side of the scaffold structure, 
required to maintain cell survival. The results therefore did not differ from those 
of the control group. The conclusions resulting from the use of a PCL scaffold 
combined with autologous bone marrow cells yielded insufficient supporting data. 
The methodology on cellular approaches to bone regeneration requires further 
study. 
The acknowledged slow degradation phenomenon of PCL, which depends on 
random hydrolytic chain scission of the ester linkages, may vary from months 
to years.47 Polymer degradation can be characterized as a decrease in the rate of 
chain scission and the onset of implant weight loss, fragmentation, and intracellular 
degradation.48 This slow degradation could even hamper bone in-growth. The PCL 
scaffold degradation in the current study was limited, and the remaining structure 
was still present at the end of the study. However, the actual amount of PCL 
degradation, e.g., molecular weight loss, was not evaluated in this study.  
Further studies will be needed to determine the optimal methodology and 
parameters prior to clinical use. In future studies, additional steps can be taken 
to increase the stability of the endoprosthesis. A surgical approach to mandibular 
reconstruction should preferably be performed extra-orally to reduce wound 
dehiscence and infection rates. PCL can be the material of choice; however, after 
insertion into the mandible, the modular components of the scaffold can be heat-
welded together to increase the rigidity of the prosthesis. Importantly, sufficient 
rigid plate(s) fixation should be used to improve the primary stability of the 
reconstructed site, especially in the initial stage of reconstruction. The protocol for 
bone marrow cell preparation and seeding requires revision if promising results are 
to be achieved. 
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Conclusion 
In conclusion, the results of our study did not confirm the original hypothesis. 
Based on the data obtained, no satisfactory bone formation occurred between the 
mandibular segments at 6 months after surgery in any of the three groups. There 
was a high rate of infection and dislodgement of the fixation plates and the PCL 
endoprosthesis scaffold. Nevertheless, the BMP-2-loaded PCL scaffolds were found 
to perform better in terms of bone formation and mechanical testing than empty 
PCL scaffolds and scaffolds loaded with autogenous BMSCs. This suggests that 
this might be a feasible approach for further study in reconstructing segmental 
mandibular defects.
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Introduction
Dental implants placed in fresh sockets after tooth extraction are called ‘immediate’ 
implants.1 Survival rate of implants placed using this technique has been shown, in a 
systematic review, to be comparable with immediate-delayed and delayed implants.2 
The advantages of immediate implants include the reduction in the number of 
surgical interventions and total treatment time.3, 4 The incongruity, however, 
between the shape and size of the dental implant and that of the socket wall may 
lead to gaps or peri-implant defects. It has been found that peri-implant defects 
of 2mm or less healed by spontaneous bone regeneration and defect resolution. In 
the presence of peri-implant defects larger than 2mm, concomitant augmentation 
procedures were required to achieve an optimal outcome.5
Localised pathologic processes may lead to damage of one or more walls of the 
extraction socket, with the formation of dehiscence defects.6 Examples include 
traumatic injuries resulting in dentoalveolar fracture, periapical granulomas or 
cysts causing resorption of the alveolar bone and periodontal disease. The socket 
wall may also be damaged in the process of exodontia. Clot stabilisation and bone 
formation after extraction of the involved teeth may be adversely affected by the 
lack of intact bony walls. Bone regeneration and aesthetic outcomes may thus be 
compromised when immediate implants are placed at these sites. Various types of 
barrier membranes and/or bone grafts have been commonly used for augmentation 
of these defects at the time of immediate implant placement. Defect reduction 
using these methods ranges from 48% to 77.4%.6,7 The use of autogenous bone 
is complicated by donor site morbidity and bone resorption over time. Allogeneic 
and xenographic bone have been used, therefore, as alternative graft materials to 
autogenous bone. A study reported that tooth sockets grafted with bovine (Bio-Oss) 
material were comprised of connective tissue and only 40% of the circumference 
of the Bio-Oss particles were in contact with woven bone.8 Another study using 
demineralised freeze-dried bone allograft (DFDBA) in tooth extraction sockets 
showed non-viable particles of DFDBA with no evidence of bone formation on 
the surfaces of the implanted particles.9 
A randomized controlled trial using various augmentation techniques at the 
time of immediate implant placement showed that a greater horizontal resorption 
of the facial bone occurred in the presence of a dehiscence defect as compared to 
intact sites.10 Another study reported a high incidence of recession of the labial 
mucosa following immediate implant placement at sites with a facial bone defect, 
despite augmentation using autogenous bone or Bio-Oss and collagen membrane.11 
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A systematic review also found strong evidence that regenerative outcomes using 
conventional augmentation materials and techniques were less successful when 
dental implants were placed in sockets with dehiscence defects as compared to those 
with intact bone walls.12 
Polycaprolactone (PCL) is regarded as a non-toxic and tissue-compatible 
material13 and has been used in many medical devices for the last 30 years. It was 
used in Capronor®, a one-year implantable subdermal contraceptive device14 and 
in bioresorbable Monocryl® monofilament sutures15. Both are FDA-approved 
clinical products. More recently it has been approved as a bone filler for craniofacial 
applications (510K FDA K051093) (http://www.accessdata.fda.gov/cdrh_
docs/pdf5/K051093.pdf ). The PCL scaffold is intended for use in the repair of 
neurosurgical burr holes, craniotomy cuts and other cranial defects and in the 
augmentation or restoration of bony contour in the craniofacial skeleton16. An 
interdisciplinary group at the National University of Singapore, in collaboration 
with Temasek Polytechnic, evaluated and patented the parameters used to process 
PCL and PCL composites by Fused Deposition Modelling (FDM).17 The unique 
feature of these FDM scaffolds lies in the 3-angle layering (0°/60°/120°) that results 
in a fully interconnected matrix architecture that provides maximum anchorage for 
cell attachment.17-19 The scaffold has mechanical properties closely similar to bone, 
exhibits slow degradation kinetics, enhances blood clot entrapment and vascular 
ingrowth and is osteoconductive. The second-generation scaffolds produced by 
FDM are based on composites. Bioactive composite 3-dimensional (3D) scaffolds 
comprising of a biodegradable polymeric phase and a bioactive phase that can 
bond spontaneously to and integrate with bone are recent innovations in the field 
of regenerative medicine. It was hypothesized that PCL-TCP scaffolds possess cell 
and protein binding sites due to the nucleation of the tricalcium phosphate on 
its surface.20, 21 The PCL-TCP scaffold was shown to have improved mechanical 
and biochemical properties as well as more favourable degradation and resorption 
kinetics than the first generation scaffolds.22-24 The use of PCL-TCP scaffolds for 
the treatment of bone defects has been tested in several animal studies.25, 26 It was 
postulated that these scaffolds would be suitable for reconstruction of tooth socket 
dehiscence defects during immediate dental implant placement because they: 1) 
eliminate the need for an autogenous donor site; 2) are available in unlimited 
quantity and consistent quality; 3) have a highly porous and honeycomb-
like architecture that facilitates the infiltration of new osteoid; 4) do not evoke 
an undesirable prolonged inflammatory response; and 5) can withstand local 
mechanical stresses.25
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The hypothesis for this study was that the insertion of a 3D bioresorbable 
PCL-TCP scaffold into tooth extraction sockets with a facial wall defect and 
simultaneous immediate dental implant placement would result in favourable 
bone regeneration of the defect, allowing optimal bone-to-implant contact and 
dental implant stability. The study compared in a monkey model (1) peri-implant 
bone healing and regeneration, (2) bone-to-implant contact and (3) dental implant 
stability, following immediate implant placement into tooth sockets with surgically 
created facial wall defects in the following treatment groups:
 (a) use of a 3D PCL-TCP scaffold as space filler (test group)
 (b) use of particulate autogenous bone as a graft (control group)
Material and Methods
Scaffold Fabrication
The PCL-20% TCP scaffolds were purchased from Osteopore International 
(Singapore). The TCP powder particle size was determined by Coulter Laser 
Diffraction LS100Q to be less than 63 µm27 . A composition of 20% TCP by 
weight was selected as it was considered to be adequate to reinforce the PCL while 
minimizing the risk of problems arising from the rheological properties during 
the micro-extrusion process used in the fabrication of the scaffolds. The scaffolds 
were fabricated by the latest FDM techniques (FDM 3000; Stratasys, Eden Prairie, 
MN), in a class 10K clean room environment. Each scaffold had a lay-down pattern 
of 0°/60°/120°, porosity of 70%, and measured 8mm x 8mm x 6mm. The PCL-
TCP scaffolds had a typical honeycomb structure with interconnected equilateral 
triangles of regular porous morphology. They were individually packed and sterilized 
using gamma irradiation. (Table 1)
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Table 1. Properties of the PCL-20%TCP scaffold
PCL-TCP Properties
(Osteopore International Pte Ltd)
pCL grade FDa approved medical grade
pCL mol weight 143850 g/mol
pCL weight % 80
tCp weight % 20
tCp particle size 60-40 μm
Manufacturing method Computer controlled micro extrusion
Manufacturing environment Clean rm Class 10k
sterilisation method Gamma irradiation
pCL-tCp lay down pattern 0/60/120
pCL-tCp rod size 0.15 mm
pCL-tCp porosity 70%
pCL-tCp pore size 500 μm
pCL-tCp stiffness 6.8 Mpa
pCL-tCp yield stress 1 Mpa
Dental Implant
Biomet 3i® (Biomet, Florida, USA) Nanotite tapered Prevail (expanded platform) 
dental implants (NIIOS3413;  implant body diameter 3.25 mm, occlusal diameter 
4.1 mm, apical diameter  2.4 mm and surface height 12.52 mm) were used. The 
titanium surfaces were dual acid-etched and with Discrete Crystalline Deposition™ 
(DCD™) of nano-scale calcium phosphate. 
Surgery 
18 male, adult monkeys (Macaca fascicularis) of about 4 years of age, weighing 
approximately 4 to 6 kg were used in this study. Permission to carry out the study 
was granted by the Institutional Animal Care and Use Committee of SingHealth 
in Singapore. 
The monkeys were fasted overnight and received 0.05mg/kg intravenous 
atropine and 10mg/kg ketamine preoperatively. Induction of anaesthesia was 
performed by a veterinarian using 3% halothane. Endotracheal intubation was done 
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using oral endotracheal tubes of gauge 3.5mm. The anaesthesia was maintained 
using 1-2% halothane. Intravenous analgesic 2mg/kg carprofen (Rimadyl®) and 
antibiotics 5mg/kg enrofloxacin (Baytril®) and 15mg/kg amoxicillin (Betamox®) 
were administered. 
The upper left permanent central and lateral incisors (#21, 22) were extracted 
and a trapezoidal mucoperiosteal flap extending from the #21 to 22 region was 
raised. A bony defect was created by removing the facial wall of the #21, 22 tooth 
sockets using an osteotome. 
Test group (N = 10): The PCL-TCP scaffold was shaped, using a no.15 surgical 
blade, to fit the #21, 22 tooth socket defect snugly. The implant site was prepared 
using successive drills as according to the Biomet 3i® (Biomet, Florida, USA) dental 
implant surgical protocol, at a drilling speed of 1200 rpm. Drilling was done 
through the PCL-TCP scaffold and into the apico-palatal bone of the tooth socket. 
The implant fixture was then inserted at insertion torque of 20 Ncm, through the 
PCL-TCP scaffold and into the apico-palatal bone (Figure 1a and 1b)
 
Figure 1. Test group – PCL-TCP scaffold and dental implant inserted into a tooth 
extraction site with a facial wall defect. a) Crestal view b) Facial view 
Control group (N = 8): The implant site was prepared using successive drills 
as according to the Biomet 3i® (Biomet, Florida, USA) dental implant surgical 
protocol, at a drilling speed of 1200 rpm. Drilling was done directly into the apico-
palatal part of the tooth socket. The implant fixture was then inserted at insertion 
torque of 20 Ncm into the apico-palatal bone. Bone from the previously removed 
facial plate of the tooth sockets in the same monkey was divided into smaller pieces 
with bone ronguers and the bone chips were grafted into the defect surrounding 
the dental implant (Figure 2a and 2b).
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Figure 2. Control group – Autogenous particulate cortical bone grafted around a 
dental implant in a tooth extraction site with a facial wall defect. a) Crestal view b) 
Facial view
For both groups, the baseline Implant Stability Quotient (ISQ) was measured by 
Resonance Frequency Analysis (RFA) using the Osstell® machine in the bucco-
lingual (B-L) and mesio-distal (M-D) directions immediately after implant 
insertion. The cover screw was then inserted. The periosteum of the labial flap 
was incised to achieve a tension-free primary closure of the surgical wound using 
4/0 Vicryl® sutures. Immediately after the surgery, an anterior maxillary occlusal 
radiograph was taken using standardised settings.  The monkeys were put on a soft 
diet for the first two weeks postoperatively. They received 2mg/kg Rimadyl® s.c., for 
analgesia for 2 days and 5mg/kg Baytril® and 15mg/kg amoxicillin s.c. for 5-7 days. 
The monkeys were sedated at 1 month and 3 month postoperatively for inspection 
of the surgical wounds.
Sacrifice
The monkeys in both the test and control groups were sacrificed at 6 months post-
op. A perfusion fixation method was used. Before sacrifice, the operated site was 
examined for any signs of infection, soft tissue dehiscence and mobility of the 
scaffold and/or dental implant. The cover screw of the dental implant was then 
exposed using a tissue punch. ISQ was determined by RFA using the Osstell® 
machine in the B-L and M-D directions. After sacrifice, en-bloc resection of the 
#21, 22 alveolus, including the dental implant, was done.  An anterior maxillary 
occlusal radiograph was taken of the specimen using the same settings as before. 
Any significant radiolucency or bone loss was noted, using the immediate post-op 
radiograph for comparison. The block was then sent for histologic preparation.
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Histology and Histomorphometry
The tissue blocks were dehydrated in a graded series of ethanol, embedded in 
methyl methacrylate resin and polymerized. The tissue blocks with implants were 
mounted in a modified inner circular saw microtome (Leica® RM 2165, Wetzlar, 
Germany), and 10µm thick sections were prepared. Three longitudinal sections 
were made parallel to the long axis of the dental implant in each of 3 control and 6 
test specimens. Three cross-sections were made perpendicular to the long axis of the 
dental implant at the crestal one-third level in each of the remaining 5 control and 4 
test specimens. The sections were stained with methylene blue and basic fuchsin for 
histologic and histomorphometric analyses. A light microscope (Olympus® CX31, 
Tokyo, Japan) was used for histologic evaluation. The sections were examined for 
bone remodelling, bone regeneration and presence of any inflammatory reaction. 
The following histomorphometric analyses were done: 
1) Modified histologic grading scale for bone implants28  
 A modified histologic grading scale was used (Table 2) to quantify the histologic 
findings of the reconstructed region surrounding the dental implants. Both the 
longitudinal and cross-sectional sections of the 8 control and 10 test specimens 
were evaluated. The grading was performed by 2 observers (GBT, NC) and 
when their grades differed, a consensus was reached after discussion. 
Table 2. Modified histologic grading scale for bone implants
Evaluation Response Score
TEST gROUP: 
Interstitial tissue
Mainly bone 4
Fibrous tissue and some bone 3
Mainly or only fibrous tissue with some 
inflammatory cells
2
only inflammatory cells 1
Bone-scaffold 
interface
Bone contact  + bone ingrowth in the scaffold 
porosities
3
Fibrous tissue + no bone ingrowth 2
Inflammatory cells 1
CONTROL gROUP: 
particulate Bone 
Graft
Bone formation, defect completely closed 3
Limited bone formation, defect partially filled, 
ingrowth of bone along implant surface
2
No bone formation, collapse of gingiva, no 
particles left
1
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2) Bone-to-implant contact (%BIC)
 The %BIC was evaluated on the longitudinal sections made in 3 control and 6 
test specimens. This was performed using the Cell A® (Olympus, Tokyo, Japan) 
imaging and histomorphometric software in a region of interest (ROI), defined 
as the labial surface of the dental implant, from the implant shoulder to the level 
where the implant inserted into native bone apically. It was calculated using the 
formula below:
%BIC = [total length of bone contact with implant surface in the ROI] X 100
  [total length of implant surface in the ROI]
3) Bone area (%BA)
 The %BA was also evaluated on the longitudinal sections made in 3 control 
and 6 test specimens. This was done using the Cell A® (Olympus, Tokyo, Japan) 
imaging and histomorphometric software in a ROI, defined as the region from 
0 to 1mm labial to the trough of the implant threads (width) and from the 
implant shoulder to the level where the implant inserted into the native bone 
apically (length) (Figure 3). It was calculated using the formula below:
%BA = [total area of bone in the ROI] X 100
  [total area in the ROI]  
 
Figure 3. ROI for %BA measurement
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Results
Clinical
All 18 monkeys were able to feed well orally and none had significant weight 
loss postoperatively. During wound inspection at 1 month, 1 animal (C1) in the 
control group presented with a small area of wound dehiscence at the crestal aspect 
resulting in an exposure of the implant cover screw. 1 animal (T6) in the test 
group presented with a relatively large area of wound dehiscence, exposing both the 
implant cover screw as well as the crestal one-third of the PCL-TCP scaffold. The 
exposed scaffold was contaminated with food debris but there was minimal swelling 
and no purulence noted in the surrounding tissues.  The exposed dental implant 
and scaffold were completely removed under general anaesthetic. A new dental 
implant and PCL-TCP scaffold were inserted and the wound was closed primarily. 
Postoperatively, the monkey received s.c. analgesics and antibiotics as previously 
described. At the 3-month postoperative wound inspection, 4 of the 8 monkeys 
in the control group showed significant ridge resorption in the buccal aspect as 
the dark metallic color of the dental implant could be seen under the soft tissues 
(Figure 4a). The previously exposed implant cover screw in the control monkey 
remained similarly exposed. In all the test animals, the ridge contour appeared to 
be well maintained (Figure 4b). There was recurrence of wound dehiscence in the 
previously re-operated monkey but this time only the implant cover screw was 
exposed but not the scaffold. There was exposure of the implant cover screw and 
scaffold in another 2 test animals (T5 and T9). No active treatment was instituted 
in these 2 animals. The observational findings in all animals prior to sacrifice at 6 
months were similar to those described at 3 months. There was no active infection 
or loss of the dental implant in any monkey throughout the duration of the study.
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Figure 4. Alveolar ridge at 6 months. a) Control animal b) Test animal
Plain Radiographs
The anterior maxillary occlusal radiographs taken at sacrifice in both control and 
test animals did not show any significant radiolucencies, crestal bone loss or other 
abnormalities in the periimplant region. The dental implants did not show any 
signs of displacement or dislodgement. (Figure 5a and 5b)
Figure 5. Anterior maxillary radiograph at 6 months (post-harvest). 
a) Control animal b) Test animal 
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Figure 6. ISQ values at baseline and 6 months of test and control groups
Descriptive Histology
Longitudinal Sections
In all the longitudinal sections, the dental implant was seen to be inserted into 
native alveolar bone at its apical third and in a few specimens, it penetrated through 
the bony nasal floor into the nasal cavity. Crestally, the gingival tissue overlying the 
cover screw was missing as it had been removed just before the euthanasia so that 
the RFA could be performed.
In the control specimens, native alveolar bone and new bone were seen in direct 
contact with at least the apical two-thirds of the implant surface on the palatal aspect. 
The labial surface of the dental implant was covered by labial muscle and mucosa, 
with a total absence of bone (Figure 7). In the test specimens, the PCL-TCP scaffold 
was seen as either brownish-grey concentric areas or empty concentric spaces as the 
scaffold was partially dissolved during the histologic processing. A greater thickness 
RFA
For the control group, the mean baseline ISQ values were 54 ± 6.9 (B-L) and 51 ± 
8.7 (M-D), while the mean 6-month ISQ values were 60 ± 6.7 (B-L) and 64 ± 7.3 
(M-D). For the test group, the mean baseline ISQ values were 51 ± 6.6 (B-L) and 
49 ± 5.4 (M-D), while the mean 6-month ISQ values were 54 ± 14.4 (B-L) and 55 
± 15.5 (M-D). Although the mean ISQ values at 6 months seemed higher than at 
baseline for both the control and test groups, this could not be proven by formal 
statistical tests due to small sample sizes. (Figure 6)
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of the PCL-TCP scaffold was always seen on the labial than the palatal aspect of the 
implant. On the palatal aspect, the scaffold appeared compressed due to the dental 
implant installation (Figure 8a). The porosities of the scaffold were mostly occupied 
by fibrous tissue with occasional islands of new bone just adjacent to the native 
palatal or apical alveolus (Figure 8b). There was almost an absence of inflammatory 
cells within the fibrous infiltrate. A ring of inflammatory cells, however, was often 
seen encircling the PCL-TCP struts (Figure 8c). In those specimens where there 
was soft tissue dehiscence clinically (T5, T6 and T9), abundant inflammatory cells 
were seen infiltrating the porosities of the scaffold.  
Figure 7. Control specimen longitudinal section (methylene blue and basic fuchsin stain)
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Figure 8a, b and c. Test specimen longitudinal section 
(methylene blue and basic fuschin stain)  S: PCL-TCP scaffold 
Cross-Sectional Sections
The cross-sectional sections were made at the crestal third level of the dental implants 
so as to avoid sectioning through the apical native alveolar bone. In the control 
specimens, bone was seen on the palatal, mesial and distal aspects, contacting the 
dental implant surface. On the labial aspect, the implant surface was covered by 
fibrous tissue and labial muscle in 3 out of 4 specimens (Figure 9). In 1 specimen, 
new bone was seen covering and in contact with the labial aspect of the dental 
implant. In the test specimens, the PCL-TCP scaffold was seen to surround the 
dental implant. Again, the scaffold was thicker on the labial than the palatal aspect. 
Similar to the longitudinal sections, fibrous tissue was seen predominantly within 
the scaffold porosities with minimal inflammatory cells, except for the specimens 
that had soft tissue dehiscence. Labially, a fibrous capsule surrounded the scaffold. 
Small islands of bone were seen growing into the porosities of the scaffold just 
adjacent to the palatal native bone. (Figure 10)
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Figure 9. Control specimen cross-sectional section 
(methylene blue and basic fuschin stain)
Figure 10. Test specimen cross-sectional section 
(methylene blue and basic fuschin stain)
Histomorphometry
1) Modified histologic grading scale for bone implants
 For the control group, the mean score for the particulate bone graft was 1.33 ± 
0.69. Only 1 specimen scored 3 for all sections while 5 specimens scored 1 for 
all sections. 
  For the test group, the mean score was 2.62 ± 0.56 for interstitial tissue. 
None of the sections scored 4. Most of the sections scored either 2 or 3, except 
for those sections belonging to animals T5 and T6, which scored 1. The mean 
score was 2.28 ± 0.74 for bone – scaffold interface. Likewise, most sections 
scored either 2 or 3 with the exception of 1 section belonging to animal T6, 
which scored 1. (Figure 11)
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Figure 12. %BIC and %BA of test and control animals
Figure 11. Histologic grading scale scores of test and control groups
2) %BIC
 The mean %BIC was 27.6 ± 19.1% for the control group and 6.8 ± 7.9% for 
the test group. Two out of the 6 test specimens had zero %BIC (T2 and T6). 
Formal statistical tests could not be performed due to small sample sizes. (Figure 
12)
3) %BA
 The mean %BA was 11.8 ± 10.1% for the control group and 6.8 ± 6.9% for 
the test group. One specimen in the test group had zero %BA (T6). Formal 
statistical tests could not be performed due to small sample sizes. (Figure 12)
 
155
Chapter 6
Discussion
The present study used a clinically relevant model to study the feasibility of using a 
PCL-TCP scaffold for reconstruction of a socket wall defect. In addition, it tested 
if dental implant placement through the scaffold, done at the same surgery, was 
technically possible. Combining the bone regenerative procedure with the dental 
implant placement not only reduced the number of surgeries and total treatment 
time, the dental implant also served as a fixation device to immobilize the scaffold. 
The monkey model was selected because of the phylogenetic relationship with 
human. The monkey is omnivorous and is considered to best represent the human 
masticatory system29. 
The PCL-TCP scaffold used in the study was prefabricated in the form of a 
standardized cuboidal block. During surgery, it could be easily shaped using a 
scalpel so as to fit the size and shape of the tooth extraction site defect. It was also 
noted during the study that the PCL-TCP scaffold possessed sufficient mechanical 
strength to withstand drilling with twist drills, without undergoing gross 
deformation or disintegration. Experience from this study therefore demonstrated 
that customization of the PCL-TCP scaffold would not be necessary for this clinical 
application. This would save production cost and time. When manually shaping the 
scaffold, however, it is important to ensure that the scaffold is not over-contoured. 
In this study, 3 test animals presented with wound dehiscence that resulted in the 
exposure of the scaffold and implant cover screw. It was likely that the scaffold 
was over-contoured and the wound closure was not completely tension-free in 
these animals. It is important to note that while healing by secondary intention 
frequently occurs when an autogenous bone graft is exposed, when a porous scaffold 
is exposed, it becomes a trap for food and oral microorganisms and healing becomes 
difficult or impossible. In this study, the histological sections of those animals that 
had soft tissue dehiscence showed an abundance of inflammatory cells and minimal 
or no bone growth.
Four of the 8 animals in the control group showed significant resorption at the 
grafted site that was noted clinically as early as 3 months post-op. This observation 
was confirmed histologically, where there was a collapse of soft tissue into the 
defect and a complete absence of bone on the labial aspect. Our findings in the 
control group were consistent with those reported by Schliephake et al 30 in a study 
that evaluated the use of autogenous particulate bone, either with or without 
a barrier membrane for the repair of alveolar ridge defects and simultaneous 
implant placement in a dog model. They found only a minor increase in bone 
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height using these augmentation techniques. The major limiting factor for bone 
regeneration appeared to be insufficient stability of the bone graft to withstand the 
overlying soft tissue pressure. It was concluded in that study that the placement 
of autogenous bone particles had little effect on the regeneration of peri-implant 
bone defects. Although autogenous bone is still considered the gold standard as a 
graft material due to its supply of osteoprogenitor cells, it is a well-known fact that 
over time, it undergoes variable but often substantial resorption. The physiology 
of particulate bone graft is explained by the Axhausen theory of osteogenesis31 
which states that surviving transplanted cells proliferate and form new random 
osteoid, which is dependent on the spatial orientation of the grafted tissue. Thus, 
the eventual quantity of bone is determined in Phase I. Phase II of osteogenesis 
results in resorption and remodeling of the random osteoid into mature osteons 
with organized structures. The quality of bone is, thus, determined in Phase II. 
The process of replacement of the immature Phase I bone with organized Phase II 
bone is dependent on the volume and cellularity of the host bone surrounding the 
defect as well as the supply of mesenchymal cells derived from the overlying soft 
tissues. It has been suggested that the reduced volume and cellularity of the bone 
at the margins of a facial bone defect is insufficient to maintain the graft volume 
during Phase II osteogenesis resulting in loss of graft volume over time.11 While 
it is questionable whether complete facial bone coverage of the implant surface is 
necessary for implant survival, the loss of labial ridge contour, soft tissue recession 
and exposure of the underlying metal implant are major concerns especially in the 
anterior aesthetic zone.
In this study, the PCL-TCP scaffold was able to maintain the labial contour 
of the alveolar ridge in the test animals over the 6-month study duration. This 
could be attributed to the mechanical stability, structural integrity and relatively 
slow degradation rate of the PCL-TCP scaffold. It is a bioengineering challenge to 
fabricate a scaffold with the ideal degradation profile that matches the rate of new 
bone formation. In principle, when implanted in the body, a bioresorbable scaffold 
degrades and is absorbed by the body over time, enabling the space occupied by the 
scaffold to be gradually replaced by newly formed bone.32 If the scaffold degrades 
too early, before sufficient bone ingrowth and consolidation can occur, it might 
not be able to withstand the load bearing forces that are present in the oral cavity. 
Conversely, if the scaffold takes too long to degrade, it will act as a barrier and 
hinder new bone formation within the defect. PCL, like other members of the 
aliphatic polyesters, undergoes a 2-step degradation process. The first step occurs by 
autocatalysis with non-enzymatic random hydrolytic chain scission of ester linkages. 
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The second step occurs as the mechanical strength and weights are lost, thereby 
increasing the surface area for bio-erosion. The final breakdown products of PCL 
are CO2 and H2O.
13 PCL scaffolds degrade at a slow rate due to its high molecular 
weight and hydrophobicity. The incorporation of TCP into a PCL polymer matrix 
produces a hybrid or composite material that allows tailoring the desired degradation 
kinetics of the polymer matrix. The added TCP particles are physically blended into 
the polymer and occupy random spaces in the polymer. Shortly after the scaffold 
is implanted in the body, the TCP particles, being hydrophilic, tend to fall off and 
interact with the surrounding body fluid. The dislodgement of TCP creates voids 
within the polymer, thus exposing their surfaces to hydrolytic attack and weakening 
the overall structure of the PCL.21 For dento-alveolar reconstruction, a scaffold 
that degrades in about 5 to 6 months is considered ideal for bone regeneration and 
remodeling.24 In this study, it was noted histologically that much of the scaffold 
was still present at 6 months. Minimal bone ingrowth was noted only in those 
areas where the scaffold was in contact with a bony wall of the socket. On the labial 
aspect, in the absence of a bony wall, there was a lack of bone regeneration. Instead, 
fibroblasts from the labial soft tissue flap grew and proliferated in the porosities of 
the scaffold. It can therefore be anticipated that over time, as the scaffold continues 
to degrade and lose its structural form, in the absence of new bone growth on the 
labial aspect, the alveolar contour will correspondingly collapse.
Dental implant survival rate was 100% in both the test and control groups at 
6 months. No drastic drop in ISQ was noted in any of the animals at 6 months, 
therefore supporting the fact that there was no loss of implant stability. 
In conclusion, although a 3D bioresorbable PCL-TCP scaffold, when employed 
for the reconstruction of a facial wall defect during immediate dental implant 
placement, showed better maintenance of the alveolar contour as compared to the 
use of autogenous particulate bone at 6 months, only minimal bone regeneration 
and bone-to-implant contact were noted in areas directly adjacent to a bony wall of 
the defect. The hypothesis for this study therefore, could not be supported.
Future studies shall explore the use of a barrier membrane to seclude the scaffold 
area from connective tissue cells and/or the use of growth factors to enhance 
osteogenesis within the scaffold. Further work shall also be done to treat or modify 
the PCL-TCP scaffold so as to achieve a more favorable degradation time of 5 to 
6 months.
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Summary
This thesis aims to investigate novel methods of oral and maxillofacial bone 
reconstruction that may potentially avoid the need to harvest bone from a donor 
site. 
In particular, it focuses on further development of the mandibular endoprosthesis 
for use in the reconstruction of a mandibular body segmental defect. The current 
thesis investigates the use of a regenerative medicine approach to favor the bone as 
well as soft tissue response to a mandibular endoprosthesis. In Chapter 1, a general 
introduction on the mandibular endoprosthesis and regenerative medicine as well 
as a description of the aims of this thesis are presented. 
Although the initial results with the endoprosthesis are promising, there are 
some issues dealing with the use of the PMMA cement as well as the final tissue 
responses (soft and hard tissue) to the body component of the device. Recently, 
advancements have been made in a new field of “regenerative medicine”. In 
regenerative medicine, biomolecules and stem cells are used to enhance tissue 
regeneration. In addition, the biomaterial (scaffold), which is used as a carrier for 
the biomolecules and stem cells, is newly designed so that it is able to direct the 
organization, growth and differentiation of the forming functional tissue. Despite 
significant surgical advances over the last decades, segmental mandibular bone 
repair remains a challenge. In light of this, tissue engineering may offer a next step 
in the evolution of mandibular reconstruction. Therefore, the purpose of Chapter 
2 was (1) to systematically review preclinical in vivo as well as clinical literature 
regarding bone tissue engineering for mandibular continuity defects, and (2) to 
analyze their effectiveness. An electronic search in the databases of the National 
Library of Medicine and ISI Web of Knowledge was carried out. Only publications 
in English were considered and the search was broadened to animals and humans. 
Furthermore, the reference lists of related review articles and publications selected 
for inclusion in this review were systematically screened. Results of histology data 
and amount of bone bridging were chosen as primary outcome variables. However, 
for human reports, clinical radiographic evidence was accepted for defined primary 
outcome variable. The biomechanical properties, scaffold degradation as well as 
clinical wound healing were selected as co-outcome variables. The electronic search 
in the databases of the National Library of Medicine and ISI Web of Knowledge 
resulted in the identification of 6727 and 5017 titles respectively. Thereafter, title 
assessment and hand search resulted in 128 abstracts, 101 full-text articles and 29 
scientific papers reporting on animal experiments as well as 11 papers presenting 
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human data on the subject of tissue engineered reconstruction of mandibular 
continuity defects that could be included in the present review. On the basis of 
these findings, it was concluded that: (1) published preclinical in vivo as well as 
clinical data are limited, and (2) tissue engineered approaches demonstrate some 
clinical potential as an alternative to autogenous bone grafting.
The aim of the study as described in Chapter 3 was to evaluate the soft tissue 
response to poly(ε-caprolactone) (PCL) implants with and without carbonate-
substituted hydroxyapatite (CHA) coating compared to the commonly used 
titanium alloy (Ti-6Al-4V)-machined surface. Experimental materials were 
implanted subcutaneously in New Zealand white rabbits for 5 weeks. The 
tissue attachment strength, as evaluated by a tissue peel test, histological and 
histomorphology analysis as well as scanning electron microscopy (SEM) were 
compared between groups. The peel test result revealed no statistically significant 
difference between groups. Histological analysis found fibrous capsule formation 
around all implant materials. The fibrous capsule around PCL implants with 
and without CHA coating was significantly thinner compared with the capsule 
thickness around the titanium implants. However, the inflammatory cells, as 
present at the fibrous capsule-implant interface, were found to be significantly 
lower in Ti- group. In conclusion, the current data do not prove that PCL or PCL 
with a CHA coating results in a superior soft tissue response compared with a 
machined titanium implant.
The study, as reported in Chapter 4, was designed to evaluate the effectiveness 
of bioactive-coated cementless modular mandibular endoprosthesis for mandibular 
reconstruction in Macaca fascicularis. The mandibular endoprosthesis was 
first introduced in 2008, composed of a body part and two stem components 
assembled together and of which the stem parts were inserted in the cancellous 
bone of the remaining stumps. These stems were fixed with polymethylmethacrylate 
(PMMA) cement. In this current thesis, we designed and explored the cementless 
mandibular modular endoprosthesis devices. The devices were implanted for 6 
months at unilateral mandibular body segmental defects in 9 monkeys. Analysis 
was performed using biomechanical testing, histological and Micro CT analysis. 
Mandibular contour and initial stability were satisfactory at 6 months post-
operation. Mechanical load bearing test showed mean stiffness value of 110.43 N/
mm. Histomorphology analysis found 64.17% bone to stem contact. There was 
fibrous capsule and woven bone around the device body. Percent bone volume 
calculated from Micro-CT around the stem surface was found to be superior to 
previously reported cemented mandibular endoprosthesis. However, intraoral 
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wound dehiscence was found in 6 animals. This newly designed cementless 
mandibular endoprosthesis is feasible in mandibular segmental reconstruction. 
The intermodular connection screw loosening has been resolved compared to the 
previous model. However, insufficient load-bearing capability and improper soft 
tissue healing were found in majority of the animals. Further modifications to the 
device and surgical technique need to be addressed in future studies.
In Chapter 5, a study was presented, which was aimed to evaluate the 
regeneration of a segmental mandibular bone defect by means of a 3-D designed 
PCL scaffold provided with a carbonate-substituted hydroxyapatite (CHA) 
coating for the delivery of osteoinductive factors to the defect site. The study 
was performed in a non-human primate model, Macaca fascicularis using an 
engineered poly(ε-caprolactone) (PCL) scaffold, provided with a carbonate 
substituted hydroxyapatite (CHA) coating. The scaffolds were implanted in 
unilateral surgically created mandibular segmental defects in 24 monkeys. Three 
experimental groups were made; (1) scaffolds with rhBMP-2 (n=8), (2) scaffolds 
with autologous mixed bone marrow cells (n=8), and (3) empty scaffolds as a 
control group (n=8). Evaluation was based on clinical observation as well as micro-
CT, mechanical and histological analyses. Apart from a high infection rate, the 
results showed that the newly designed PCL scaffold had insufficient load-bearing 
capability and a complete bony union could not be achieved after 6 months of 
implantation. Nevertheless, the group that was implanted with PCL scaffold loaded 
with rhBMP-2 showed evidence of bone regenerative potential as compared to 
the group implanted with PCL and autologous mixed bone marrow cells and the 
control group.
The last study, as described in Chapter 6, was focused on peri-implant bone 
regeneration and implant stability following immediate implant placement into 
tooth sockets with facial wall defects in 2 treatment groups. In 8 monkeys, the 
bone defect was reconstructed with autogenous particulate bone, while in 10 
other monkeys an experimental PCL-TCP scaffold was used. The monkeys were 
sacrificed after 6 months and the specimens were analyzed by histology and 
histomorphometry. Better maintenance of facial bone contour was noted in the 
experimental group, however bone regeneration was seen only at areas adjacent to 
a bony wall of the defect. The mean bone-to-implant contact was 27.6 ± 19.1% 
(control group) versus 6.8 ± 7.9% (experimental group). The mean bone area 
percentage was 11.8 ± 10.1% (control group) versus 6.8 ± 6.9% (experimental 
group). Implant survival was 100% at 6 months for both groups. It was concluded 
that although the use of a PCL-TCP scaffold showed better maintenance of the 
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alveolar contour as compared to autogenous particulate bone at 6 months, there 
was minimal bone regeneration within the defect.
Closing Remarks and Future Perspectives
The results of this thesis have shown that alternative methods to the use of 
autogenous bone for oral and maxillofacial bone reconstruction are promising, 
although several drawbacks in the design of the modular endoprosthesis and tissue 
engineering techniques need to be addressed.
The metallic bioactive-coated cementless modular endoprosthesis design 
reported in this thesis for reconstruction of mandibular segmental defects is an 
improvement to the previously reported cemented device. This is based on the study 
findings of increased bone-to-stem contact and that the screw-less intermodular 
locking mechanism seems to have resolved the problem of component loosening. 
A screw-less locking design should therefore be adopted in future modifications 
of the device. Problems that persisted even in this cementless endoprosthesis are 
soft tissue dehiscence and insufficient load-bearing capability. These problems 
may be partly due to the use of an animal model where it is impossible to apply 
intermaxillary fixation in the immediate postoperative period and that the monkeys 
are able to disturb the surgical wound with their fingers. In future studies, the 
use of an alternative animal model e.g. goat or sheep and an extra-oral surgical 
approach will be considered. As with dental implants, a period of healing to allow 
for osseointegration before loading the cementless device should be considered for 
future experiments. To achieve this, the rigid interlocking of the modules may have 
to be delayed and performed at a second surgery several months later. By doing this, 
the stems of the device will be spared from loading during the early healing period. 
The search for an ideal surface modification or coating that will enhance soft tissue 
adhesion to the metal surface should also continue.
Tissue engineering methods to grow the patient’s own bone, if successful, 
will undoubtedly be the ideal solution for bone reconstruction. Although many 
successful reports of bone engineering are available in in vitro and small animal 
models, reports of clinical success are scarce. The less positive results in clinical 
cases are due to various factors including insufficient vascularization of the tissue-
engineered construct, compromised soft tissue bed and biomechanical factors. 
In this thesis, bone tissue engineering was tested for regeneration of a small 
sized alveolar defect and also for a large sized mandibular segmental defect that was 
subjected to functional loading. From these studies, it seems that the PCL scaffold, 
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whether incorporated with TCP or coated with CHA, is not osteoinductive. The 
ideal scaffold material should have a resorption time that matches the rate of new 
bone ingrowth. As the PCL composite scaffold may be taking too long to resorb, 
it is treated as a foreign material by the body resulting in fibrous tissue invasion. 
Research should therefore be done to modify or treat the PCL scaffold so as to 
achieve a more ideal resorption time. 
For mandibular reconstruction, the PCL scaffold was shown to have insufficient 
load-bearing capability. There was a high rate of infection and dislodgement of 
the fixation plates and the PCL endoprosthesis scaffold. Nevertheless, the BMP-
2-loaded PCL scaffolds were found to perform better in terms of bone formation 
and mechanical testing than empty PCL scaffolds and scaffolds loaded with 
autogenous BMSCs. However, there is an increasing number of reports e.g. Perri 
et al., 2007, Shah et al., 2008 and Carragee et al, 2013, which describe that the 
clinical use of BMP-2 for bone regeneration is associated with massive soft tissue 
swelling postoperatively, ectopic bone formation and potential oncogenic effects. 
These complications, in addition to its high cost may limit its routine clinical 
use.  Currently, the Centre for Devices and Radiological Health (CDRH) of the 
U.S. Food and Drug Administration (FDA) has not licensed rhBMP-2 for use in 
mandibular continuity defects and therefore this application will be considered 
“off-label”.
Research to improve the success of bone tissue engineering in the clinical setting 
should therefore continue. For a load-bearing, large size defect such as the mandible, 
particular attention should be given to evaluation of the complex biomechanical 
forces. Microvascular anastomosis may still be necessary in combination with 
bone tissue engineering methods to ensure adequate vascularization of the entire 
construct.
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Samenvatting
Dit proefschrift wil nieuwe methoden van orale en maxillofaciale botreconstructie 
onderzoeken waardoor het misschien niet meer nodig zal zijn om bot uit een 
donorsite weg te nemen.
De aandacht gaat met name uit naar de verdere ontwikkeling van de 
mandibulaire endoprothese voor gebruik bij de reconstructie van een mandibulair 
segmentaal defect in het lichaam. In de diverse studies wordt het gebruik van 
regeneratieve geneeskunde voor een betere respons van zowel het bot als de weke 
delen op een mandibulaire endoprothese onderzocht. In Hoofdstuk 1 wordt er een 
algemene inleiding gegeven over de mandibulaire endoprothese en de regeneratieve 
geneeskunde, en worden ook de doelstellingen van dit proefschrift beschreven. 
Ondanks de veelbelovende resultaten met de endoprothese, zijn er toch wel een 
aantal problemen met het gebruik van het PMMA-cement en met de uiteindelijke 
respons van de weefsels (zowel de weke delen als het harde weefsel) op dit 
implantaat. Onlangs werd er vooruitgang geboekt in het nieuwe wetenschapsgebied 
van de ‘regeneratieve geneeskunde’. In de regeneratieve geneeskunde wordt er 
gebruik gemaakt van biomoleculen en stamcellen om de regeneratie van weefsel 
te stimuleren. Bovendien is het biomateriaal (scaffold), dat gebruikt wordt om 
de biomoleculen en stamcellen te transporteren, zodanig ontworpen dat het de 
structuur, groei en differentiatie van het vormende functionele weefsel kan sturen. 
Hoewel er de laatste decennia op chirurgisch vlak heel wat vooruitgang is geboekt, 
blijft segmentaal mandibulair botherstel een uitdaging. In het licht hiervan kan 
weefselengineering een volgende stap betekenen in de evolutie van mandibulaire 
reconstructie. Allereerst hebben wij Hoofdstuk 2 (1) systematisch de preklinische 
in vivo en klinische literatuur over botweefselengineering voor mandibulaire 
continuïteitsdefecten bestudeert en (2) vervolgens de doeltreffendheid hiervan 
geanalyseerd. Er werd elektronisch opzoekingswerk verricht met behulp van de 
databanken van de National Library of Medicine en ISI Web of Knowledge. 
Enkel publicaties in het Engels werden in aanmerking genomen en de opzoeking 
werd uitgebreid tot mensen en dieren. Bovendien werden de referentielijsten 
van aanverwante recensieartikelen en publicaties, die geselecteerd werden om in 
deze beoordeling te worden opgenomen, systematisch gescreend. De resultaten 
van histologische gegevens en de hoeveelheid botoverbrugging werden gekozen 
als primaire uitkomstvariabelen. Voor verslagen over mensen werd echter klinisch 
röntgenologisch bewijs aanvaard als een gedefinieerde primaire uitkomstvariabele. 
De biomechanische eigenschappen, de afbraak van de scaffold en de klinische 
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wondheling werden gekozen als co-uitkomstvariabelen. De elektronische opzoeking 
in de databanken van de National Library of Medicine en ISI Web of Knowledge 
leidde tot de identificatie van respectievelijk 6727 en 5017 titels. Uiteindelijk 
resulteerde de beoordeling van de titels en het handmatige zoeken in de inclusief 
van128 samenvattingen, 101 volledige tekstartikelen en 29 wetenschappelijke papers 
die betrekking hadden op dierstudies, en 11 humane studies waar mandibulaire 
continuïteitsdefecten gereconstrueerd weren met gekweekt weefsel. Op basis van 
deze bevindingen werd het volgende geconcludeerd, dat: (1) er zijn slechts beperkte 
gepubliceerde preklinische in vivo en klinische gegevens, en (2) weefselengineering 
toont klinisch potentieel als een alternatief voor autologe bottransplantatie.
Het doel van het onderzoek zoals beschreven in Hoofdstuk 3 was het evalueren 
van de respons van de weke delen op poly(ε-caprolacton) (PCL) implantaten 
met en zonder carbonaatvervangende hydroxyapatiet (CHA) laag in vergelijking 
met de vaak gebruikte machinaal bewerkte titaniumlegering (Ti-6Al-4V). De 
experimentele materialen werden gedurende vijf weken subcutaan geimgeplanteerd 
in Nieuw-Zeelandse witte konijnen. De sterkte van de weefselaanhechting, zoals 
beoordeeld aan de hand van een weefselpeltest,  histologische en histomorfologische 
analyse, en scanning elektronenmicroscopie (SEM), werd vergeleken. De peltest liet 
geen statistisch significant verschil zien tussen de groepen. De histologische analyse 
toonde de vorming van een fibreus kapsel rond alle implantaten aan. Het fibreuze 
kapsel rond de PCL implantaten met en zonder CHA laag was aanzienlijk dunner 
dan het kapsel rond de titaniumimplantaten. Het aantal ontstekingscellen, die op 
het raakvlak van het implantaat met het fibreuze kapsel terug te vinden waren, was 
echter aanzienlijk lager in de Ti-groep. Er kan hieruit geconcludeerd worden dat 
de huidige gegevens niet aantonen dat PCL of PCL met een CHA laag resulteert 
in een betere respons van de weke delen in vergelijking met een machinaal bewerkt 
titaniumimplantaat.
Het onderzoek, zoals gerapporteerd in Hoofdstuk 4, was opgezet om de 
doeltreffendheid te evalueren van een cementloze modulaire mandibulaire 
endoprothese welke voorzien was van een bioactieve deklaag. De studie werd 
uitgevoerd in Macaca fascicularis. De mandibulaire endoprothese werd in 2008 
voor het eerst geïntroduceerd. Ze bestond uit een dik middengedeelte en twee 
dunne stelen die worden samengevoegd en waarvan de stelen in het poreuze bot 
van de resterende botstompen worden ingebracht. Deze stelen worden vastgezet 
met PMMA-cement (polymethylmethacrylaat). In dit proefschrift hebben we 
gebruik gemaakt van eencementloze mandibulaire modulaire endoprothese. 
Deze endoprothese werden gedurende 6 maanden unilateraal geïmplanteerd in 
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mandibulaire segmentale defecten bij 9 apen. Na opoffering werd biomechanisch, 
histologische en micro-CT-analyse uitgevoerd. Zes maanden na de operatie waren de 
mandibulaire omtrek en de aanvankelijke stabiliteit bevredigend. De mechanische 
belastingsproef toonde een gemiddelde stijfheidswaarde van 110,43 N/mm. Uit de 
histomorfologische analyse bleek dat er 61.47% bot contact te zij met de steel van 
de endoprothese. Rondom het implantaat was een fibreus kapsel en trabeculair bot 
aanwezig. Het percentage botvolume berekend op basis van micro-CT rond het 
steeloppervlak bleek groter te zijn dan bij de eerder gerapporteerde gecementeerde 
mandibulaire endoprothese. Bij 6 dieren werd er echter intraorale wonddehiscentie 
aangetroffen. Deze nieuw ontwikkelde cementloze mandibulaire endoprothese is 
bruikbaar in geval van een mandibulaire segmentale reconstructie. In tegenstelling 
tot het vorige model komen de schroeven waarmee de verschillende modules 
met elkaar worden verbonden niet meer los. De weerstand tegen belasting en de 
genezing van de weke delen is echter nog niet optimaal. In toekomstig onderzoek 
moeten niet alleen de endoprothesen zelf verder worden aangepast, maar ook de 
gebruikte chirurgische techniek.
In Hoofdstuk 5 is een onderzoek beschreven waarbij een segmentaal mandibulair 
botdefect werd gereconstrueerd d.m.v. een driedimensionaal ontwikkelde poly(ε-
caprolacton) (PCL) scaffold met een carbonaatvervangende hydroxyapatiet (CHA) 
laag voor het afleveren van osteoinductieve factoren op de plaats van het defect. Het 
onderzoek werd uitgevoerd bij een niet-menselijke primaat, Macaca fascicularis. 
De scaffolds werden bij 24 apen ingeplant in unilaterale chirurgisch gecreëerde 
mandibulaire segmentale defecten. Er werden drie experimentele groepen gevormd: 
(1) scaffolds geladen met rhBMP-2 (n=8), (2) scaffolds geladen met autologe 
beenmergcellen (n=8) en (3) lege scaffolds als controlegroep (n=8). De evaluatie 
was gebaseerd op klinische observatie, en micro-CT-, mechanische en histologische 
analyse. Naast een hoog infectiepercentage toonden de resultaten ook aan dat er 
de ontwikkelde PCL scaffold in onvoldoende mate belasting man weerstaan. Zes 
maanden na de implantatie was er ook nog steeds geen volledige botverbinding. De 
meeste botvorming werd waargenomen in de PCL scaffold welke geladen waren 
met rhBMP-2.
Het laatste onderzoek, beschreven in Hoofdstuk 6, was toegespitst op 
botregeneratie rond een tandimplantaat dat wordt geplaats in een implantaatbed, 
waarvan de botwand deels verdwenen is. De implantaten werden geplaats bij apen, 
waarbij in 8 apen  het botdefect werd gereconstrueerd met autologe botdeeltjes, 
terwijl bij 10 andere apen de experimentele PCL-TCP scaffold werd gebruikt. 
Na 6 maanden werden de apen opgeofferd en de weefselmonsters geanalyseerd 
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door middel van histologie en histomorfometrie. Na 6 maanden waren alle 
implantaten in beide groepen nog steeds aanwezig. In de experimentele groep werd 
opgemerkt dat de de contour van de processus alveolaris werd gehandhaafd, maar 
botregeneratie werd alleen waargenomen in  het gebied dat vlak aan de rand van het 
defect grensde. Het gemiddelde contact tussen bot en implantaat bedroeg 27,6 ± 
19,1 % (controlegroep) versus 6,8 ± 7,9 % (experimentele groep). De gemiddelde 
hoeveelheid bot in het defectgebied bedroeg 11,8 ± 10,1 % (controlegroep) versus 
6,8 ± 6,9 % (experimentele groep). Er werd geconcludeerd dat, hoewel het gebruik 
van een PCL-TCP scaffold een betere handhaving aantoonde van de alveolaire 
contour in vergelijking met autologe botdeeltjes, er slechts sprake was van een 
minimale botregeneratie in het defect.
Slotopmerkingen en Toekomstige Vooruitzichten
Uit de resultaten van dit proefschrift blijkt dat alternatieve methoden voor 
het gebruik van autoloog bot voor orale en maxillofaciale botreconstructie 
veelbelovend zijn, hoewel het ontwerp van de modulaire endoprothese en de weefsel 
engineeringtechnieken op bepaalde vlakken toch wel moeten worden aangepast.
Het metalen cementloze modulaire ontwerp van de endoprothese met bioactieve 
laag die in dit proefschrift wordt besproken voor de reconstructie van mandibulaire 
segmentale defecten is een verbetering van de gecementeerde prothese. Dit 
is gebaseerd op de onderzoeksbevindingen, waarbij meer botcontact met de 
implantaatsteel werd waargenomen en het feit dat het nieuwe mechanisme om de 
verschillende modules vast te zetten het probleem van de loskomende onderdelen 
blijkbaar heeft opgelost. De problemen die zelfs met deze cementloze endoprothese 
blijven bestaan, zijn dehiscentie van de weke delen en een onvoldoende vermogen 
om belasting te weerstaan. Deze problemen kunnen deels te wijten zijn aan het 
gebruik van het huidige proefdiermodel, waarbij intermaxillaire fixatie onmiddellijk 
na de operatie onmogelijk is, maar ook aan het feit dat de apen met hun vingers aan 
de wond zitten, waardoor goede genezing belemmerd kan worden. In toekomstige 
onderzoek dient het gebruik van een ander proefdiermodel, zoals geiten of schapen, 
en een extraorale chirurgische benadering te worden overwogen. Net zoals bij 
tandimplantaten moet ook voor toekomstige experimenten een genezingsperiode 
voor osseo-integratie worden overwogen voordat het cementloze implantaat wordt 
ingebracht. Derhalve dient onderzocht te worden of het mogelijk is dat het stevig 
in elkaar verankeren van de modules kan worden uitgesteld tot een tweede operatie 
verscheidene maanden later. Zo zullen de stelen van het implantaat niet worden 
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belast tijdens de initiële genezingsperiode. Ook de zoektocht naar een ideale 
aanpassing van het oppervlak of coating om de weke delen beter aan het metalen 
oppervlak te laten hechten, moet verder gaan.
Weefsel engineering methoden om eigen bot van de patiënt te kweken, zullen 
ongetwijfeld de ideale oplossing zijn voor botreconstructie. Ook al zijn er heel 
wat succesvolle verslagen van botengineering beschikbaar in in vitro en kleine 
proefdiermodellen, toch zijn er maar weinig verslagen van klinisch succes. De 
minder positieve resultaten bij de klinische gevallen zijn te wijten aan verschillende 
factoren, waaronder een onvoldoende vascularisatie van het implantaat en het 
gekweekte weefsel, een gecompromitteerd zacht weefsel bed en biomechanische 
factoren. 
In dit proefschrift werd botweefselengineering getest voor de regeneratie van 
een klein alveolair defect en van een groot mandibulair segmentaal defect dat 
onderhevig was aan functionele belasting. Uit deze onderzoeken blijkt dat de PCL 
scaffold, ingeplant met TCP of bedekt met een CHA laag, niet osteoinductief is. 
Het ideale scaffold materiaal zou een resorptietijd moeten hebben die overeenstemt 
met de snelheid van nieuwe botingroei. Aangezien de PCL scaffold mogelijk te 
veel tijd nodig heeft om te degraderen, wordt deze door het lichaam gezien als een 
vreemd materiaal, wat aanleiding geeft tot fibreuze afkapseling. Daarom moet er 
onderzoek worden uitgevoerd om de PCL scaffold zodanig aan te passen dat er een 
optimalere resorptietijd ontstaat. 
Voor mandibulaire reconstructie bleek de PCL scaffold in onvoldoende mate 
belasting te kunnen weerstaan. Er was een hoog infectiepercentage en ook kwamen 
de fixatieplaten en de PCL endoprothese kwamen los. Niettemin presteerden de 
PCL scaffolds met BMP-2 beter wat betreft botvorming en mechanische testen 
dan lege PCL scaffolds en scaffolds geladen met autologe BMSC’s. Toch zijn er 
steeds meer verslagen, zoals bijv. Perri et al., 2007, Shah et al., 2008 en Carragee et 
al, 2013, die beschrijven dat het klinische gebruik van BMP-2 voor botregeneratie 
geassocieerd wordt met een enorme zwelling van de weke delen na de operatie, 
ectopische botvorming en mogelijke oncogene effecten. Deze complicaties en ook 
de hoge kostprijs kunnen het routinematige klinische gebruik hiervan dan ook in 
de weg staan. Momenteel heeft het Centre for Devices and Radiological Health 
(CDRH) van de Amerikaanse Food and Drug Administration (FDA) rhBMP-2 
nog niet goedgekeurd voor gebruik bij mandibulaire continuïteitsdefecten en 
daarom dient deze toepassing te worden beschouwd als ‘off-label’.
Er moet dus verder onderzoek worden uitgevoerd zodat botweefsel engineering 
op klinisch vlak nog meer succes behaalt. Voor een groot defect dat een mechanische 
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belasting moet aankunnen zoals de mandibula moet er bijzondere aandacht 
worden besteed aan de evaluatie van de complexe biomechanische krachten. Een 
microvasculaire anastomose kan nog steeds nodig zijn in combinatie met botweefsel 
engineering methodes om een voldoende vascularisatie van de reconstructie te 
bereiken.
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